<!DOCTYPE html>

<html lang="en">


<!doctype html>
<html lang="en" class="no-js">
  <head>
    
      <meta charset="utf-8">
      <meta name="viewport" content="width=device-width,initial-scale=1">
      
      
      
      
        <link rel="prev" href="../Immunology/">
      
      
      
      <link rel="icon" href="../assets/images/favicon.png">
      <meta name="generator" content="mkdocs-1.5.3, mkdocs-material-9.5.12">
    
    
<title>Literature Survey (VPE)</title>

    
      <link rel="stylesheet" href="../assets/stylesheets/main.7e359304.min.css">
      
        
        <link rel="stylesheet" href="../assets/stylesheets/palette.06af60db.min.css">
      
      


    
    
  <!-- Add scripts that need to run before here -->
  <!-- Add jquery script -->
  <script src="https://code.jquery.com/jquery-3.7.1.js"></script>
  <!-- Add data table libraries -->
  <script src="https://cdn.datatables.net/2.0.1/js/dataTables.js"></script>
  <link rel="stylesheet" href="https://cdn.datatables.net/2.0.1/css/dataTables.dataTables.css">
  <!-- Load plotly.js into the DOM -->
	<script src='https://cdn.plot.ly/plotly-2.29.1.min.js'></script>
  <link rel="stylesheet" href="https://cdn.datatables.net/buttons/3.0.1/css/buttons.dataTables.css">
  <!-- fixedColumns -->
  <script src="https://cdn.datatables.net/fixedcolumns/5.0.0/js/dataTables.fixedColumns.js"></script>
  <script src="https://cdn.datatables.net/fixedcolumns/5.0.0/js/fixedColumns.dataTables.js"></script>
  <link rel="stylesheet" href="https://cdn.datatables.net/fixedcolumns/5.0.0/css/fixedColumns.dataTables.css">
  <!-- Already specified in mkdocs.yml -->
  <!-- <link rel="stylesheet" href="../docs/custom.css"> -->
  <script src="https://cdn.datatables.net/buttons/3.0.1/js/dataTables.buttons.js"></script>
  <script src="https://cdn.datatables.net/buttons/3.0.1/js/buttons.dataTables.js"></script>
  <script src="https://cdnjs.cloudflare.com/ajax/libs/jszip/3.10.1/jszip.min.js"></script>
  <script src="https://cdnjs.cloudflare.com/ajax/libs/pdfmake/0.2.7/pdfmake.min.js"></script>
  <script src="https://cdnjs.cloudflare.com/ajax/libs/pdfmake/0.2.7/vfs_fonts.js"></script>
  <script src="https://cdn.datatables.net/buttons/3.0.1/js/buttons.html5.min.js"></script>
  <script src="https://cdn.datatables.net/buttons/3.0.1/js/buttons.print.min.js"></script>
  <!-- Google fonts -->
  <link rel="stylesheet" href="https://fonts.googleapis.com/icon?family=Material+Icons">
  <!-- Intro.js -->
  <script src="https://cdn.jsdelivr.net/npm/intro.js@7.2.0/intro.min.js"></script>
  <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/intro.js@7.2.0/minified/introjs.min.css">


  <!-- 
      
     -->
  <!-- Add scripts that need to run afterwards here -->

    
      
        
        
        <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
        <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto:300,300i,400,400i,700,700i%7CRoboto+Mono:400,400i,700,700i&display=fallback">
        <style>:root{--md-text-font:"Roboto";--md-code-font:"Roboto Mono"}</style>
      
    
    
      <link rel="stylesheet" href="../assets/_mkdocstrings.css">
    
      <link rel="stylesheet" href="../custom.css">
    
    <script>__md_scope=new URL("..",location),__md_hash=e=>[...e].reduce((e,_)=>(e<<5)-e+_.charCodeAt(0),0),__md_get=(e,_=localStorage,t=__md_scope)=>JSON.parse(_.getItem(t.pathname+"."+e)),__md_set=(e,_,t=localStorage,a=__md_scope)=>{try{t.setItem(a.pathname+"."+e,JSON.stringify(_))}catch(e){}}</script>
    
      

    
    
    
  </head>
  
  
    
    
      
    
    
    
    
    <body dir="ltr" data-md-color-scheme="default" data-md-color-primary="white" data-md-color-accent="black">
  
    
    <input class="md-toggle" data-md-toggle="drawer" type="checkbox" id="__drawer" autocomplete="off">
    <input class="md-toggle" data-md-toggle="search" type="checkbox" id="__search" autocomplete="off">
    <label class="md-overlay" for="__drawer"></label>
    <div data-md-component="skip">
      
    </div>
    <div data-md-component="announce">
      
    </div>
    
    
      

<header class="md-header" data-md-component="header">
  <nav class="md-header__inner md-grid" aria-label="Header">
    <a href=".." title="Literature Survey for Swathi" class="md-header__button md-logo" aria-label="Literature Survey for Swathi" data-md-component="logo">
      
  <img src="../assets/VPE.png" alt="logo">

    </a>
    <label class="md-header__button md-icon" for="__drawer">
      
      <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M3 6h18v2H3V6m0 5h18v2H3v-2m0 5h18v2H3v-2Z"/></svg>
    </label>
    <div class="md-header__title" data-md-component="header-title">
      <div class="md-header__ellipsis">
        <div class="md-header__topic">
          <span class="md-ellipsis">
            Literature Survey for Swathi
          </span>
        </div>
        <div class="md-header__topic" data-md-component="header-topic">
          <span class="md-ellipsis">
            
              Oncology
            
          </span>
        </div>
      </div>
    </div>
    
      
        <form class="md-header__option" data-md-component="palette">
  
    
    
    
    <input class="md-option" data-md-color-media="" data-md-color-scheme="default" data-md-color-primary="white" data-md-color-accent="black"  aria-label="Switch to dark mode"  type="radio" name="__palette" id="__palette_0">
    
      <label class="md-header__button md-icon" title="Switch to dark mode" for="__palette_1" hidden>
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M17 6H7c-3.31 0-6 2.69-6 6s2.69 6 6 6h10c3.31 0 6-2.69 6-6s-2.69-6-6-6zm0 10H7c-2.21 0-4-1.79-4-4s1.79-4 4-4h10c2.21 0 4 1.79 4 4s-1.79 4-4 4zM7 9c-1.66 0-3 1.34-3 3s1.34 3 3 3 3-1.34 3-3-1.34-3-3-3z"/></svg>
      </label>
    
  
    
    
    
    <input class="md-option" data-md-color-media="" data-md-color-scheme="slate" data-md-color-primary="white" data-md-color-accent="black"  aria-label="Switch to light mode"  type="radio" name="__palette" id="__palette_1">
    
      <label class="md-header__button md-icon" title="Switch to light mode" for="__palette_0" hidden>
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M17 7H7a5 5 0 0 0-5 5 5 5 0 0 0 5 5h10a5 5 0 0 0 5-5 5 5 0 0 0-5-5m0 8a3 3 0 0 1-3-3 3 3 0 0 1 3-3 3 3 0 0 1 3 3 3 3 0 0 1-3 3Z"/></svg>
      </label>
    
  
</form>
      
    
    
      <script>var media,input,key,value,palette=__md_get("__palette");if(palette&&palette.color){"(prefers-color-scheme)"===palette.color.media&&(media=matchMedia("(prefers-color-scheme: light)"),input=document.querySelector(media.matches?"[data-md-color-media='(prefers-color-scheme: light)']":"[data-md-color-media='(prefers-color-scheme: dark)']"),palette.color.media=input.getAttribute("data-md-color-media"),palette.color.scheme=input.getAttribute("data-md-color-scheme"),palette.color.primary=input.getAttribute("data-md-color-primary"),palette.color.accent=input.getAttribute("data-md-color-accent"));for([key,value]of Object.entries(palette.color))document.body.setAttribute("data-md-color-"+key,value)}</script>
    
    
    
      <label class="md-header__button md-icon" for="__search">
        
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M9.5 3A6.5 6.5 0 0 1 16 9.5c0 1.61-.59 3.09-1.56 4.23l.27.27h.79l5 5-1.5 1.5-5-5v-.79l-.27-.27A6.516 6.516 0 0 1 9.5 16 6.5 6.5 0 0 1 3 9.5 6.5 6.5 0 0 1 9.5 3m0 2C7 5 5 7 5 9.5S7 14 9.5 14 14 12 14 9.5 12 5 9.5 5Z"/></svg>
      </label>
      <div class="md-search" data-md-component="search" role="dialog">
  <label class="md-search__overlay" for="__search"></label>
  <div class="md-search__inner" role="search">
    <form class="md-search__form" name="search">
      <input type="text" class="md-search__input" name="query" aria-label="Search" placeholder="Search" autocapitalize="off" autocorrect="off" autocomplete="off" spellcheck="false" data-md-component="search-query" required>
      <label class="md-search__icon md-icon" for="__search">
        
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M9.5 3A6.5 6.5 0 0 1 16 9.5c0 1.61-.59 3.09-1.56 4.23l.27.27h.79l5 5-1.5 1.5-5-5v-.79l-.27-.27A6.516 6.516 0 0 1 9.5 16 6.5 6.5 0 0 1 3 9.5 6.5 6.5 0 0 1 9.5 3m0 2C7 5 5 7 5 9.5S7 14 9.5 14 14 12 14 9.5 12 5 9.5 5Z"/></svg>
        
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M20 11v2H8l5.5 5.5-1.42 1.42L4.16 12l7.92-7.92L13.5 5.5 8 11h12Z"/></svg>
      </label>
      <nav class="md-search__options" aria-label="Search">
        
        <button type="reset" class="md-search__icon md-icon" title="Clear" aria-label="Clear" tabindex="-1">
          
          <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M19 6.41 17.59 5 12 10.59 6.41 5 5 6.41 10.59 12 5 17.59 6.41 19 12 13.41 17.59 19 19 17.59 13.41 12 19 6.41Z"/></svg>
        </button>
      </nav>
      
    </form>
    <div class="md-search__output">
      <div class="md-search__scrollwrap" data-md-scrollfix>
        <div class="md-search-result" data-md-component="search-result">
          <div class="md-search-result__meta">
            Initializing search
          </div>
          <ol class="md-search-result__list" role="presentation"></ol>
        </div>
      </div>
    </div>
  </div>
</div>
    
    
      <div class="md-header__source">
        <a href="https://github.com/VirtualPatientEngine/literatureSurvey" title="Go to repository" class="md-source" data-md-component="source">
  <div class="md-source__icon md-icon">
    
    <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 496 512"><!--! Font Awesome Free 6.5.1 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2023 Fonticons, Inc.--><path d="M165.9 397.4c0 2-2.3 3.6-5.2 3.6-3.3.3-5.6-1.3-5.6-3.6 0-2 2.3-3.6 5.2-3.6 3-.3 5.6 1.3 5.6 3.6zm-31.1-4.5c-.7 2 1.3 4.3 4.3 4.9 2.6 1 5.6 0 6.2-2s-1.3-4.3-4.3-5.2c-2.6-.7-5.5.3-6.2 2.3zm44.2-1.7c-2.9.7-4.9 2.6-4.6 4.9.3 2 2.9 3.3 5.9 2.6 2.9-.7 4.9-2.6 4.6-4.6-.3-1.9-3-3.2-5.9-2.9zM244.8 8C106.1 8 0 113.3 0 252c0 110.9 69.8 205.8 169.5 239.2 12.8 2.3 17.3-5.6 17.3-12.1 0-6.2-.3-40.4-.3-61.4 0 0-70 15-84.7-29.8 0 0-11.4-29.1-27.8-36.6 0 0-22.9-15.7 1.6-15.4 0 0 24.9 2 38.6 25.8 21.9 38.6 58.6 27.5 72.9 20.9 2.3-16 8.8-27.1 16-33.7-55.9-6.2-112.3-14.3-112.3-110.5 0-27.5 7.6-41.3 23.6-58.9-2.6-6.5-11.1-33.3 2.6-67.9 20.9-6.5 69 27 69 27 20-5.6 41.5-8.5 62.8-8.5s42.8 2.9 62.8 8.5c0 0 48.1-33.6 69-27 13.7 34.7 5.2 61.4 2.6 67.9 16 17.7 25.8 31.5 25.8 58.9 0 96.5-58.9 104.2-114.8 110.5 9.2 7.9 17 22.9 17 46.4 0 33.7-.3 75.4-.3 83.6 0 6.5 4.6 14.4 17.3 12.1C428.2 457.8 496 362.9 496 252 496 113.3 383.5 8 244.8 8zM97.2 352.9c-1.3 1-1 3.3.7 5.2 1.6 1.6 3.9 2.3 5.2 1 1.3-1 1-3.3-.7-5.2-1.6-1.6-3.9-2.3-5.2-1zm-10.8-8.1c-.7 1.3.3 2.9 2.3 3.9 1.6 1 3.6.7 4.3-.7.7-1.3-.3-2.9-2.3-3.9-2-.6-3.6-.3-4.3.7zm32.4 35.6c-1.6 1.3-1 4.3 1.3 6.2 2.3 2.3 5.2 2.6 6.5 1 1.3-1.3.7-4.3-1.3-6.2-2.2-2.3-5.2-2.6-6.5-1zm-11.4-14.7c-1.6 1-1.6 3.6 0 5.9 1.6 2.3 4.3 3.3 5.6 2.3 1.6-1.3 1.6-3.9 0-6.2-1.4-2.3-4-3.3-5.6-2z"/></svg>
  </div>
  <div class="md-source__repository">
    VPE/LiteratureSurvey
  </div>
</a>
      </div>
    
  </nav>
  
</header>
    
    <div class="md-container" data-md-component="container">
      
      
        
          
            
<nav class="md-tabs" aria-label="Tabs" data-md-component="tabs">
  <div class="md-grid">
    <ul class="md-tabs__list">
      
        
  
  
  
    <li class="md-tabs__item">
      <a href=".." class="md-tabs__link">
        
  
    
  
  Home

      </a>
    </li>
  

      
        
  
  
  
    <li class="md-tabs__item">
      <a href="../Immunology/" class="md-tabs__link">
        
  
    
  
  Immunology

      </a>
    </li>
  

      
        
  
  
    
  
  
    <li class="md-tabs__item md-tabs__item--active">
      <a href="./" class="md-tabs__link">
        
  
    
  
  Oncology

      </a>
    </li>
  

      
    </ul>
  </div>
</nav>
          
        
      
      <main class="md-main" data-md-component="main">
        <div class="md-main__inner md-grid">
          
            
              
                
              
              <div class="md-sidebar md-sidebar--primary" data-md-component="sidebar" data-md-type="navigation" hidden>
                <div class="md-sidebar__scrollwrap">
                  <div class="md-sidebar__inner">
                    


  


<nav class="md-nav md-nav--primary md-nav--lifted" aria-label="Navigation" data-md-level="0">
  <label class="md-nav__title" for="__drawer">
    <a href=".." title="Literature Survey for Swathi" class="md-nav__button md-logo" aria-label="Literature Survey for Swathi" data-md-component="logo">
      
  <img src="../assets/VPE.png" alt="logo">

    </a>
    Literature Survey for Swathi
  </label>
  
    <div class="md-nav__source">
      <a href="https://github.com/VirtualPatientEngine/literatureSurvey" title="Go to repository" class="md-source" data-md-component="source">
  <div class="md-source__icon md-icon">
    
    <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 496 512"><!--! Font Awesome Free 6.5.1 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2023 Fonticons, Inc.--><path d="M165.9 397.4c0 2-2.3 3.6-5.2 3.6-3.3.3-5.6-1.3-5.6-3.6 0-2 2.3-3.6 5.2-3.6 3-.3 5.6 1.3 5.6 3.6zm-31.1-4.5c-.7 2 1.3 4.3 4.3 4.9 2.6 1 5.6 0 6.2-2s-1.3-4.3-4.3-5.2c-2.6-.7-5.5.3-6.2 2.3zm44.2-1.7c-2.9.7-4.9 2.6-4.6 4.9.3 2 2.9 3.3 5.9 2.6 2.9-.7 4.9-2.6 4.6-4.6-.3-1.9-3-3.2-5.9-2.9zM244.8 8C106.1 8 0 113.3 0 252c0 110.9 69.8 205.8 169.5 239.2 12.8 2.3 17.3-5.6 17.3-12.1 0-6.2-.3-40.4-.3-61.4 0 0-70 15-84.7-29.8 0 0-11.4-29.1-27.8-36.6 0 0-22.9-15.7 1.6-15.4 0 0 24.9 2 38.6 25.8 21.9 38.6 58.6 27.5 72.9 20.9 2.3-16 8.8-27.1 16-33.7-55.9-6.2-112.3-14.3-112.3-110.5 0-27.5 7.6-41.3 23.6-58.9-2.6-6.5-11.1-33.3 2.6-67.9 20.9-6.5 69 27 69 27 20-5.6 41.5-8.5 62.8-8.5s42.8 2.9 62.8 8.5c0 0 48.1-33.6 69-27 13.7 34.7 5.2 61.4 2.6 67.9 16 17.7 25.8 31.5 25.8 58.9 0 96.5-58.9 104.2-114.8 110.5 9.2 7.9 17 22.9 17 46.4 0 33.7-.3 75.4-.3 83.6 0 6.5 4.6 14.4 17.3 12.1C428.2 457.8 496 362.9 496 252 496 113.3 383.5 8 244.8 8zM97.2 352.9c-1.3 1-1 3.3.7 5.2 1.6 1.6 3.9 2.3 5.2 1 1.3-1 1-3.3-.7-5.2-1.6-1.6-3.9-2.3-5.2-1zm-10.8-8.1c-.7 1.3.3 2.9 2.3 3.9 1.6 1 3.6.7 4.3-.7.7-1.3-.3-2.9-2.3-3.9-2-.6-3.6-.3-4.3.7zm32.4 35.6c-1.6 1.3-1 4.3 1.3 6.2 2.3 2.3 5.2 2.6 6.5 1 1.3-1.3.7-4.3-1.3-6.2-2.2-2.3-5.2-2.6-6.5-1zm-11.4-14.7c-1.6 1-1.6 3.6 0 5.9 1.6 2.3 4.3 3.3 5.6 2.3 1.6-1.3 1.6-3.9 0-6.2-1.4-2.3-4-3.3-5.6-2z"/></svg>
  </div>
  <div class="md-source__repository">
    VPE/LiteratureSurvey
  </div>
</a>
    </div>
  
  <ul class="md-nav__list" data-md-scrollfix>
    
      
      
  
  
  
  
    <li class="md-nav__item">
      <a href=".." class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Home
  </span>
  

      </a>
    </li>
  

    
      
      
  
  
  
  
    <li class="md-nav__item">
      <a href="../Immunology/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Immunology
  </span>
  

      </a>
    </li>
  

    
      
      
  
  
    
  
  
  
    <li class="md-nav__item md-nav__item--active">
      
      <input class="md-nav__toggle md-toggle" type="checkbox" id="__toc">
      
      
      
      <a href="./" class="md-nav__link md-nav__link--active">
        
  
  <span class="md-ellipsis">
    Oncology
  </span>
  

      </a>
      
    </li>
  

    
  </ul>
</nav>
                  </div>
                </div>
              </div>
            
            
              
                
              
              <div class="md-sidebar md-sidebar--secondary" data-md-component="sidebar" data-md-type="toc" >
                <div class="md-sidebar__scrollwrap">
                  <div class="md-sidebar__inner">
                    

<nav class="md-nav md-nav--secondary" aria-label="Table of contents">
  
  
  
  
</nav>
                  </div>
                </div>
              </div>
            
          
          
            <div class="md-content" data-md-component="content">
              <article class="md-content__inner md-typeset">
                
                  

  
  


  <h1>Oncology</h1>

<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8">
</head>

<body>
  <p>
  <i class="footer">This page was last updated on 2025-12-29 09:23:18 UTC</i>
  </p>

  <div class="note info" onclick="startIntro()">
    <p>
      <button type="button" class="buttons">
        <div style="display: flex; align-items: center;">
        Click here for a quick intro of the page! <i class="material-icons">help</i>
        </div>
      </button>
    </p>
  </div>

  <!--
  <div data-intro='Table of contents'>
    <p>
    <h3>Table of Contents</h3>
      <a href="#plot1">1. Citations over time on Oncology</a><br>
      <a href="#manually_curated_articles">2. Manually curated articles on Oncology</a><br>
      <a href="#recommended_articles">3. Recommended articles on Oncology</a><br>
    <p>
  </div>

  <div data-intro='Plot displaying number of citations over time 
                  on the given topic based on recommended articles'>
    <p>
    <h3 id="plot1">1. Citations over time on Oncology</h3>
      <div id='myDiv1'>
      </div>
    </p>
  </div>
  -->

  <div data-intro='Manually curated articles on the given topic'>
    <p>
    <h3 id="manually_curated_articles">Manually curated articles on <i>Oncology</i></h3>
    <table id="table1" class="display" style="width:100%">
    <thead>
      <tr>
          <th data-intro='Click to view the abstract (if available)'>Abstract</th>
          <th>Title</th>
          <th>Authors</th>
          <th>Publication Date</th>
          <th>Journal/ Conference</th>
          <th>Citation count</th>
          <th data-intro='Highest h-index among the authors'>Highest h-index</th>
          <th data-intro='Recommended articles extracted by considering
                          only the given article'>
              View recommendations
              </th>
      </tr>
    </thead>
    <tbody>

        <tr id="Sustained smouldering, or low-grade activation, of myeloid cells is a common hallmark of several chronic neurological diseases, including multiple sclerosis1. Distinct metabolic and mitochondrial features guide the activation and the diverse functional states of myeloid cells2. However, how these metabolic features act to perpetuate inflammation of the central nervous system is unclear. Here, using a multiomics approach, we identify a molecular signature that sustains the activation of microglia through mitochondrial complex I activity driving reverse electron transport and the production of reactive oxygen species. Mechanistically, blocking complex I in pro-inflammatory microglia protects the central nervous system against neurotoxic damage and improves functional outcomes in an animal disease model in vivo. Complex I activity in microglia is a potential therapeutic target to foster neuroprotection in chronic inflammatory disorders of the central nervous system3. Blocking mitochondrial complex I in pro-inflammatory microglia protects the central nervous system against neurotoxic damage and improves functional outcomes in vivo in an animal disease model.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/21fcaf99ddc745b1c9ce7be98fe589c812c89ddf" target='_blank'>
                Mitochondrial complex I activity in microglia sustains neuroinflammation
                </a>
              </td>
          <td>
            L. Peruzzotti-Jametti, C. Willis, G. Krzak, R. Hamel, L. Pirvan, Rosana-Bristena Ionescu, J. Reisz, H. Prag, M. E. Garcia-Segura, V. Wu, Y. Xiang, B. Barlas, A. Casey, A. van den Bosch, A. Nicaise, L. Roth, G. R. Bates, H. Huang, P. Prasad, A. E. Vincent, C. Frezza, C. Viscomi, G. Balmus, Z. Takáts, J. Marioni, A. D'alessandro, M. P. Murphy, I. Mohorianu, S. Pluchino
          </td>
          <td>2024-03-13</td>
          <td>Nature</td>
          <td>135</td>
          <td>31</td>

            <td><a href='../recommendations/21fcaf99ddc745b1c9ce7be98fe589c812c89ddf' target='_blank'>
              <i class="material-icons">open_in_new</i></a>
            </td>

        </tr>

        <tr id="The COVID-19 pandemic is an ongoing global health threat, yet our understanding of the dynamics of early cellular responses to this disease remains limited1. Here in our SARS-CoV-2 human challenge study, we used single-cell multi-omics profiling of nasopharyngeal swabs and blood to temporally resolve abortive, transient and sustained infections in seronegative individuals challenged with pre-Alpha SARS-CoV-2. Our analyses revealed rapid changes in cell-type proportions and dozens of highly dynamic cellular response states in epithelial and immune cells associated with specific time points and infection status. We observed that the interferon response in blood preceded the nasopharyngeal response. Moreover, nasopharyngeal immune infiltration occurred early in samples from individuals with only transient infection and later in samples from individuals with sustained infection. High expression of HLA-DQA2 before inoculation was associated with preventing sustained infection. Ciliated cells showed multiple immune responses and were most permissive for viral replication, whereas nasopharyngeal T cells and macrophages were infected non-productively. We resolved 54 T cell states, including acutely activated T cells that clonally expanded while carrying convergent SARS-CoV-2 motifs. Our new computational pipeline Cell2TCR identifies activated antigen-responding T cells based on a gene expression signature and clusters these into clonotype groups and motifs. Overall, our detailed time series data can serve as a Rosetta stone for epithelial and immune cell responses and reveals early dynamic responses associated with protection against infection. A human SARS-CoV-2 challenge study in individuals without previous exposure to the virus or vaccines provides detailed profiles of local and systemic epithelial and immune cell response dynamics over time and infection status.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/380489b0c6f9106219184f0c5fe6612e0b4e165a" target='_blank'>
                Human SARS-CoV-2 challenge uncovers local and systemic response dynamics
                </a>
              </td>
          <td>
            Rik G. H. Lindeboom, Kaylee B. Worlock, L. Dratva, M. Yoshida, David Scobie, Helen R. Wagstaffe, Laura Richardson, A. Wilbrey-Clark, Josephine L. Barnes, Lorenz Kretschmer, K. Polański, J. Allen-Hyttinen, Puja Mehta, D. Sumanaweera, J. M. Boccacino, W. Sungnak, R. Elmentaite, Ni Huang, L. Mamanova, R. Kapuge, L. Bolt, E. Prigmore, B. Killingley, M. Kalinova, Maria Mayer, A. Boyers, Alex J. Mann, Leo Swadling, M. Woodall, Samuel Ellis, Claire M. Smith, V. Teixeira, Sam M. Janes, R. Chambers, M. Haniffa, A. Catchpole, R. Heyderman, M. Noursadeghi, Benjamin M. Chain, Andreas Mayer, Kerstin B. Meyer, Christopher Chiu, Marko Z. Nikolić, Sarah A. Teichmann
          </td>
          <td>2024-06-19</td>
          <td>Nature</td>
          <td>74</td>
          <td>75</td>

            <td><a href='../recommendations/380489b0c6f9106219184f0c5fe6612e0b4e165a' target='_blank'>
              <i class="material-icons">open_in_new</i></a>
            </td>

        </tr>

    </tbody>
    <tfoot>
      <tr>
          <th>Abstract</th>
          <th>Title</th>
          <th>Authors</th>
          <th>Publication Date</th>
          <th>Journal/ Conference</th>
          <th>Citation count</th>
          <th>Highest h-index</th>
          <th>View recommendations</th>
      </tr>
    </tfoot>
    </table>
    </p>
  </div>

  <div data-intro='Recommended articles extracted by contrasting
                  articles that are relevant against not relevant for Oncology'>
    <p>
    <h3 id="recommended_articles">Recommended articles on <i>Oncology</i></h3>
    <table id="table2" class="display" style="width:100%">
    <thead>
      <tr>
          <th>Abstract</th>
          <th>Title</th>
          <th>Authors</th>
          <th>Publication Date</th>
          <th>Journal/Conference</th>
          <th>Citation count</th>
          <th>Highest h-index</th>
      </tr>
    </thead>
    <tbody>

        <tr id="Severe pneumonia is associated with an increased risk of cognitive decline and dementia, particularly in the elderly. Changes in microglia, the most abundant immune cell population in the brain, are also associated with cognitive decline and dementia, including the emergence of a transcriptional cell state referred to as disease-associated microglia (DAM). We sought to test the hypothesis that non-neuroinvasive influenza A virus (IAV) pneumonia results in transcriptional responses in brain microglia that drive premature expansion of DAM. Using bulk and single-cell RNA-sequencing, metabolomics, and spatial transcriptomics, we profiled neuroimmune populations in young, middle-aged, and old male mice during IAV infection and recovery. We observed an increased abundance of DAM, interferon-responsive microglia (IRM), CD4+ T cells, and CD8+ T cells in white matter regions beginning in middle age and persisting in old animals, irrespective of IAV infection. DAM exhibited a metabolic shift toward aerobic glycolysis with disrupted TCA cycling, citrulline depletion, and an elevated itaconate/α-ketoglutarate ratio. Spatial transcriptomic profiling of the human middle frontal gyrus (MFG) in normal agers, SuperAgers, and patients with dementia revealed an analogous accumulation of DAM and CD8+ T cells in white matter. IAV pneumonia induced a transient immunosenescent-like response in microglia, marked by glucocorticoid-responsive gene expression and Ccnd3 upregulation. In response to IAV pneumonia, DAM expanded in middle-aged mice, whereas old mice were elevated at baseline and were largely unaffected by IAV infection. The age-related expansion of DAM was unaffected by pharmacological depletion and repopulation of microglia with a CSF1R antagonist or genetic gain or loss of function of the phagocytic receptor MERTK, suggesting the DAM phenotype is driven by the CNS microenvironment, rather than cell-intrinsic mechanisms. Our findings suggest that IAV pneumonia induces an acute immunosenescence response in microglia and accelerates the age-dependent expansion of DAM in white matter.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/0fda447848e1da3e24e80cd9f6f09a302a4923b4" target='_blank'>
              Influenza A infection accelerates disease-associated microglia formation during physiological aging
              </a>
            </td>
          <td>
            R. Grant, C. Runyan, Grace Minogue, J. Stoolman, Satoshi Watanabe, Fei Chen, Karolina J. Senkow, L. Cusick, M. Schleck, R. Nafikova, Ziyan Lu, E. Bunyan, H. Abdala-Valencia, Jacob I. Sznajder, Robert J. Vassar, Rudy J Castellani, Changiz Geula, T. Gefen, Navdeep S. Chandel, A. Misharin, G. S. Budinger
          </td>
          <td>2025-12-14</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>45</td>
        </tr>

        <tr id="Aging and cerebrovascular pathology drive neuroinflammation in vascular dementia (VaD) but immune mechanisms underlying this interplay remain unresolved. Leveraging multi-modal high-dimensional imaging, flow cytometry, and split pool ligation transcriptomic sequencing in a mouse model of VaD, we constructed a brain immune cell atlas spanning young and aged mice in health and disease. We profiled microglia, T cells, macrophages, neutrophils, and B cells and integrated transcriptomics, cell-cell communication, multiplex imaging, and comparative analysis with human microglia. We found striking depletion of Ccr7+ naïve T cells and expansion of Gzmk+ cytotoxic Cd8+ effector memory T cells in the aging brain. At the same time, microglia shifted toward a pro-inflammatory state with enhanced activity of major histocompatibility class complex I (MHC-I) to T cell receptor and co-stimulation from CD86 to CD28. These shifts suggest enhanced neuroinflammatory polarization within the aged brain and in VaD. These signals were strongest from activated microglia to Gzmk+ Cd8+ TEM cells, indicating that age-related microglial polarization may sustain cytotoxic T cell activation in the aged brain. Our findings suggest pro-inflammatory microglia and Gzmk+ CD8+ TEM cells are central drivers of immune brain aging and highlights a therapeutic potential to disrupt age-related neuroinflammatory cascades in VaD.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/42ac3a3908e79bc0f916a88d264039358a6730c2" target='_blank'>
              High-Dimensional Single-Cell Analysis Reveals Coordinated Age-Dependent Neuroinflammatory Microglia-T cell Circuits in the Brain
              </a>
            </td>
          <td>
            Md Akkas Ali, Md. Hasanul Banna Siam, Donald Vardaman, Chase Bolding, J. N. Brazell, Ashleigh D. Whatley, Christopher A. Risley, Harrison Tidwell, Syed Nakib Hossain, Juhi Samal, Ashley S. Harms, Mallikarjun Patil, Daniel J. Tyrrell
          </td>
          <td>2025-12-13</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>7</td>
        </tr>

        <tr id="Cytomegalovirus is the leading viral cause of congenital infection with neurological sequelae. Effective medical treatments are limited due to an inadequate understanding of the underlying pathogenesis. Here, we applied single-cell transcriptomics to analyze neonatal mouse brains with congenital cytomegalovirus infection (cCMV). We profiled cCMV in 22 cell types and identified neural progenitor cells (NPCs) and monocyte-derived macrophages (MDMs) as the most commonly infected cells. Infected NPCs exhibited dysregulated neurodevelopment-associated signaling pathways, correlating with viral transcript levels that indicate viral replication levels. Genes associated with phagocytosis and antigen presentation were downregulated exclusively in infected MDMs but remained largely unaffected in microglia and barrier-associated macrophages regardless of infection status. Analysis of intrinsic and induced interferon-stimulated gene expression revealed great heterogeneity across cell types but no direct correlation with cCMV susceptibility. Furthermore, our findings indicate that interferon type II is crucial for the control of cCMV and consequent cortical damage and calcification in the neonatal brain. This study advances our understanding of cCMV tropism and the molecular details of cCMV-induced neurodevelopmental impairment, cerebral immune response, and brain pathology.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/37e868bb50c4bf02ba4bc61b84aaec7d5968b07e" target='_blank'>
              Molecular features of congenital cytomegalovirus infection in neonatal mouse brain at single-cell resolution
              </a>
            </td>
          <td>
            Meng-Jie Mei, Yue-Peng Zhou, Yu-Ting Pan, Jin-yan Sun, Wen-Bo Zeng, Tong Wu, M. McVoy, William J. Britt, Wen Zhou, Bo Yang, Xuan Jiang, Simon Rayner, Han Cheng, Min-Hua Luo
          </td>
          <td>2025-11-17</td>
          <td>Acta Neuropathologica Communications</td>
          <td>0</td>
          <td>34</td>
        </tr>

        <tr id="Aberrant and sustained activation of microglia is implicated in the progression and severity of multiple sclerosis (MS). However, whether intrinsic alterations in microglial function impact the pathogenesis of this disease remains unclear. We conducted transcriptomic and functional analyses of microglia-like cells (iMGLs) differentiated from induced pluripotent stem cells (iPSCs) from patients with MS (pwMS) to answer this question. We generated iPSCs from six pwMS showing increased microglial activity via translocator protein (TSPO)-PET imaging. We demonstrated that the differentiated iMGL transcriptional profile resembled the microglial signature found in MS lesions. Importantly, compared with healthy controls, MS iMGLs presented cell-autonomous differences in their regulation of inflammation, both in the basal state and following inflammatory lipopolysaccharide challenge. Through transcriptomic profiling, we showed that MS iMGLs display increased expression of genes known to be upregulated in MS microglia. Furthermore, upregulated genes in MS iMGLs were associated with immune receptor activation, antigen presentation, and the complement system, with known MS implications. Finally, functional analyses indicated that the transcriptional changes in MS iMGLs corresponded with alterations in the secretion of inflammatory cytokines and chemokines and increased phagocytosis. Together, our results provide evidence of putative cell-autonomous microglial activation in pwMS and identify transcriptomic and functional changes that recapitulate the phenotypes observed in vivo in microglia from pwMS. These findings indicate that MS disease-specific iPSCs are valuable tools for studying disease-specific microglial activation in vitro and highlight microglia as potential therapeutic targets in MS.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/ce483627b1620ca8e2ea90bf499e8cad452ba523" target='_blank'>
              Microglia from patients with multiple sclerosis display a cell-autonomous immune activation state
              </a>
            </td>
          <td>
            Tanja Hyvärinen, J. Lotila, Luca Giudice, Iisa Tujula, M. Nylund, S. Ohtonen, Flavia Scoyni, Henna Jäntti, Sara Pihlava, H. Skottman, Susanna Narkilahti, L. Airas, T. Malm, S. Hagman
          </td>
          <td>2024-12-11</td>
          <td>Journal of Neuroinflammation</td>
          <td>2</td>
          <td>47</td>
        </tr>

        <tr id="Severe SARS-CoV-2 infection is characterized by lung hyperinflammation, impaired interferon responses, and defective T-cell activation, yet the molecular drivers of these immune dysregulations remain incompletely understood. Caspase-11 (CASP11), a key mediator of the non-canonical inflammasome, has been shown to mediate an innate hyperinflammatory response and cytokine release in a non-severe, non-lethal SARS-CoV-2 infection model. However, the role played by CASP11 in severe SARS-CoV-2 disease and how it impacts adaptive immunity is not identified. Here, we newly discover that CASP11 exacerbates severe SARS-CoV-2 pathogenesis by amplifying early innate immune responses while concurrently impairing antiviral CD8 T-cell immunity. Using global knockouts, reciprocal bone marrow chimeras, and phagocyte-monocyte system (PMS) cell-specific CASP11 deletion models, we show that CASP11 deletion in monocyte-derived cells reduces lung inflammation, enhances type I and II interferon signaling, and promotes robust virus-specific effector CD8⁺ T-cell response. This was associated with enhanced viral clearance and improved survival, even under lethal infection conditions. Importantly, CASP11 KO mice also exhibited faster resolution of post-viral inflammation, suggesting a role in long-term immune remodeling. These findings position CASP11 as a promising immunomodulatory target for acute and delayed manifestations of severe SARS-CoV-2.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/fa0d09c722147bd759ef9cedc307b8c6a5fb7718" target='_blank'>
              Caspase-11 Mediated Hyperinflammation Impairs CD8+ T Cell Immunity and Viral Clearance in Severe SARS-CoV-2 Infection
              </a>
            </td>
          <td>
            Mostafa Eltobgy, Mohamed M. Shamseldin, Owen Whitham, Heba M Amer, Jeffery Atkinson, Asmaa Badr, Jesse Hall, Jihad Omran, Gauruv A. Gupta, Yara Hassan, Rabab Abdelaleem, Richard Perez, Sarah Faber, Maciej Pietrzak, Amy Webb, Xiaoli Zhang, A. Kenney, Destiny Bissel, Shady Z K Estfanous, Kylene P. Daily, Andrew Mcnamara, Mahesh Kc, M. Peeples, Emily A. Hemann, Shahid M. Nimjee, E. Cormet-Boyaka, Jianrong Li, P. Boyaka, Jacob S. Yount, Benjamin M. Segal, Purnima Dubey, Amal O Amer
          </td>
          <td>2025-11-03</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>43</td>
        </tr>

        <tr id="Abstract After severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, a minority of patients experience persistent or emerging symptoms, termed ‘long coronavirus disease (COVID)’ or post-acute sequelae of COVID-19. The molecular causes of long COVID remain unclear, but disrupted immune functions, such as inflammation and immune deficit, have been posited as factors. In this retrospective cohort study, we measured markers of immune function in a group of patients with long COVID up to 40 months post infection. As proxies for immune function, we measured serum antibody levels, antibody neutralizing capability and production of IFN gamma (IFN-γ) and IL-2 against SARS-CoV-2 and other viral peptides. As expected, serum antibody levels increased over time with vaccinations and reinfections with later variants of SARS-CoV-2. Patients also showed corresponding increasing SARS-CoV-2-specific IL-2 responses and stable IFN-γ responses. We observed no significant differences in immune responses among patients with ongoing long COVID, those who had recovered from it or individuals who recovered from acute COVID-19. Overall, we found no indication of a reduction in these aspects of immune function after SARS-CoV-2 infection. This study provides a valuable foundation for further research aimed at understanding the causes of long COVID.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/dd9f2a9af816e4527bff007fe6bd487c949ce190" target='_blank'>
              Robust antibody and T cell responses tracked longitudinally in patients with long COVID
              </a>
            </td>
          <td>
            M. Metaxaki, Ranjana Ram, Marianne Perera, Mark Wills, Ben Krishna, N. Sithole
          </td>
          <td>2025-12-01</td>
          <td>The Journal of General Virology</td>
          <td>0</td>
          <td>5</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c559472c33293babdbbd5dda4f528462a56a71a7" target='_blank'>
              Meningeal γδ T cells facilitate bacterial entry into the brain in neonatal meningitis and trigger long-term behavioural sequelae
              </a>
            </td>
          <td>
            Inês Lorga, Joana Soares, Joana Bravo, Pedro Mesquita, Nuno Ribeiro, João Rodrigues, Ahmed Hassan, Morgana Mesquita, Bruno Cavadas, Hristo Georgiev, Ana Magalhães, T. Summavielle, Manuel Vilanova, J. Ribot, Elva Bonifácio Andrade
          </td>
          <td>2025-11-09</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>26</td>
        </tr>

        <tr id="Circadian disruptions perturb the brain and immune system and increase the risk of developing Alzheimer’s Disease (AD), yet whether this involves dysregulation of brain immunity remains less clear. Here, we perform single-cell RNA sequencing of the brain immune compartment around the day-night cycle and identify brain border-associated macrophages (BAMs) as highly rhythmic cells. During the rest phase, we find that BAMs exhibit coordinated upregulation of endocytic genes and enhanced uptake of extracellular fluid-borne material including amyloid-beta (Aβ). Rhythmicity in BAM scavenging is regulated by the clock gene Bmal1, mediated by the endocytic receptor CD206, and perturbed with age. In a mouse model of AD, we show that deletion of Bmal1 in BAMs worsens perivascular and leptomeningeal Aβ plaque burden. Our results identify endocytosis as a specialized and rhythmic BAM function and identify perturbed timing of brain border immune functions as a potential mechanism by which circadian disruptions precipitate amyloidosis.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a0c471e03c2aa28dba89ca368e4c1fb780adb456" target='_blank'>
              The circadian clock regulates scavenging of fluid-borne substrates by brain border-associated macrophages
              </a>
            </td>
          <td>
            Helena J. Barr, Sydney K. Caldwell, Justin M. Reimertz, Constanze Depp, Alec J. Walker, Samuel E. Marsh, Anushree S. Gupte, Maximilian Hingerl, Jasmin Patel, Sang-O Park, Sarah Ferraro, Jonathan Lipton, Beth Stevens
          </td>
          <td>2025-12-11</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infections worldwide, particularly affecting infants, older adults, and immunocompromised individuals. Understanding the cellular immune response to RSV infection is essential for developing effective treatments for infection and its complications. In this study, we investigated the susceptibility of blood-derived primary monocytes and monocytic THP-1 cells to infection with a contemporary RSV A-ON1 strain and characterized the subsequent cytokine and chemokine secretion, as well as the expression of surface markers involved in antigen presentation. Our findings demonstrate that primary monocytes and related THP-1 cells are permissive to abortive infection by RSV, leading to increased expression of proinflammatory cytokines and chemokines, including IP-10, IL-6, and CCL2. Furthermore, primary monocytes expressed CD80, CD86, and HLA-DR upon direct infection or through potential paracrine stimulation. Collectively, these findings demonstrate the activation of monocytes by RSV infection, suggesting their contributory role in orchestrating early immune responses during infection.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e0a13235925d18993e167d01b4f6d405002e8701" target='_blank'>
              A contemporary strain of RSV activates primary human monocytes after abortive infection
              </a>
            </td>
          <td>
            Ayse Agac, M. Ludlow, Marie-Christin Knittler, C. K. Prajeeth, G. Saletti, A. Osterhaus, Robert Meineke, G. Rimmelzwaan
          </td>
          <td>2025-11-07</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>96</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/69df5fd6672a630864c6251428da30e869ad36a2" target='_blank'>
              Neuronal activity promotes repair by microglial reprogramming following demyelination
              </a>
            </td>
          <td>
            C. Perrot, R. Ronzano, Z. Li, M.S. Aigrot, V. Pantazou, P. Stheneur, FX Lejeune, B. Zalc, F. Quintana, B. Stankoff, C. Lubetzki, A. Desmazières
          </td>
          <td>2025-12-02</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>16</td>
        </tr>

        <tr id="


 Caspase 11 is a critical component of the noncanonical inflammasome with multifaceted roles in the innate immune response, contributing to host defense against pathogens. We demonstrated that Casp11 deletion improved disease outcomes in SARS-CoV-2 infection by modulating the innate inflammatory response. However, its role in shaping adaptive immune responses after SARS-CoV-2 infection remains unclear. We found that Casp11-/- MA10 infected mice exhibited higher numbers of activated lung resident memory T cells at Day 7 post-infection compared to wild-type (WT) controls, independent of lung viral load. Ex vivo stimulation of lung-resident T cells with SARS-CoV-2 peptides and tetramer staining revealed that T cells from Casp11-/- mice retained their activation status, antigen specificity, and phenotype. This suggests that Casp11 deletion promotes the expansion and activation of lung resident T cells without impairing their functionality. Using Casp11-/- bone marrow chimera and Casp11-/- Cre-flox mouse models, we identified that the enhanced adaptive immune response was mediated by Casp11 in peripheral immune cells, particularly myeloid cells. These findings indicate that Casp11 deletion leads to a more robust lung-resident adaptive immune response by modulating the early innate immune response. This enhanced adaptive immunity contributed to more effective viral clearance, improved infection control, and reduced progression to severe disease in a P30 severe infection model.



 NIH 1P01AI175399-01A1 NIH 5R01HL168501-02



 Viral Immunology (VIR)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f4123fdbf56086c0c4d68d79c27fddbd6c198d90" target='_blank'>
              Caspase11 modulates the adaptive immune response in SARS-CoV-2 infection through innate immune regulation 4503
              </a>
            </td>
          <td>
            Mostafa Eltobgy, Benjamin Segal, Eugene M. Oltz, Jacob Yount, Shahid M. Nimjee, Purnima Dubey, Amal O Amer
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>10</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/91babd22d3b6b86432a313b4b21fca0bc39e8c82" target='_blank'>
              Single cell RNA sequencing reveals limited effects of Lrrk2 genotype in a mouse model of acute CNS inflammation
              </a>
            </td>
          <td>
            Alice Kaganovich, Liam Horan-Portelance, Natalie Landeck, Dominic J. Acri, Jinhui Ding, R. Langston, Mark R. Cookson
          </td>
          <td>2025-12-22</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>25</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/687800177db6f90a1dee9be6bba3ed7087d04c6e" target='_blank'>
              Oncolytic Reovirus mediates innate-driven SARS-CoV-2 elimination in the absence of cell toxicity
              </a>
            </td>
          <td>
            Samantha Garcia-Cardenas, Gemma Swinscoe, Amy Moran, Liam Barningham, Graham P. Cook, A. Samson, Sam J. Wilson, Michael Malim, Russell Hughes, Stephen Griffin
          </td>
          <td>2025-12-18</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="


 The reasons for varied SARS-CoV-2 transmission risk among infected individuals remain unclear. In this study, we identify cellular immune signatures associated with the speed of viral clearance in individuals with acute SARS-CoV-2 infection. We utilized mass cytometry (CyTOF) on peripheral blood mononuclear cells (PBMCs) from 34 vaccinated and unvaccinated individuals sampled during acute SARS-CoV-2 infection (4-6 days post-symptom onset), with uninfected controls for comparison (n = 5). Amongst unvaccinated participants, greater activation of non-naïve CD8+ T cells, plasmablasts, Th1 CD4+ T cells, and γδ T cells correlated significantly with faster viral clearance (Spearman’s p_adj < 0.05). In addition, coordinated activation between 297 pairs of innate and/or adaptive immune cell features was observed uniquely in infected and not in uninfected individuals (Spearman’s p_adj < 0.05, r > |0.65|). Finally, vaccinated individuals had a cellular immune signature during acute SARS-CoV-2 infection that was similar to uninfected participants, and showed significantly less immune activation across broad cell types (T/B/NK cells and monocytes) compared to unvaccinated individuals with similar duration of viral shedding (p_adj < 0.05, Kruskal-Wallis test). Our findings provide crucial insight into early immune signatures associated with the speed of clearance of infectious SARS-CoV-2 and could inform future vaccine strategies and therapeutic approaches to reduce transmission.



 Supported by the Centers for Disease Control and Prevention Broad Agency Announcement (contract 75D30120C08009)



 Viral Immunology (VIR)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/90fd04a5d1a5966484b843aab431d168630f313d" target='_blank'>
              Cellular immune signatures associated with fast versus slow clearance of infectious SARS-CoV-2 4227
              </a>
            </td>
          <td>
            L. Zemelko, Rafael Tibúrcio, Yen Y. Wang, Christian M. Constantz, G. Borgo, M. Spitzer, K. Anglin, Jeffrey N. Martin, M. Peluso, J. Kelly, A. Deitchman, R. Rutishauser
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>23</td>
        </tr>

        <tr id="SARS-CoV-2 infection is associated with long-lasting neuropsychiatric and cognitive symptoms, collectively referred to as neuro-PASC. Emerging studies indicates that accelerate brain aging and cellular senescence in COVID brain could lead to altered neuroimmune responses and neurodegenerative outcomes. However, little is known about how cellular senescence is development in neuro-PASC. Here, we examined the role of spike protein subunit S1, a persistent viral antigen, in driving the development of cellular senescence in primary human astrocytes. We have demonstrated that S1 enters endolysosomes and induces endolysosome dysfunction and cellular senescence. Moreover, the multibasic motif is critical for such S1-induced damaging effects. Importantly, we identified Toll-like receptor 7 (TLR7), an endolysosome-resident pattern recognition receptor, as a critical mediator of S1-induced damaging effects. Mechanistically, S1 interacts with TLR7 at the site of the endolysosome lumen and activates p38 MAPK signaling of downstream of TLR7, which drive the development of cellular senescence. Together, these findings suggest that TLR7 mediates S1-induced endolysosome dysfunction and cellular senescence, and that TLR7 represents a therapeutic target for mitigating neuro-PASC.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/8ee07e08edc89cce8e4214928941b26b2316b896" target='_blank'>
              SARS-CoV-2 spike triggers TLR7-dependent endolysosome dysfunction and senescence in human astrocytes
              </a>
            </td>
          <td>
            Wendie A. Hasler, Emily McKay, Gaurav Datta, Samantha Johnson, Neda Rezagholizadeh, Xuesong Chen
          </td>
          <td>2025-10-31</td>
          <td>Journal of Neuroinflammation</td>
          <td>0</td>
          <td>12</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/907f1f4b30075c4fd386fadca819b4f5e1e1f8f5" target='_blank'>
              Dysregulation of transcription networks regulating oligodendrogenesis in age-related decline in CNS remyelination
              </a>
            </td>
          <td>
            Penelope Dimas, Samuel Morabito, Khalil S. Rawji, Qing Wang, Fynn N Krause, Juan F. Cubillos, Nejma Belaadi, Peggy Assinck, Zechuan Shi, Zhenkun Cao, Holger Heyn, R. Kawaguchi, Daniel H. Geschwind, Vivek Swarup, Robin J. M. Franklin
          </td>
          <td>2025-11-14</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>41</td>
        </tr>

        <tr id="West Nile virus (WNV) is a mosquito-borne virus that causes severe neurological disease in humans. Despite substantial advances, our knowledge of the mechanisms involved in damaging the human brain is still limited. To address this gap, we developed a physiologically relevant in vitro model using human neuronal/glial cells and aimed to determine WNV tropism, assess whether the virus induces innate immune and inflammatory responses, and elucidate the resulting pathophysiological consequences. We found that WNV productively infected glial cells, whereas neurons exhibited a remarkable and unexpected resistance to infection. Despite the induction of a robust innate immune response mediated by IFN signalling and a rapid control of WNV replication in glial cells, we observed substantial death of astrocytes, oligodendrocytes, and neurons. Analysis of cytokine and chemokine expression further revealed that infection triggered an inflammatory response, potentially contributing to bystander cell death. We also showed that IFN signaling did not contribute to the resistance of neurons and identified IFI6 as an effector of the antiviral response in human glial cells. Together, our results underscore the importance of human neural models for confirming previous findings obtained in less physiologically relevant models and for unravelling novel cellular and molecular mechanisms. Supplementary Information The online version contains supplementary material available at 10.1038/s41598-025-27954-2.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/435c1519049ea8d464c2e723fc442d3c3c80d655" target='_blank'>
              Role of innate immune and inflammatory signaling in West Nile virus tropism and neuronal and glial cell death
              </a>
            </td>
          <td>
            Valentine Chaillot, François Piumi, Kamila Gorna, Noémie Berry, Jennifer Richardson, Alexandra Benchoua, Muriel Coulpier
          </td>
          <td>2025-12-19</td>
          <td>Scientific Reports</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c11565e00df96d730b6130fa5ba4b31516b47635" target='_blank'>
              PI3Kδ promotes T cell effector differentiation and plasticity during chronic infection
              </a>
            </td>
          <td>
            Andrea C. Pichler, J. Cannons, Dominic P. Golec, Julie M. Reilley, Dan Corral, Eduard Ansaldo, Qin Xu, Subrata Paul, Paul Schaughency, Francisco A. Otaizo-Carrasquero, Stacie M. Anderson, Anshu Deewan, Dorian B. McGavern, Pamela L. Schwartzberg
          </td>
          <td>2025-12-23</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>37</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/0a82efc5b2c9cc4922bf6d2b205d9310648f4f84" target='_blank'>
              Single-cell multiomics reveals epigenetic rewiring of splenic memory B cells in murine malaria reinfection
              </a>
            </td>
          <td>
            Montserrat Coronado, Á. Vincelle-Nieto, Isabel G. Azcárate, S. Pérez-Benavente, A. Puyet, Amalia Díez, José M. Bautista, A. Reyes-Palomares
          </td>
          <td>2025-12-16</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>25</td>
        </tr>

        <tr id="Pediatric acute-onset neuropsychiatric syndrome (PANS) is characterized by the sudden onset of obsessive-compulsive symptoms alongside a constellation of neuropsychiatric and somatic features. Disease progression typically includes flare and recovery states, with some patients exhibiting a persistent disease course (> 12 months of flare). We characterized circulating monocyte subsets during flare and recovery in pediatric patients with PANS, uncovering disease-state–dependent shifts in polarization and trafficking phenotypes. Inflammatory M1-like monocytes and monocyte-derived dendritic cells were elevated during flare, while anti-inflammatory M2-like monocytes were enriched in recovery. We also identified a circulating subset with a surface phenotype consistent with central nervous system (CNS) homing, which was reduced during flare and restored in recovery. These cells were detectable in the cerebrospinal fluid (CSF) of new-onset patients but not in persistent cases, suggesting differential compartmentalization during disease progression. Notably, monocyte phenotypes, including M2 polarization (monocytosis) and circulating CNS-homing profiles, exhibited striking sex-associated differences, particularly during recovery, with several subsets enriched in males but not females. Plasma from flare-phase patients modestly induced CNS-homing markers in monocytes from healthy donors, indicating the presence of circulating modulators. Together, these findings support a model in which distinct myeloid phenotypes—including sex-biased patterns—may contribute to both the pathogenesis and resolution of neuroinflammation in PANS.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/ab805830c315ccc3f7c69d468623a69aa039f03c" target='_blank'>
              Sex-associated and disease state-dependent monocyte polarization and CNS-trafficking phenotypes in pediatric acute-onset neuropsychiatric syndrome (PANS)
              </a>
            </td>
          <td>
            Shamma S. Rahman, Noor Hussein, Silvia Giulia Galfrè, Fabian Gaertner, C. Macaubas, Avis L. Chan, Laurie Columbo, Jaynelle Gao, Samira Galehdari, Batuhan Bayram, Meiqian Ma, C. Manko, Kate Miles, B. Farhadian, M. Silverman, M. Thienemann, Noga Or-Geva, Keith Van Haren, Kari C. Nadeau, Lu Tian, Jennifer Frankovich, Elizabeth D. Mellins
          </td>
          <td>2025-11-18</td>
          <td>Journal of Neuroinflammation</td>
          <td>0</td>
          <td>35</td>
        </tr>

        <tr id="Subjects with Long COVID, also known as post-acute sequelae of SARS-CoV-2 infection (PASC), experience a wide range of symptoms, including fatigue and respiratory disturbances, affecting their quality of life. Despite the increasing prevalence of Long COVID, the underlying pathogenic mechanisms remain poorly understood. Extracellular vesicles (EVs) are known to be involved in various processes, such as tissue repair and the transmission of viral particles. However, the specific characteristics and functional roles of EVs derived- from patients with Long COVID (LC-EVs) are poorly characterized. To uncover systemic mechanisms underlying Long COVID, we performed a comprehensive characterization of patient-derived extracellular vesicles (EVs) via Nanoparticle Tracking analysis (NTA), Atomic Force Microscopy (AFM), Transmission Electron Microscope (TEM) and flow cytometry. These EVs were applied to lung cells, Mesenchymal Stem Cell (MSCs), Human Umbilical Vein Endothelial Cells (HUVECs) and Aortic Smooth Muscle Cells (ASMCs), revealing stress responses through SESN1, SESN2, and p53 activation. We further assessed mitochondrial respiration to evaluate metabolic dysfunction, and conducted targeted transfection experiments to dissect the molecular pathways involved, shedding light on EV-driven cellular reprogramming. Thus, we observed that Long COVID (LC) patients experienced breathlessness and leg discomfort during exertion. Our data highlighted that LC-EVs induce aberrant RUNX2 expression and activate the p53/p21 pathway in lung cells as well stress responses. Additionally, LC-EVs impair mitochondrial function and cellular adaptability under metabolic stress, reducing maximal respiration and ATP production at high cell densities. Protein interaction analysis showed RUNX2 involvement in key biological processes and post-transcriptional regulation by hsa-miR-204-5p was identified. Finally, LC-EVs also activated stress pathways and increased RUNX2, SESN, p53, and p21 levels in endothelial cells, aortic smooth muscle cells, and mesenchymal stem cells. In conclusions, these findings provide new insights into the role of extracellular vesicles in Long COVID, revealing their involvement in cellular stress and impaired mitochondrial function.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/4d9f706bfa4303fba5e18198656479afdf7b243a" target='_blank'>
              Extracellular vesicles from long COVID patients promote RUNX2-mediated cellular stress via dysregulated miR-204 and p53 pathway activation
              </a>
            </td>
          <td>
            Luca Dalle Carbonare, Arianna Minoia, Sharazed Zouari, Michele Braggio, M. Cominacini, S. Gaglio, Francesca Cristiana Piritore, Pamela Lorenzi, Mirko Meneghel, Kevin Dervishi, Andrea Corsi, A. Pedrinolla, G. Giuriato, Alessandra Fiore, Adriana Celesia, Laura Guerricchio, M. Venturelli, Federico Schena, M. Donadelli, M. Mottes, Maria Grazia Romanelli, M. Perduca, Daniele Guardavaccaro, Ernesto Crisafulli, D. Zipeto, Lucio Barile, M. Valenti
          </td>
          <td>2025-11-26</td>
          <td>Cell Communication and Signaling : CCS</td>
          <td>0</td>
          <td>29</td>
        </tr>

        <tr id="Abstract Objective Examine the role of T cells in shaping and sustaining humoral immunity to SARS‐CoV‐2 and identify immune factors associated with durable antibody responses. Methods Unvaccinated adults (n = 67) with SARS‐CoV‐2 infection (Wuhan) of any severity were followed longitudinally for up to 14 months. Anti‐Spike (S) binding and neutralising antibodies were measured. Bulk T cell IFNγ and IL‐2 responses were assessed by Fluorospot to multiple viral proteins. S‐specific T‐cell subsets and functions were analysed in detail by flow cytometry in a subset of participants (n = 14), combining activation‐induced markers (AIMs) and cytokines. Correlations between S‐specific T‐cell subsets, their polyfunctionality and antibody levels over time were defined. Results Over 14 months post infection, anti‐S IgG and neutralising antibodies declined significantly but remained detectable in > 85% of participants. Bulk T‐cell IFNγ and IL‐2 responses persisted without significant reduction. However, S‐specific CD4 T cells declined over time. A large proportion of these were peripheral helper T cells (Tph; CXCR5−PD‐1+), which were the main producers of IL‐21 and showed marked polyfunctionality during early convalescence, in contrast to circulating follicular helper T cells (cTfh). The early presence of polyfunctional, IL‐21‐producing Tph strongly correlated with S‐specific IgG and neutralising antibodies early post‐infection and predicted neutralising antibody maintenance a year later. Older age correlated with higher Tph and antibody levels. Conclusion Early S‐specific T‐cell responses—particularly polyfunctional, IL‐21‐producing Tph cells—play a key role in sustaining durable antibody levels post‐infection, offering insights for future vaccine strategies and understanding long‐term immunity.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/63995037b8ae83290f6bb5ffec2deaef5580d4b2" target='_blank'>
              Polyfunctional T peripheral helper cells are associated with the magnitude and durability of antibody responses after COVID‐19
              </a>
            </td>
          <td>
            Katie Tungatt, Gabriela Martins Costa Gomes, Nicole L. Fewings, Aija Stubis, C. Doyle, V. Merheb, A. Aggarwal, K. Byth, Harry Robertson, S. Dervish, Susan Maddocks, Janette Taylor, R. Bull, M. Martinello, F. Brilot, S. Turville, Anthony L. Cunningham, K. Sandgren
          </td>
          <td>2025-01-01</td>
          <td>Clinical & Translational Immunology</td>
          <td>0</td>
          <td>36</td>
        </tr>

        <tr id="The COVID-19 pandemic has left a lasting imprint on immune function, particularly in the elderly—a population already vulnerable to immunosenescence. While acute and long-COVID immune responses have been widely studied, the long-term apoptotic behavior of peripheral blood mononuclear cells (PBMCs) remains underexplored. This study aims to investigate the legacy of SARS-CoV-2 on PBMC apoptosis in elderly individuals during the post-COVID era, shedding light on potential persistent immune dysregulation. In this cross-sectional study, PBMCs were isolated from peripheral blood samples of elderly individuals (> 65 years old) with a documented history of COVID-19 infection at least six months prior. Using multiparametric flow cytometry, we quantified early and late apoptosis markers (Annexin V/PI), mitochondrial membrane potential disruption (ΔΨm), and expression of pro-apoptotic (Bax, Caspase-3) and anti-apoptotic (Bcl-2) proteins. Statistical analyses were performed to assess intergroup differences and correlations with clinical history. This study was conducted in 2025. Elderly post-COVID individuals exhibited a significantly elevated proportion of apoptotic PBMCs compared to controls (p < 0.01), particularly within the CD4 + and CD8 + T-cell subsets. Mitochondrial depolarization and increased Bax/Bcl-2 ratios indicated a shift toward intrinsic apoptotic pathways. Caspase-3 activation was also heightened in the post-COVID group. Notably, apoptotic burden correlated with time since infection and severity of initial illness. Our findings suggest a prolonged apoptotic signature in the immune cells of elderly individuals following recovery from COVID-19. These alterations may reflect a sustained immune exhaustion or maladaptive remodeling of lymphocyte populations, potentially contributing to impaired immunosurveillance and increased vulnerability to secondary infections or chronic inflammatory conditions. COVID-19 may cast a long immunological shadow in the elderly, with persistent PBMC apoptosis representing a novel facet of post-viral immune dysregulation. Flow cytometry reveals a unique apoptotic phenotype that could serve as a biomarker for long-term immune health and guide post-pandemic clinical management strategies for aging populations.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/096a986d262753a585b2bfff92537948a29f8c5b" target='_blank'>
              Investigating apoptosis in peripheral blood mononuclear cells among the elderly in the post-COVID-19 era
              </a>
            </td>
          <td>
            Elaheh Abiri, Najmeh Hemmatian
          </td>
          <td>2025-10-31</td>
          <td>BMC Immunology</td>
          <td>0</td>
          <td>1</td>
        </tr>

        <tr id="Background Ischemic stroke remains a leading cause of mortality and disability worldwide. Microglia, the resident immune cells of the central nervous system, perform critical roles in immune surveillance, debris clearance, and tissue repair. Analyzing the heterogeneity, activation trajectories, and metabolic states of microglia in ischemic stroke is essential for discovering therapeutic targets. Methods We performed single-cell RNA sequencing (scRNA-seq) on brains from ischemic and control rats and identified transcriptionally distinct microglial subpopulations. We conducted differential expression, pathway enrichment, pseudotime analysis, regulatory network inference, and cell-cell communication mapping to characterize functional states, key transcription factors, and intercellular crosstalk underlying microglial responses following cerebral ischemia-reperfusion injury. We used Real-Time Quantitative PCR (RT-qPCR), Western blot, and immunohistochemistry to measure relative RNA and protein expression levels. Results We identified seven microglial subclusters with distinct transcriptional signatures. Ischemia-associated clusters exhibited strong activation of inflammatory pathways, increased glycolysis and lipid metabolism, and suppressed TCA cycle and oxidative phosphorylation (OXPHOS), reflecting a shift toward proinflammatory, energy-demanding phenotypes. Pseudotime analysis revealed transitions from homeostatic to pathological states, highlighting potential therapeutic windows. Regulatory network analysis identified activating transcription factor 3 (ATF3) as a central regulator controlling the expression of cholesterol 25-hydroxylase (CH25H) and secreted phosphoprotein 1 (SPP1). Notably, ATF3 overexpression enhanced CH25H expression and selectively increased proinflammatory cytokine production, linking metabolic reprogramming to neuroinflammatory responses. Cell-cell communication analysis further revealed extensive remodeling of interactions with astrocytes, endothelial cells, and fibroblasts, potentially amplifying postischemic neuroinflammation. Conclusion Our study demonstrates that cerebral ischemia induces transcriptionally and functionally distinct microglial subpopulations, characterized by metabolic reprogramming and proinflammatory activation. ATF3 serves as a central regulator linking CH25H-mediated metabolic changes to cytokine-driven neuroinflammation, highlighting potential therapeutic targets for modulating microglial responses and mitigating ischemia-induced brain injury.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/21c20effa3ad945d21b01c8ec4f5a72133113a12" target='_blank'>
              Single-Cell RNA Sequencing Reveals Microglial Heterogeneity and Functional States After Cerebral Ischemia-Reperfusion Injury
              </a>
            </td>
          <td>
            Yu-jing Tang, Qi Zhang, Yewei Qu, Lian Yi, Fangqin Li, Changda Qu, Shanshan Shi, Byron Fei Pan, Shirong Wen, Ruohan Sun, Yujun Pan
          </td>
          <td>2025-12-01</td>
          <td>Journal of Inflammation Research</td>
          <td>0</td>
          <td>5</td>
        </tr>

        <tr id="Gastrointestinal (GI) dysfunction, characterized by severe diarrhea and dehydration, is a central contributor to morbidity and mortality in filovirus disease in patients, yet the role of the epithelium in this clinical outcome remains poorly defined. Here, we employ induced pluripotent stem cell (iPSC)-derived human intestinal (HIOs) and colonic organoids (HCOs) to model Ebola virus (EBOV) and Marburg virus (MARV) infection. These organoids are permissive to filovirus infection and support viral replication. Bulk RNA sequencing revealed distinct intestinal and colonic epithelial responses, including apical and junctional disruption and a delayed virus-specific induction of interferon-stimulated genes. Moreover, infection impaired adenylate cyclase signaling and CFTR-mediated ion transport, providing mechanistic insight into virus-induced secretory diarrhea. This platform recapitulates key features of human GI pathology in filoviral disease and serves as a powerful system to dissect host-pathogen interactions and identify therapeutic targets.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c68db2f80b5b3b83a6105b9d72af121706a4d306" target='_blank'>
              Filovirus infection disrupts epithelial barrier function and ion transport in human iPSC-derived gut organoids
              </a>
            </td>
          <td>
            Elizabeth Y. Flores, A. Hume, J. Olejnik, A. Mithal, Andrew D’Amico, Mengwei Yang, P. Bawa, Feiya Wang, A. O’Connell, Anna E. Tseng, Nicholas A. Crossland, Gustavo Mostoslavsky, Elke Mühlberger
          </td>
          <td>2025-11-01</td>
          <td>PLOS Pathogens</td>
          <td>0</td>
          <td>25</td>
        </tr>

        <tr id="Ischemic stroke remains a major global health burden. Enterococcus, which is enriched in the gut of stroke patients, produces cytolysin—a pore-forming toxin that disrupts cell membranes. Gut barrier damage may allow such toxins to enter circulation and impair the blood–brain barrier (BBB). In this study, cytolysin-induced BBB disruption via NLRP3 inflammasome activation was investigated with the aim of identifying new therapeutic targets for stroke. Ischemic stroke patients were enrolled within 48 h of onset at the First Affiliated Hospital of Wenzhou Medical University. Rectal swabs were collected for 16 S rRNA sequencing and analyzed via QIIME. To investigate the effects of cytolysin-positive Enterococcus on BBB integrity and NLRP3 activation, a photothrombotic stroke model in C57BL/6J mice and in vitro studies with bEnd.3 cells were performed. Cerebral blood flow, BBB permeability, and intestinal barrier function were assessed using established physiological and molecular assays. NLRP3 pathway activation was evaluated by RNA sequencing, qPCR, Western blotting, and ELISA, and its functional role was further confirmed by administration of the selective NLRP3 inhibitor MCC950. Statistical significance was defined as p < 0.05. In a cohort of 100 stroke patients, rectal swabs were collected for 16 S rRNA sequencing and qPCR analysis, and the results identified elevated Enterococcus and cylA gene levels as potential prognostic biomarkers for 360-day mortality. In a photothrombotic stroke mouse model, cytolysin-positive Enterococcus exacerbated stroke severity by increasing BBB permeability. Mechanistically, cytolysin activated nucleotide-binding oligomerization domain-like receptor family pyrin domain containing 3 (NLRP3) inflammasome-mediated pyroptosis, further compromising BBB integrity. Additionally, cytolysin disrupted the intestinal barrier, increased permeability, and may facilitate its entry into the circulation, potentially contributing to BBB damage. Notably, NLRP3 inhibition with MCC950 mitigated neurological deficits and restored BBB integrity. Cytolysin aggravates ischemic stroke by compromising the BBB via NLRP3 activation and disrupting the intestinal barrier. Targeting cytolysin and NLRP3 holds promise as a therapeutic strategy for neuroprotection during ischemic stroke.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/0929108221c5d405f33957997e4f47cde50477fb" target='_blank'>
              Enterococcus-derived cytolysin exacerbates ischemic stroke by disrupting the blood–brain barrier via NLRP3 activation
              </a>
            </td>
          <td>
            Jia-ni Huang, Wei-hao Zhuang, Yi-si Lin, Jia-Xue Xu, Yan-lei Zhang, Jia Li, Meng Huang, Cheng-long Xie, Ruo-ting Xu
          </td>
          <td>2025-11-11</td>
          <td>Journal of Neuroinflammation</td>
          <td>0</td>
          <td>1</td>
        </tr>

        <tr id="There is a subgroup of people infected with the SARS-CoV-2 virus who manifest lingering sequelae (LongC), with neurological symptoms (nLongC). We recruited 86 COVID-19 volunteers, 35 of whom were fully recovered (Cov) and 51 who had neurological symptoms (nLongC) 4–53 months after infection and compared them to 51 healthy pre-pandemic controls (HC). Thirty-five percent of nLongC individuals carried the apolipoprotein E4 (APOE4) gene, compared to 11% of Cov. Four plasma proteins, interleukin 1 beta (IL-1β), interleukin 8 (IL-8), glial fibrillary acidic protein (GFAP), and hemopexin, continued to be elevated in both Cov and nLongC compared to HC. Soluble CD14 was elevated in nLongC but not Cov. As a group, IL-1β decreased over time in Cov but not nLongC. Two of the elevated proteins, IL-8 and GFAP, correlated with age, with both Cov and nLongC showing higher levels than HC. Using a combination of four plasma proteins, along with age, body mass index, and APOE4 presence, we were able to achieve an area under the curve (AUC) of 0.81. These results suggest that SARS-CoV-2 infection causes a low-grade inflammatory process that, even months or years after infection, does not return to pre-COVID-19 levels, which may contribute to neurologic sequelae and accelerated aging.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/d6dc097b9097119d707ae7261b40c50b96e52a07" target='_blank'>
              Chronic Inflammation and Altered Immune Responses in LongCOVID Associate with Neurological Manifestations and Accelerated Aging
              </a>
            </td>
          <td>
            Norina Tang, Judith M. Ford, Kaitlyn Dal Bon, Lynn Pulliam
          </td>
          <td>2025-11-26</td>
          <td>Cells</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="The COVID-19 pandemic, which began in 2019 due to SARS-CoV-2, remains a global health crisis, especially as new variants emerge that could trigger widespread outbreaks again. While various aspects of SARS-CoV-2 infection warrant attention, the antiviral innate immune response is a crucial area of focus. Understanding how viruses evade host defenses is vital for developing effective vaccines and therapies. SARS-CoV-2 targets key components of the innate immune system for its survival, and this interference with the host immune system is central to the virus's ability to cause disease. However, the specific mechanisms by which the innate immune response counteracts SARS-CoV-2 infection have not been fully clarified. This review examines key elements of the antiviral innate immune response to SARS-CoV-2 infection, concentrating on viral evasion strategies and potential therapeutic targets.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/2283fdb7927a9966d77a4f3f180d82163d69d72b" target='_blank'>
              Host’s innate immune response to SARS-CoV-2 infection—Current understanding and trends
              </a>
            </td>
          <td>
            Nitin Saksena
          </td>
          <td>2025-11-08</td>
          <td>Journal of Cellular and Molecular Immunology</td>
          <td>0</td>
          <td>0</td>
        </tr>

        <tr id="The mechanisms by which Enterovirus D68 (EV-D68) infection leads to acute flaccid myelitis (AFM), a severe neurological condition characterized by sudden muscle weakness and paralysis, remain poorly understood. To investigate the cellular tropism and infection dynamics of EV-D68, we profiled naive and EV-D68-infected human spinal cord organoids (hSCOs) derived from induced pluripotent stem cells (iPSCs) using single-cell RNA sequencing (scRNA-seq). Examining the cellular composition of healthy hSCOs, we found that hSCOs include diverse cell types, including neurons, astrocytes, oligodendrocyte progenitor cells (OPCs), and multipotent glial progenitor cells (mGPCs). Upon infection with 2 EV-D68 strains, US/IL/14-18952 (a B2 strain) and US/MA/18-23089 (a B3 strain), we observed distinct viral tropism and host transcriptional responses. Notably, US/IL/14-18952 showed a significant preference for neurons, while US/MA/18-23089 exhibited higher rates of infection in cycling astrocytes and OPCs. These findings provide novel insights into the host cell tropism of EV-D68 in the spinal cord, offering insight into the potential mechanisms underlying AFM pathogenesis. Understanding the dynamics of infection at single-cell resolution will inform future therapeutic strategies aimed at mitigating the neurological impact of enterovirus infections.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/fb54cf51aa995a2705a7d71cb812e43393ceb04a" target='_blank'>
              Strain-specific tropism and transcriptional responses of enterovirus D68 infection in human spinal cord organoids
              </a>
            </td>
          <td>
            Nathânia Dábilla, Sarah Maya, Colton McNinch, Taylor Eddens, Patrick T. Dolan, M. Freeman
          </td>
          <td>2025-11-19</td>
          <td>Frontiers in Microbiology</td>
          <td>0</td>
          <td>5</td>
        </tr>

        <tr id="ABSTRACT Understanding the protective mechanism of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines against severe COVID is important for therapeutic development to mitigate disease-associated lung pathologies. Here, we investigated the association between vaccination and the disease severity with a particular emphasis on viral-induced pulmonary fibrin formation in 43 COVID individuals. While COVID vaccination reduced the disease severity in this cohort, their plasma coagulation indices, including prothrombin time (PT), partial thromboplastin time (PTT), and D-dimer concentrations, remain unchanged between the vaccinated and non-vaccinated individuals. In contrast, vaccination lowered pulmonary inflammatory and coagulation signatures, reduced fibrinogen concentrations, and prevented prothrombin activation in bronchoalveolar lavage fluid (BALF), such that no viral-induced fibrin was observed in the vaccinated BALF. The formation of viral-induced fibrin correlated with the disease severity and was observed in non-vaccinated BALF samples containing high concentrations of fibrinogen and prothrombin, suggesting vaccination protected against the viral-induced pulmonary fibrin formation. Our finding highlights the use of pulmonary rather than plasma fibrinogen levels as a risk indicator for severe COVID disease. IMPORTANCE Understanding the protective mechanism of COVID-19 vaccines against the severity of the disease is important for therapeutic development, and thus, subject to intense investigation. Here, we studied a cohort of 43 COVID patients based on their vaccination status. We showed that (i) COVID disease severity is associated with the formation of SARS-CoV-2-induced pulmonary fibrin, (ii) vaccination protected against severe COVID disease by reducing infiltration of coagulants, preventing prothrombin activation and fibrin deposition in infected lungs, and (iii) plasma coagulation indices are not useful indicators for fibrin deposition in infected lungs. Rather, the level of pulmonary fibrinogen provides an informative indicator for COVID-associated coagulation in lung. Understanding the protective mechanism of COVID-19 vaccines against the severity of the disease is important for therapeutic development, and thus, subject to intense investigation. Here, we studied a cohort of 43 COVID patients based on their vaccination status. We showed that (i) COVID disease severity is associated with the formation of SARS-CoV-2-induced pulmonary fibrin, (ii) vaccination protected against severe COVID disease by reducing infiltration of coagulants, preventing prothrombin activation and fibrin deposition in infected lungs, and (iii) plasma coagulation indices are not useful indicators for fibrin deposition in infected lungs. Rather, the level of pulmonary fibrinogen provides an informative indicator for COVID-associated coagulation in lung.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/27118e0d8c7e391446d9e4844b490cabe504b043" target='_blank'>
              Vaccination protects against COVID-associated pulmonary fibrin deposition
              </a>
            </td>
          <td>
            Joanna Ireland, David Myers, Chang Huang, Cameron Allen, Gwynne Roth, Zhongcheng Zou, Ming Zhao, Motoshi Suzuki, Lisa Olano, Joshua Tan, Shreya Kanth, J.A. Huapaya, Homer Twigg, A. Suffredini, Peter D Sun
          </td>
          <td>2025-11-01</td>
          <td>Journal of Virology</td>
          <td>0</td>
          <td>64</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/561fc69832beac4c1e41655e3f435bfb03fefa41" target='_blank'>
              Oncogene c-Myc Regulates Upper Respiratory Epithelial Repair for Host Immunity During Acute Influenza Infection
              </a>
            </td>
          <td>
            Alexander G. Foote, Le Xu, J. Verheyden, Belle Pan, Nikita Katoch, Xin Sun
          </td>
          <td>2025-12-23</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>4</td>
        </tr>

        <tr id="Dogs play a major role in sustaining transmission of Leishmania infantum to people, thus prevention and treatment of canine leishmaniosis (CanL) to reduce transmission represents an unmet public health need. Although advances have been made in understanding how immunopathology correlates to infectiousness as CanL progresses, the immune mechanisms underlying transition between disease stages and terminal decline remain ill-defined. To address this knowledge gap, we generated a comprehensive atlas of peripheral immune cells from control dogs and naturally-infected dogs using single-cell RNA sequencing. The LeishDog Atlas captures the cellular and transcriptional complexity underlying CanL, tracing shifts in immune composition and gene expression across progressive, well-defined disease stages. Notably, we identified distinct myeloid, CD4+ and CD8+ T cell phenotypes and transcriptional states associated with disease progression. This resource provides a valuable framework for understanding systemic immune dysregulation in CanL, including determinants of T cell exhaustion and myeloid cell activation, and establishes a foundation for comparative, translational, and mechanistic studies of CanL immunopathology and transmissibility.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/8412687f28e64e4d6b2558529c494e2ee4440eca" target='_blank'>
              A single-cell transcriptomic atlas of peripheral blood immune cells spanning progressive canine leishmaniosis
              </a>
            </td>
          <td>
            Danielle P. Uhl, Daniel J. Holbrook, Max C Waugh, S. Dey, Najmeeyah Brown, Karen I. Cyndari, Jacob J. Oleson, Paul M. Kaye, Christine A. Petersen
          </td>
          <td>2025-12-21</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>22</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/679a7b822ce567d8ac2ac1c2ea01dd417c348cfe" target='_blank'>
              The SARS-CoV-2 nucleocapsid protein induces microglia senescence-mediated cognitive impairment via Glycolysis.
              </a>
            </td>
          <td>
            Nan-Shi-Yu Yang, Han-Xi Sha, Chen-Yu Zhang, Hui Chen, Yu-Biao Liu, Jian-Bing Xiong, J. Duan, Jun Zhang, Cha-Xiang Guan, Yong Zhou, Feng Su, W. Zhong
          </td>
          <td>2025-12-12</td>
          <td>Molecular medicine</td>
          <td>0</td>
          <td>21</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/739f6e063b8b00cadccca089e149426560e106a8" target='_blank'>
              Characterization of the African Swine Fever Virus transcriptome and the associated innate immune response reveals key features of virulence
              </a>
            </td>
          <td>
            Aurélien Leroy, J. Dupré, Chloé Styranec, Pauline Barbarin, Théo Ferré, Vanaïque Guillory, Isabelle Fleurot, Marie-Frédérique Le Potier, O. Bourry, Julien Pichon, Sascha Trapp, G. Caignard, Ignacio Caballero, Ferdinand Roesch
          </td>
          <td>2025-10-31</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>18</td>
        </tr>

        <tr id="


 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a single-stranded positive sense RNA virus that is responsible for the COVID-19 pandemic. While most patients can mount proper immune responses to control the viral infection, a small percentage of the population develop severe disease symptoms which results in dysregulated immune activation that leads to injury of the lung and other organs. Severe COVID-19 patients have an increased recruitment and accumulation of CCR10+ antibody-secreting plasma cells (IgA-ASCs) in the lungs compared to healthy and mild patients, suggesting a role of CCR10-regulated mucosal IgA responses in SARS-CoV-2 infection. CCR10 is a chemokine receptor that can regulate localization and maintenance of IgA-ASCs through interaction with its ligand CCL28, which is highly expressed in mucosal tissues. We investigated how CCR10-regulated mucosal IgA responses are involved in clearance of SARS-CoV-2 viral infection versus immunopathological development using CCR10-knockout (KO) mice. Compared to CCR10-sufficent mice, SARS-CoV-2 infected CCR10-KO mice developed more severe lung pathology associated with impaired localization of IgA+ plasma cells and reduced antigen-specific IgA responses in lungs. On the hand, CCR10-KO mice were still able to control SARS-CoV-2 infections. Our findings revealed a primary role of CCR10-regulated mucosal IgA responses in protection against over-active immune pathological damage to the lung by the viral infection.



 Supported by NIH R21 AI169430; R01 AI174181-01A1S1



 Mucosal and Regional Immunology (MUC)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/5b36d2329f917c0cde84acfcdf02e5a273326d7a" target='_blank'>
              Roles of CCR10-regulated mucosal IgA responses in lung SARS-CoV-2 infection clearance and pathogenesis 3261
              </a>
            </td>
          <td>
            Juan Garcia, Na Xiong
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>1</td>
        </tr>

        <tr id="Peripheral immune cell infiltration plays a key role in the excessive intracranial inflammatory response during sepsis, contributing to cognitive dysfunction and increased mortality. This study aims to elucidate the immune inflammatory status of hippocampal tissue in septic mice, providing potential targets for treatment and prevention. Male C57BL/6J mice underwent cecal ligation and puncture (CLP) or sham surgery. Twenty‐four hours post‐surgery, hippocampal tissues were harvested for transcriptome sequencing and immunofluorescence analysis. Immune cell infiltration was assessed using the xCell package, and structural changes in brain microvessels were evaluated by transmission electron microscopy. Flow cytometry and immunofluorescence confirmed immune cell presence in the hippocampus. Hub genes related to immune responses were identified using protein–protein interaction networks, weighted gene co‐expression network analysis, and enrichment analysis of immune‐related biological processes. In CLP mice, microvessel endothelial cells were separated, with swelling and damage to tight junctions. Significant infiltration of myeloid immune cells, including dendritic cells, monocytes and neutrophils, was observed in the hippocampus. Seven immune‐related hub genes (Fcer1g, Fcgr2b, Fcgr3, Icam1, Itgb2, Ptprc and Slc11a1) play a pivotal role in mediating immune responses. Fcer1g, Fcgr2b and Slc11a1 were positively correlated with monocytes and neutrophils, suggesting their involvement in the recruitment of immune cells to the brain. This study enhances our understanding of peripheral immune cell infiltration in sepsis and provides novel insights into potential therapeutic targets for sepsis‐associated encephalopathy.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/245a88b1e684b6e2b4373d4be2ee46cd6cf621de" target='_blank'>
              Peripheral Immune Cell Infiltration in the Hippocampus of Sepsis Mice
              </a>
            </td>
          <td>
            Hui Zhang, Meixian Zhang, Yanan Gao, Qian Chen, Qiang Liu, Fanbing Meng, Xiaoxiao Sun, Miaomiao Fei, Cheng Li, Lize Xiong
          </td>
          <td>2025-10-31</td>
          <td>Journal of Cellular and Molecular Medicine</td>
          <td>0</td>
          <td>4</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/8a1eeb94ba00b3791cf49e1ba52939a4a9de01a3" target='_blank'>
              Sickness engrams modulate anticipatory immune responses
              </a>
            </td>
          <td>
            A. Douglas, Andrea Muñoz Zamora, Paul B. Conway, Esteban Urrieta, Lydia Lynch, T. Ryan
          </td>
          <td>2025-11-05</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>7</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/ebd7c1c95a72fa42446be74525f1dfe8c58ae064" target='_blank'>
              Decoding acute neuroinflammatory states from the 3D architecture of in vitro microglia
              </a>
            </td>
          <td>
            Anthoula Chatzimpinou, Johanna Huber, Xenia Podlipensky, J. Cairns, Ayse Erozan, Jian-Hua Chen, V. Loconte, M. Le Gros, Carsten Hopf, Carolyn A. Larabell, V. Weinhardt
          </td>
          <td>2025-12-22</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>29</td>
        </tr>

        <tr id="Aging is a major risk factor for increased morbidity and mortality following acute respiratory virus infections. To elucidate the immune determinants underlying viral pathogenesis and delayed lung repair in the aged lung, a comprehensive time-course study was conducted. Single-cell RNA sequencing (scRNAseq) and high-dimensional flow cytometry were utilized to compare lungs from young and aged mice infected with influenza A virus (IAV). Aged hosts displayed diminished alveolar macrophage (AM) and dendritic cell (DC) but elevated monocyte-derived macrophage (MoM) and interstitial macrophage (IM) presence following infection. Additionally, enhanced accumulation of adaptive immune cells, including CD4+ tissue-resident helper (TRH) cells, CD8+ tissue-resident memory (TRM) cells, and a B cell subset resembling age-associated B cells, was observed in the memory phase. Pathway analysis revealed that elevated type I and II interferon (IFNα/γ) signaling, especially in MoM/IM subsets, distinguished the aged hosts from the young. Inhibition of IFNα/γ signaling after viral clearance improved long-term respiratory outcomes and reduced both IM and TRH populations in aged mice. These findings highlight the pivotal role of IFNα/γ signaling, likely within MoM/IM subsets, in driving the exuberant persistence of adaptive immune cells and chronic immunopathology in the aged lung following acute viral infection.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/79fbb4abcb1eeb6127549b886296b47a4c3b2fa0" target='_blank'>
              Temporal single-cell analysis reveals age-associated delay in immune resolution after respiratory viral infection
              </a>
            </td>
          <td>
            Yue Wu, Chaofan Li, Jinyi Tang, Xiaochen Gao, I. Cheon, Bibo Zhu, Ruixuan Zhang, C. Fain, S. Hu, H. Narasimhan, Gislane de Almeida Santos, K. Ayasoufi, , Hui Zong, Chongzhi Zang, Haidong Dong, Jie Sun
          </td>
          <td>2025-12-17</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>27</td>
        </tr>

        <tr id="Background Human T-lymphotropic virus type 1 (HTLV-1) infects up to ten million people worldwide, and causes severe diseases, including adult T-cell leukemia/lymphoma and HTLV-1–associated myelopathy/tropical spastic paraparesis (HAM/TSP). Individuals with HAM/TSP are prone to pulmonary complications (e.g., bronchiectasis). Their bronchoalveolar lavage fluid typically shows increased levels of inflammatory cytokines, chemokines and cell adhesion molecules contributing to chronic inflammation. Results This study assessed the impact of HTLV-1 infection on lung inflammation by analyzing the alveolar transcriptome of A549 epithelial cells following exposure to HTLV-1. Co-culture with HTLV-1-infected MT-2 cells caused transcriptomic changes related to viral response, NF-κB activation, and inflammation. RT-qPCR confirmed elevated expression of the chemokine monocyte chemotactic protein-1 (MCP-1/CCL2) and colony stimulating factor 1 (CSF-1) in A549 MT-2 co-cultures. Increased CSF-1 expression was mechanistically linked to NF-κB signaling, using CRISPR/Cas9 RELA knockout. Supernatant from A549 MT-2 co-cultures triggered chemotaxis and macrophage differentiation of THP-1 and primary monocytes. Systems biology analysis revealed enrichment in pathways associated with monocyte infiltration and bronchiectasis. Finally, we validate the in vivo relevance of our in vitro model through multi-cohort multi-omics analysis combining bulk and single-cell transcriptomics, viral interactomics and multi-ancestry GWAS. Conclusions We describe an in vitro co-culture model that recapitulates HTLV-1-triggered lung inflammation, through RELA/NF-kB-dependent release of pro-inflammatory cytokines and chemokines resulting in monocyte chemotaxis, activation and differentiation. Integrated multi-omics analysis confirmed the in vivo relevance of our in vitro model.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f2fcc915bbd12bb88b05e375c5c2d91f60fb7f15" target='_blank'>
              Deciphering HTLV-1-associated Lung Pathology through Integrated in vitro and Multi-cohort Multi-omics Analysis: Inflammation, Monocyte Recruitment and Differentiation Triggered by HTLV-1-exposed Alveolar Epithelial Cells
              </a>
            </td>
          <td>
            Clément J F Heymann, M. Gouwy, Robin Hermans, J. Twizere, Tatiana Assone, J. Casseb, Isaac Racine, Isabelle Cleynen, Edward L. Murphy, Roberta Bruhn, Dominique Schols, E. Vanderlinden, J. V. Weyenbergh
          </td>
          <td>2025-11-24</td>
          <td>Research Square</td>
          <td>0</td>
          <td>36</td>
        </tr>

        <tr id="ABSTRACT Long-term non-progressors (LTNPs) represent a valuable model to investigate immunological features associated with non-progression in chronic HIV infection. In this study, single-cell RNA sequencing was performed on peripheral blood mononuclear cells obtained from 12 individuals, including 4 LTNPs, 4 typical progressors (TPs), and 4 healthy donors (HDs). Compared with TPs, LTNPs exhibited a higher percentage of naive T cells, whereas TPs showed a higher percentage of CD8+ Effector-GNLY cells. LTNPs also exhibited lower gene-expression scores related to T-cell activation, cytotoxicity, inflammation, and interferon-alpha response across multiple effector-state T-cell subsets. GO enrichment analysis showed that compared with HDs and TPs, LTNPs exhibited downregulation of migration, translation, and antiviral response pathways in both CD4+ and CD8+ T cells, with upregulation of stress/inflammatory response and differentiation programs in CD4+ T cells and of immune differentiation/activation pathways in CD8+ T cells. High-dimensional weighted gene co-expression network analysis (hdWGCNA) further revealed higher module eigengene expression of innate and myeloid-related modules and lower expression of B-cell and cytotoxicity-related modules in LTNPs compared with TPs. Additionally, HIV-1 RNA+ cells were detected more frequently in TPs than in LTNPs and predominantly identified within CD4+ T cells. Together, these findings reveal a transcriptionally balanced and favorable immunological profile associated with non-progressive HIV infection and inform the design of immune-based strategies toward a functional HIV cure. IMPORTANCE Understanding molecular traits associated with natural control in LTNPs is critical for advancing HIV remission and cure strategies. Using single-cell RNA sequencing, we found that LTNPs had more naive T cells and fewer CD8+ effector-GNLY cells than typical progressors, along with lower activation, cytotoxicity, inflammation, and IFN-α scores across effector-state T-cell subsets. Differential expression and GO analyses showed predominant downregulation of migration, translation, and antiviral pathways, while preserving early activation markers. Co-expression network analysis revealed higher innate/immune-regulatory module activity and lower B-cell and cytotoxicity modules in LTNPs. HIV-1 RNA+ cells were detected less frequently in LTNPs and mainly detected in CD4+ T cells. These findings highlight balanced immune programs in LTNPs, which may inform strategies toward a functional HIV cure. Understanding molecular traits associated with natural control in LTNPs is critical for advancing HIV remission and cure strategies. Using single-cell RNA sequencing, we found that LTNPs had more naive T cells and fewer CD8+ effector-GNLY cells than typical progressors, along with lower activation, cytotoxicity, inflammation, and IFN-α scores across effector-state T-cell subsets. Differential expression and GO analyses showed predominant downregulation of migration, translation, and antiviral pathways, while preserving early activation markers. Co-expression network analysis revealed higher innate/immune-regulatory module activity and lower B-cell and cytotoxicity modules in LTNPs. HIV-1 RNA+ cells were detected less frequently in LTNPs and mainly detected in CD4+ T cells. These findings highlight balanced immune programs in LTNPs, which may inform strategies toward a functional HIV cure.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a6171a97ed7fcf5c1b6659f49943539558df22b4" target='_blank'>
              Single-cell transcriptome profiling reveals immunological fitness of HIV long-term non-progressors
              </a>
            </td>
          <td>
            Minjuan Shi, Rongfeng Chen, Tongjin Wu, Yu Liao, Tongxue Qin, Ziyu Wen, Junqi Liu, Xiu Chen, Beibei Lu, Chunxing Yi, Li Ye, Hao Liang, Caijun Sun, Junjun Jiang
          </td>
          <td>2025-11-24</td>
          <td>Journal of Virology</td>
          <td>0</td>
          <td>12</td>
        </tr>

        <tr id="Cytotoxic T cell (CTL) dysfunction is a hallmark of immune paralysis after major surgery, increasing susceptibility to severe nosocomial infections and contributing to mortality in critically ill patients. The mechanisms remain poorly understood. We demonstrate that reactive oxygen species (ROS) released by myeloid-derived suppressor cells (MDSC) transiently emerging after surgery, drive perioperative CTL immunoparalysis. These ROS damage CTL mitochondria, triggering secondary mitochondrial ROS amplification and overwhelming antioxidant defenses. The resulting oxidative cascade impairs oxidative phosphorylation and suppresses CTL effector function. Concurrently, stress-induced mitochondrial hyperfusion disrupts fission-dependent translocation to the immunological synapse, exacerbating bioenergetic failure. MitoTEMPO, a mitochondria-targeted antioxidant, partially mitigates these effects, highlighting mitochondrial stabilization as a potential strategy to prevent perioperative immune dysfunction. Major surgery is associated with transient suppression of T-cell immunity, increasing susceptibility to severe infections. This study identifies a previously unrecognized mechanism that drives cytotoxic T lymphocyte (CTL) suppression in the postoperative period. Postoperative oxidative stress is primarily generated by Myeloid-Derived Suppressor Cells (MDSC) and exceeds the antioxidant capacity of CTL, resulting in mitochondrial damage. This dysfunction leads to excessive ROS production, stress-induced mitochondrial hyperfusion, impaired ATP generation, and reduced CTL effector function. CTL mitochondrial function and immune competence are restored by mitochondria-targeted antioxidant therapy. Postoperative oxidative stress is primarily generated by Myeloid-Derived Suppressor Cells (MDSC) and exceeds the antioxidant capacity of CTL, resulting in mitochondrial damage. This dysfunction leads to excessive ROS production, stress-induced mitochondrial hyperfusion, impaired ATP generation, and reduced CTL effector function. CTL mitochondrial function and immune competence are restored by mitochondria-targeted antioxidant therapy. Major surgery is associated with transient suppression of T-cell immunity, increasing susceptibility to severe infections. This study identifies a previously unrecognized mechanism that drives cytotoxic T lymphocyte (CTL) suppression in the postoperative period.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/4ecfd94a6acc8bae59497180259a7eb1030fe58a" target='_blank'>
              Mitochondrial damage drives T-cell immunometabolic paralysis after major surgery
              </a>
            </td>
          <td>
            S. Hirschberger, Martin B Müller, Hannah Mascolo, Melissa Seitz, Stefan Nibler, David Effinger, Kun Lu, Joscha Büch, Martin Bender, Tobias Kammerer, Sven Peterß, K. Kleigrewe, Miriam Abele, Teresa Barth, Olga Kushnir, A. Imhof, Steffen Dietzel, Bernd Wegener, Ralf Sowa, Frank Vogel, Peter Lamm, Roland Tomasi, Kristian Unger, M. Sperandio, Erich Kilger, Simone Kreth, Max Hübner
          </td>
          <td>2025-11-03</td>
          <td>EMBO Molecular Medicine</td>
          <td>0</td>
          <td>11</td>
        </tr>

        <tr id="Enterovirus D68 (EV-D68) is a significant global pathogen associated with severe respiratory infections and acute flaccid myelitis in children. Currently, there are no vaccines or antiviral drugs available for EV-D68, and a robust model to elucidate the pathogenesis of EV-D68 and evaluate treatment methods is lacking. We developed a mouse-adapted EV-D68 strain that caused progressive limb paralysis after intramuscular inoculation in 7-day-old mice. Viral load analysis showed that the skeletal muscle and spinal cord had the highest titers and most severe injuries. RNA sequencing of the infected muscle, brain, spinal cord, and lung tissues revealed differentially expressed genes (DEGs) associated with viral infection and pathogenesis. DEGs were significantly enriched in various pathways associated with antiviral immunity, interferon responses, and cytokine signaling. In the spinal cord, DEGs highlighted mitochondrial dysfunction and oxidative stress as crucial contributors to neural damage. Flow cytometry analysis of spinal cord cells showed that EV-D68 activates the immune system, leading to systemic inflammation and significant increases in CD8+ and CD4+ T cells, but limited neutrophil and monocyte infiltration. This mouse model provides a valuable tool for studying EV-D68 pathogenesis and evaluating antiviral and vaccine efficacy, thereby advancing the understanding of its neuropathological mechanisms. Importance: We developed a novel mouse model of EV-D68 that provides a valuable tool for studying its pathogenesis and evaluating antiviral and vaccine efficacy, deepening the understanding of its neuropathological basis.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/ec65cdb91c340614db24a50d4f78be18da8803ac" target='_blank'>
              Spinal Cord Injury in Enterovirus D68 Infection: Mechanisms and Pathophysiology in a Mouse Model
              </a>
            </td>
          <td>
            Wei Duan, Jichen Li, Ying Liu, Rui Wang, Qian Yang, Huijie Li, Yucai Liang, Qi Shi, Jiao Wang, Jinbo Xiao, Jianfang Zhou, Qiang Sun, Yong Zhang
          </td>
          <td>2025-11-01</td>
          <td>Viruses</td>
          <td>0</td>
          <td>10</td>
        </tr>

        <tr id="Viruses, like influenza and Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), remain major causes of upper respiratory tract infections worldwide, with symptoms ranging from asymptomatic to lethal outcomes. While antivirals and vaccines have helped ameliorate disease morbidity and mortality, these infections still pose significant challenges. Probiotics, including Lactococcus lactis strain plasma (LC-Plasma), have recently shown antiviral effects by activating plasmacytoid dendritic cells (pDCs), though their detailed mechanism remains unclear. In this study, we stimulated peripheral blood mononuclear cells (PBMCs) collected from healthy participants with LC-Plasma and conducted immunological analyses to investigate the immunomodulatory mechanisms of LC-Plasma. The supernatant derived from LC-Plasma-stimulated PBMCs (LCP Sup) exhibited dose-dependent inhibition of replication in Influenza A virus subtype H1N1 (H1N1) and SARS-CoV-2. LCP Sup significantly reduced the SARS-CoV-2 viral load in Huh-7 cells. However, in the H1N1 antiviral assay using A549 cells, LCP Sup was required at a higher concentration against H1N1 in A549 cells compared with SARS-CoV-2 in Huh-7 cells. Treatment with LCP Sup significantly upregulated interferon-stimulated genes (ISG) expression, particularly MxA, in A549 cells. While MxA showed the most notable increase, other ISGs also exhibited elevated expression levels compared with the negative control. Other cytokines, chemokines, and growth factors were also induced by LC-Plasma and CpG-DNA stimulation, and the effects of LC-Plasma were much higher than those of CpG-DNA. These results provide in vitro evidence of the antiviral mechanisms of LC-Plasma via upregulation of interferon-α (IFN-α) and related ISGs for host defense against respiratory viruses.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/54c1e93f06d05aceebdf2e0d94bd475aa2743cdf" target='_blank'>
              Stimulation of Peripheral Blood Mononuclear Cells with Lactococcus lactis Strain Plasma Elicits Antiviral Effects Against H1N1 and SARS-CoV-2
              </a>
            </td>
          <td>
            Zhao Xuan Low, Owen Woo, Osamu Kanauchi, P. Hassandarvish, V. Tiong, Sazaly AbuBakar
          </td>
          <td>2025-11-28</td>
          <td>International Journal of Molecular Sciences</td>
          <td>0</td>
          <td>33</td>
        </tr>

        <tr id="Early immune perturbations increase the risk of neurodegenerative and neurodevelopmental disorders, yet the mechanisms underlying the maturation of microglia, the resident immune cells of the brain parenchyma, remain poorly defined. Specifically, how proliferation, morphological differentiation, and phagocytosis are coordinated among microglia progenitors as they colonize the embryonic brain remains unclear. Here, we combined mathematical modeling with spatiotemporal analyses of the murine hippocampus and cerebellum from postnatal day 2 (P2) to P60 to reconstruct the trajectory of microglial development. We identified a proliferative-to-quiescent (P/Q) switch around P3/P4 that preceded the acquisition of morphological complexity and efficient phagocytosis and was accompanied by coordinated shifts in cell-cycle dynamics and metabolic state. Strikingly, this P/Q switch was recapitulated in repopulation contexts in mice and in the human fetal brain, where later stages displayed enhanced phagocytic function coupled to reduced proliferation. Perturbing the proliferative phase through pharmacological or genetic disruption of CSF1R signaling impaired subsequent microglial complexity and phagocytosis efficiency, revealing an unexpected reliance of phagocytosis on proliferation-driven colonization. Finally, we show that microglia stepwise maturation during development is associated with chromatin remodeling and driven by the epigenetic regulator Ikaros. Together, these findings uncover the sequential milestones of microglial development, revealing a potential period of early vulnerability and establishing an unexpected linkage between proliferation and phagocytosis essential to understanding how these processes are coordinated in neurodegenerative disorders.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/bb674fe85695033b3a066007d0322414981ac69f" target='_blank'>
              Epigenetic control of microglial developmental milestones from proliferative progenitors to efficient phagocytes
              </a>
            </td>
          <td>
            Marta Pereira-Iglesias, Duncan Martinson, Carles Falcó, Joel Maldonado-Teixidó, Marco González-Domínguez, Rodrigo Senovilla-Ganzo, S. Beccari, Jorge Valero, Bella Mora-Romero, I. Ballasch, Sarah Viguier, Philipp Hane, Molly Boettiger, J. Reisz, Alba Elías-Tersa, Yasmina Manso, L. Parkkinen, A. M. Aransay, Federico N. Soria, A. D'alessandro, Eduardo Soriano, M. S. Thion, S. Garel, M. Greter, A. Giralt, Alberto Pascual, Fernando García-Moreno, D. Menassa, José A. Carrillo, Amanda Sierra
          </td>
          <td>2025-11-04</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>49</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f3f466a8b6bbef99c55e8bb31d40feefddd8931f" target='_blank'>
              Tuberculous meningitis alters the proteomic landscape of brain-derived extracellular vesicles
              </a>
            </td>
          <td>
            Blanca V. Rodriguez, Nerketa N. L. Damiba, Nicole Beaubien, Daisy Puca, D. B. Foster, Samarjit Das, Elizabeth W. Tucker
          </td>
          <td>2025-12-08</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>1</td>
        </tr>

        <tr id="Abstract Background Postacute sequelae of SARS-CoV-2 infection, also known as long COVID (LC), is a complex and heterogenous condition affecting millions worldwide with a poorly understood underlying pathology. Although metabolic dysregulations have been described in LC, it remains unclear whether circulating immune cells exhibit immunometabolic alterations. Methods We conducted a detailed clinical, immunologic, and mitochondrial analysis on 27 patients with LC and 27 who recovered from COVID-19 and were healthy. Symptom burden and severity were assessed and quantified via a digital platform with the modified COVID-19 Yorkshire Rehabilitation Scale. Mitochondrial function of circulating immune cell populations (lymphocytes and monocytes) was analyzed by measuring mitochondrial mass and mitochondrial membrane potential. Production of 11 cytokines after whole blood stimulation with bacterial and viral agonists was measured by multiplex immunoassay. Relationships between mitochondrial and immune parameters with LC symptoms were investigated. Results Patients with LC exhibited significant symptom burden, with worsening across all symptom domains as compared with their health state before SARS-CoV-2 infection. They also had a decreased mitochondrial membrane potential of CD56bright natural killer cells, particularly in patients experiencing dizziness, whereas reduced mitochondrial membrane potential in CD4+ lymphocytes was found in patients with worsening breathlessness. Upon LPS stimulation, patients with LC demonstrated significantly lower IFN-γ production. In response to viral ligand R848, impaired IFN-β and IL-10 responses were associated with worsening cough and executive functions. Conclusions Symptom severity in LC is associated with immune cell mitochondrial dysfunction and altered cytokine responses, highlighting potential disease biomarkers and targets for future therapeutic strategies.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/0904ca34a4e483fad93aba4e12dab5090971f617" target='_blank'>
              Digitally Assessed Long COVID Symptomatology Is Associated With Lymphocyte Mitochondrial Dysfunction and Altered Immune Potential
              </a>
            </td>
          <td>
            Vasile Mihai Sularea, L. Townsend, Cian Reid, Andreea V Atanasescu, A. Dyer, F. Giangrazi, R. Lawrence, Manoj Sivan, Barry Moran, Derek G Doherty, Niall P Conlon, A. Long, Cliona O’Farrelly
          </td>
          <td>2025-11-01</td>
          <td>Open Forum Infectious Diseases</td>
          <td>0</td>
          <td>23</td>
        </tr>

        <tr id="Introduction Despite extensive research, the pathogenesis and predispositions underlying long COVID (long-term coronavirus disease 2019) remain poorly understood. Methods To address this, we analyzed the immunological landscapes of 44 patients with long COVID and 44 matched convalescents using single-cell RNA sequencing (scRNA-seq) of peripheral blood mononuclear cells (PBMCs) and validated the findings with plasma cytokine measurements via Luminex technology. Results While the immune cell compositions showed minimal quantitative differences only among natural killer (NK) cells, the transcriptome analyses identified distinct gene expression patterns, particularly in classical monocytes: patients with long COVID exhibited downregulation of the inflammation-associated genes, including IL1B and CXCL2. Imputation of the transcription factor activity hinted at a reduced inflammasome activity (via SNAI1) and an impaired monocyte differentiation (via ATF2) in long COVID. The RNA velocity data supported the presence of immature classical monocytes in these patients. Discussion These findings show that monocytes might be dysregulated and/or exhausted in patients with long COVID.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/3892a0439deb222191d646b042b2e39ae2bf0fef" target='_blank'>
              Transcriptome analysis of classical blood cells reveals downregulation of pro-inflammatory genes in the classical monocytes of long COVID patients
              </a>
            </td>
          <td>
            Florian Fricke, Franz Mai, Christine Wossidlo, Felix Steinbeck, Wendy Bergmann-Ewert, Marcel Kordt, Karin Kraft, Britta Müller, Emil C. Reisinger, Brigitte Müller-Hilke
          </td>
          <td>2025-11-07</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f06caba0f4cc503c8b0aa1aadbc7d5f878826110" target='_blank'>
              GPR34 regulation of disease-associated microglial states and responses to physiological stimuli
              </a>
            </td>
          <td>
            Ana Geller, Min Jee Kwon, Sean K Simmons, Qihong Xu, William E. Martenis, Jordan L. Doman, Sahana Natarajan, Katherine J. Stalnaker, Jixiang Zhang, Xian Adiconis, Trang Nguyen, Matthew Demers, Donovan L. Batzli, Antia Valle-Tojeiro, Christy Biji, Sameer Aryal, Horia Pribiag, Constanze Depp, Nader Morshed, Deeksha Misri, Diana Bohannon, Elena Longhi, Hasmik Keshishian, Steven A. Carr, David McKinney, Alexandra E.Gould, Evan P Lebois, M. Weïwer, Matthew Johnson, Joshua Z. Levin, Yan-Ling Zhang, Morgan Sheng, Prabhat S. Kunwar
          </td>
          <td>2025-12-01</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>38</td>
        </tr>

        <tr id="


 SARS-CoV2 infection is uniquely characterized by the sudden onset of anosmia and dysgeusia in many individuals. While most recover, a subset continues to experience persistent symptoms known as long-COVID, with 30% reporting dysgeusia. In our long-COVID cohort, objective testing revealed significant distortion in the perception of bitter and sweet tastes. Although polymorphisms in TAS2R38 and gustin genes are linked to bitter taste perception, haplotype analysis in our long-COVID cohort was inconclusive. We hypothesized that a disrupted homeostasis between taste cell loss and replenishment due to chronic inflammation leads to dysgeusia. Single cell transcriptomic analysis revealed cellular heterogeneity including epithelial cells (such as KRT14, KRT15, SPRR3), cells exhibiting neuronal markers (such as SNAP25, SNAP47, KCNQ2) suggestive of taste receptor cells and immune cells in saliva. However, differences in marker expressions between the long-COVID and healthy cohort were not significant except for inflammatory chemokine and interleukin genes. Immunofluorescence and flow cytometry confirmed the presence of epithelial cells, taste receptor like cells and immune cells in saliva. Elevated proinflammatory cytokine expression in saliva indicated persistent localized inflammatory immune response. Collectively these findings suggest that persistent epithelial-neuro-immune response locally in the tongue following SARS-CoV2 infection contributes to the dysgeusia in long-COVID.



 DENTAL RESEARCH FOUNDATION #44-76-254



 Innate Immune Responses and Host Defense: Molecular Mechanisms (INM)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/605d94a3b6b43a60bc2e61018169ec477647406c" target='_blank'>
              Epithelial-neuro-immune dynamics in dysgeusia triggered by chronic viral infection 3795
              </a>
            </td>
          <td>
            Shveta Jaishankar, David Schaeper, S. Janga, Mythily Srinivasan
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>39</td>
        </tr>

        <tr id="Clinical observations suggest that obstructive sleep apnea (OSA) and Alzheimer’s disease (AD) pathology may be linked; however, causal mechanisms and relationships are unclear. To investigate the potential interaction between amyloidosis and intermittent hypoxia (IH), a hallmark of OSA, starting at 4 months of age 5XFAD mice were exposed to chronic IH (CIH) consisting of 20 episodes per hour of hypoxia for 12 h/day, daily for 4 months (males) or 6 months (females). CIH did not induce significant changes in amyloid burden or the number of astrocytes in males or females, but there was a slight decrease in the number of microglia observed in the cortex of 5XFAD mice of both sexes. To further explore this effect, we performed bulk RNA sequencing on isolated microglia. In WT mice, the most robust gene changes induced by CIH were identified in male microglia, many of which were pro-inflammatory. In microglia from 5XFAD mice, compared to normoxia (NX), CIH exposure induced comparatively more DEGs in males. Further, in genes that were upregulated by CIH in WT vs 5XFAD mice of both sexes, there was an enrichment of pathways associated with oxidative phosphorylation, aerobic and cellular respiration, and ATP synthesis. These changes indicate that CIH has a more robust effect on the microglial transcriptome in 5XFAD mice than in WT mice, suggesting that the synergy between AD and OSA pathologies may be driven by metabolic changes in the microglial transcriptome. These observations are particularly interesting given the known sex differences in OSA and AD pathology in human disease.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/8727e54e7992921c8779ef401d96df0e163a6576" target='_blank'>
              Chronic Intermittent Hypoxia Exposure Induces a Unique Microglial Transcriptome in 5XFAD Mice
              </a>
            </td>
          <td>
            Kaitlyn M. Marino, Andrea C. Ewald, Jaidynne N. Lash, Erin C. McCann, Shibani Ram, Phinea Z. Romero, Tao Wang, Abby Watters, A. Radcliff, Daniel C. Shippy, Tracy L. Baker, Tyler K. Ulland, Jyoti J. Watters
          </td>
          <td>2025-11-19</td>
          <td>Molecular Neurobiology</td>
          <td>1</td>
          <td>16</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/5d5581192995f28d24b781c1e7c2e69bf2aa53d8" target='_blank'>
              Systems Immunology of Long Covid: Insights from the STOP-PASC Clinical Trial
              </a>
            </td>
          <td>
            E. Maestri, W. J. Kwon, H. Zheng, T. Prestwood, H. Hedlin, J. W. Liang, H. McCann, B. Shaw, L. Tian, B. Jones, R. Lu, G. Wiley, E. Haraguchi, O. Wirz, J. Afaghani, B. Lam, D. F. D. Mahmood, N. A. Phillips, M. M. S. Sim, J. P. Wood, J. R. Heath, S. D. Boyd, J. Guthridge, U. Singh, H. Bonilla, P. Jagannathan, P. Utz, L. Geng, P. Khatri
          </td>
          <td>2025-12-05</td>
          <td>None</td>
          <td>0</td>
          <td>61</td>
        </tr>

        <tr id="Despite effective viral suppression with antiretroviral therapy (ART), people living with HIV (PLWH) experience persistent inflammation, immune dysfunction, and premature onset of cardiovascular and aging-related comorbidities. To define the underlying mechanisms, we performed longitudinal transcriptomic profiling in peripheral blood mononuclear cells (PBMCs) from a cohort of simian immunodeficiency virus (SIV)-infected rhesus macaques spanning four key stages: pre-infection, acute infection, short-term ART, and long-term ART. Bulk RNA sequencing revealed dynamic immune remodeling across infection and treatment. Acute SIV infection induced robust antiviral and inflammatory programs, with upregulation of interferon-stimulated genes (ISGs), IL-27, JAK/STAT, and NF-κB signaling, coupled with suppression of T- and B-cell activation pathways. Short-term ART effectively reversed these transcriptional perturbations, restoring adaptive immune gene expression and reducing innate antiviral responses to near-baseline levels. In contrast, chronic SIV infection on long-term ART maintained viral suppression but was characterized by reactivation of innate immune pathways, including TLR2/TLR4/MYD88, NF-κB, and inflammasome (NLRP3/or NLRP12, caspase-1) signaling, along with sustained macrophage activation, platelet/coagulation signaling, and senescence-associated secretory phenotype. Protein analyses confirmed persistent CASPASE-1 and NF-κB activation in spleen tissue. Pathologic evaluation of a carotid artery from an SIV-infected, long-term ART– treated macaque revealed macrophage-rich plaques with p21⁺ senescent cells with intraluminal thrombus formation, recapitulating key features of HIV-associated atherogenesis. Together, these findings demonstrate that while ART normalizes acute infection–induced immune dysregulation, chronic SIV infection sustains a chronic, macrophage- and TLR-driven inflammatory state linked to vascular injury and aging process regardless of long-term suppression of viremia. Targeting inflammasome, NF-κB, and senescence pathways may mitigate non-AIDS comorbidities in PLWH.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c7a8f96a2324d1327914a92bba9009e04dbf070e" target='_blank'>
              Persistent Activation of Monocytes/Macrophages and Cell Senescence in SIV-Infected Macaques on ART
              </a>
            </td>
          <td>
            Yilin Chen, Xiaofeng Ding, Sonalika Ray, Siva Thirugnanam, Robert V. Blair, Ahmad Saied, S. Sukhanov, J. Kolls, Woong-ki Kim, P. Delafontaine, Jay Rappaport, Xuebin Qin, Namita Rout
          </td>
          <td>2025-11-06</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>46</td>
        </tr>

        <tr id="Organ transplant recipients are at high risk of developing chronic infection when exposed to hepatitis E virus (HEV), which can rapidly progress to liver fibrosis and cirrhosis. Macrophages play a key role in the response to the infection and disease progression. However, the interactions amongst immunosuppressants, macrophages, the course of HEV infection and activation of inflammatory response remain unclear. In this study, we generated M0, M1 and M2 macrophages from the human THP‐1 cell line. These macrophages were then infected with HEV and treated with different immunosuppressants. We visualised viral infection using laser confocal microscopy, and quantitatively analysed viral replication and inflammatory responses by bulk sequencing, RT‐qPCR, ELISA and Western blotting. We found that the M1 inflammatory macrophages exhibited the highest, while M2 macrophages had the lowest levels of viral RNA. Genome‐wide transcriptome analysis indicated that viral, inflammation and immunity‐related pathways were predominantly upregulated by HEV infection. Dexamethasone exerted potent inhibitory effects on inflammatory response in macrophages. Mycophenolic acid (MPA) demonstrated inhibitory effects on viral replication, IL‐1β and TNF‐α expression, whereas mTOR inhibitors had the opposite effects, and tacrolimus showed no clear effect. In conclusion, immunosuppressants can differentially affect HEV replication and the subsequent inflammatory responses in macrophages.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/eac70274038702e260d9f4da11346625f1871599" target='_blank'>
              The Differential Effects of Immunosuppressants on Hepatitis E Virus Replication and the Triggered Inflammatory Responses in Macrophages
              </a>
            </td>
          <td>
            Jiahua Zhou, Kuan Liu, P. Boor, Qiuwei Pan, I. Ayada
          </td>
          <td>2025-12-16</td>
          <td>Journal of Viral Hepatitis</td>
          <td>0</td>
          <td>9</td>
        </tr>

        <tr id="Inflammatory responses including glial activation, and upregulated inflammatory factors occurred after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infected central nervous system. Blood-brain barrier (BBB) disruption has been implicated in coronavirus disease 2019 (COVID-19) pathogenesis and may predispose to the long-lasting neurological damage even after the epidemic ends. The BBB is a highly selective dynamic interface to protects the brain from neurotoxins and the elimination of byproducts of brain metabolism via efflux transporters. The COVID-19 pandemic has introduced new challenges in managing neurological conditions, and understanding SARS-CoV-2 journey through BBB and the interconnections between the members of BBB is crucial. This review aims to summarize and elucidate the damage to the main constituent cells of BBB, including brain microvascular endothelial cells, astrocytes, and microglia and its contribution to COVID-19. Further understanding of these interactions may facilitate the development of improved treatment options and preventative measures of central nervous system injury due to COVID-19.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/85e1f8e6db59f325d648f88b5923eb205b1a3a64" target='_blank'>
              Exploring SARS-CoV-2 impact on blood-brain barrier and its composition: A review
              </a>
            </td>
          <td>
            Jin Li, Shangfu Xu, Sixu Guo
          </td>
          <td>2025-11-21</td>
          <td>Medicine</td>
          <td>0</td>
          <td>1</td>
        </tr>

        <tr id="A hallmark of COVID-19 patients is the reduction of the lymphocyte population accompanied by activation, senescence, and exhaustion markers. We investigated patients admitted to hospital wards who either recovered after a short hospitalization or progressed to critical illness. Patients (n=48) were recruited between May and September 2020; 19 healthy volunteers were enrolled as controls. Blood samples were collected on days 0, 3, and 7 of hospitalization and around 30 days after discharge (convalescence sample, CS30). Lymphocyte counts and extended immunophenotyping were performed by flow cytometry and analyzed using conventional and stochastic methods. At D0 and D7, total lymphocytes, natural killer cells, T cells, TCD4 cells, and TCD8 cells were lower in patients than in volunteers but were restored at CS30. The stochastic analysis identified 11 distinct clusters of lymphocytes, nine of them with significant differences between patients and healthy controls. Clusters of TCD8+ memory cells showing activation, senescence, and exhaustion were increased in patients during hospitalization and in the convalescence samples. In contrast, clusters 5 (TCD4+ Central Memory exhausted activated) and 7 (TCD4+ Central Memory exhausted) were decreased in patients during the disease compared to healthy controls. Overall, the conventional flow cytometry analyses corroborated the findings from the stochastic analysis, showing that effector memory (EM) and TEMRA subsets exhibited sustained markers of exhaustion and senescence, particularly in TCD8+ cells. Our findings reinforce lymphopenia, T cell activation, senescence, and exhaustion as essential immunological features of COVID-19; while cell counts fully recovered, lymphocytes remained dysfunctional in convalescent samples.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/ccf36a0bfe213bfeb842f9d7a3a65163a5e63e4c" target='_blank'>
              Tracking immune dysregulation in COVID-19: lymphocyte dynamics from hospitalization to recovery
              </a>
            </td>
          <td>
            G.S. Eburneo, M.B. Sousa, M. Brunialti, S. Santos, J.G.D. Silva, P. Ferreira, N.C.J. Bellei, J.S.O. Arakaki, Giuseppe G F Leite, R. Salomão
          </td>
          <td>2025-11-14</td>
          <td>Brazilian Journal of Medical and Biological Research</td>
          <td>0</td>
          <td>5</td>
        </tr>

        <tr id="


 SARS-CoV2 devastated the world in 2019, with over 774 million cases and around 7 million deaths. Our lab has previously reported the role Caspase-4/11 plays in the innate immune response against SARS-CoV2, associating it with exacerbated lung pathology and immunothrombosis, indicating its therapeutic potential. In a recent project, we investigated how Casp-11 affects the adaptive immune response. We infected C57/BL6 mice expressing or lacking Casp-11 with the mouse-adapted SARS-CoV-2 strain (MA10). We then assessed the mice for signs of severe disease, such as weight loss, and their localized and systemic immune responses, measuring virus-specific immunoglobulins, circulating or lung resident CD4+ and CD8+ T cells (Trm), and lung cytokines. Our results indicated that Casp-11-/- mice have faster recovery than wild-type mice, along with reduced proinflammatory cytokine levels, further confirming the role of Casp-11 in lung inflammation. Additionally, the number of virus-specific CD8+ Trm cells was significantly lower in Casp-11-/- mice’s lungs than in wild-type mice. However, both groups’ levels of virus-specific CD4+ Trm and lung IgGs remained comparable. Notably, Casp-11-/- mice had higher serum levels of spike-specific IgG, suggesting a potential dichotomy in the localized versus systemic immune responses. These findings indicate that targeting Casp-11 may effectively decrease disease severity while improving the acquired protective immune response.



 Viral Immunology (VIR)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/d1a9cc4379a0daa37f9489968ae37c42b020811d" target='_blank'>
              Caspase-4/11 induces lung inflammation and dampens the humoral immune response in SARS-CoV2 infected mice 3644
              </a>
            </td>
          <td>
            Mohamed Medhat Samir Ibrahim Ahmed Shamseldin, Mostafa Eltobgy, Heba M Amer, Owen Witham, Jihad Omran, Rabab Abdelaleem, Amal O Amer
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>8</td>
        </tr>

        <tr id="
 Background:
 SARS-CoV-2 and influenza infections are associated with an increased risk of cardiovascular events. While the underlying mechanisms remain incompletely defined, mounting evidence points towards endothelial dysfunction and thrombotic activation, caused either directly or indirectly by viral infection.


 Aims:
 We sought to characterise the temporal effects of mild SARS-CoV-2 and H3N2 influenza infection on plasma biomarkers of endothelial, thrombotic and renal function.


 Methods:
 Plasma samples were collected from healthy volunteers enrolled in SARS-CoV-2 (n=7-10) and H3N2 (n=7-11) human challenge studies. Samples were taken at baseline (day 0/–1) and at days 3, 7, 10, 14, and 28 post-inoculation. Commercial ELISAs/colorimetric assays were used to quantify endothelial dysfunction using biomarkers of endothelial-mediated vasomotor control (endothelin-1, nitrate/nitrite, prostacyclin, ADMA, arginine), thrombosis (sCD40L, P-selectin, PSGL-1, tPA, PAI-1, D-dimer, factor IX), and renal function (uromodulin, NGAL, cystatin C, TFF3, OPN). One-way ANOVA, or a mixed effects model, and Dunnet’s test to correct for multiple comparisons, were used to compare baseline biomarker levels with levels at subsequent timepoints.


 Results:
 Infection with SARS-CoV-2 significantly increased thrombosis biomarkers (Figs. 1&2): P-selectin (p=0.025), PSGL-1 (p=0.024), sCD40L (p=0.048), PAI-1 (p=0.008) and tPA (p=0.006&0.008) at days 7 to 14. In contrast, infection with H3N2 resulted in a significant increase in D-dimer levels at day 14 (p=0.025) and no changes in other biomarkers of thrombosis. No changes from baseline were detected in biomarkers of endothelial dysfunction in either group. Uromodulin levels declined by day 28 in the SARS-CoV-2 group (p=0.034), otherwise no changes in biomarkers of renal function were noted in either group.


 Conclusions:
 There are two striking results of this study. Firstly, that for both H3N2 and SARS-CoV-2 infection, it was markers of platelet activation/thrombosis, without changes in endothelial or renal function, that increased after infection. Secondly, that a broader spectrum of these markers was increased in volunteers infected with SARS-CoV-2. These findings suggest distinct thrombotic mechanisms are activated by SARS-CoV-2 and H3N2 and support further investigation of thrombotic profiles in patients infected with other respiratory viruses allowing for strategies to identify and mitigate associated cardiovascular events.
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/107604fa6ee17ee4f404ea6d1e3e14fcc6268770" target='_blank'>
              Abstract 4367854: The impact of viral infection with SARS-CoV-2 and influenza on plasma endothelial, thrombotic and renal biomarkers
              </a>
            </td>
          <td>
            Ahmed Bakr, Helen Wagstaffe, L. Papargyris, R. Vaja, Christopher Chiu, N. Kirkby, Jane A Mitchell
          </td>
          <td>2025-11-04</td>
          <td>Circulation</td>
          <td>0</td>
          <td>30</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/4b30b34de10d73c9f922bb678272c07c41f6fdb9" target='_blank'>
              Dysregulation of homeostatic cytokine receptors drives prolonged T cell activation following acute SARS-CoV-2 infection in humans.
              </a>
            </td>
          <td>
            Laura Ceglarek, Patrick Taeschler, Alp Inci, Yves Zurbuchen, Sarah Adamo, Carlo Cervia-Hasler, M. E. Raeber, O. Boyman
          </td>
          <td>2025-11-27</td>
          <td>Nature communications</td>
          <td>0</td>
          <td>63</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e3bbdd9bcc92736e4b8070a3a41a9e7c618c1a80" target='_blank'>
              ILC2s govern imprinting of alveolar macrophage-mediated immunity upon secondary helminth infection in the lung
              </a>
            </td>
          <td>
            Jonathan Pollock, , Lisa-Marie Graf, Andreas Ruhl, Daniel Radtke, David Voehringer
          </td>
          <td>2025-12-23</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>12</td>
        </tr>

        <tr id="


 SARS-CoV-2 infected individuals frequently develop mild disease; however, the underlying mechanisms of improved outcomes are unknown. Using a training cohort, integrated clinical and molecular parameters revealed signatures that discriminated mild from moderate and severe outcomes. Early on, some mild individuals had higher antibody titer, lower viral loads, had allergic diseases and increased expression of Th2 cytokines. In contrast, moderate/severe individuals had higher viral loads, lower antibody titers, and increased IL-8, IP10 and IL-10 levels. A distinct blood transcriptional profile of these mild individuals suggested a mechanistic role for Th2 responses in modulating disease severity. Human tracheobronchial epithelial cells (HTBE) incubated with IL-4 and/or IL-13 to recapitulate a Th2 milieu in vitro, had increased levels of IFNγ, decreased SARS-CoV-2 replication, and inhibited IL-6 induction. IL-4 and IL-13 induced a differential gene expression profile that was not significantly altered upon SARS-CoV-2 infection. Multiome analysis of treated HTBEs showed an enrichment in the transcription factor binding sites of STAT6 and KLF4. Th2 treatment induced cell specific antiviral pathways, including SLC, autophagy and RAS genes, whereas pro-viral and inflammatory gene pathways, such as IL1B/IL6, cell cycle and transcription, were repressed. This suggests that during mild COVID-19, Th2 responses modulate early innate immune responses leading to the control of viral load.



 Supported by the FLUOMICS and SYBIL Consortium NIH-NIAID grant U19AI135972), Center for Research on Influenza Pathogenesis (CRIP), an NIAID Center of Excellence for Influenza Research and Surveillance (CEIRS) contract HHSN272201400008C, FONDECYT 1212023 grant from ANID of Chile, Postdoctoral grants FONDECYT 3190706 and 3190648, ANID Becas/Doctorado Nacional 21212258.



 Viral Immunology (VIR)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/d8cf3072db740d91b488dff672f775c71c4bf63f" target='_blank'>
              Th2 immune responses promote anti-viral and anti-inflammatory activity during mild COVID-19 9405
              </a>
            </td>
          <td>
            Rafael A. Medina, Tamara García-Salum, Slim Fourati, Gonzalo Valenzuela, C. Pardo-Roa, E. Serrano, Susan Pereira, Michael Schotsaert, Jorge Levica, M. Avendaño, Ana Carolina Santana, Perla Del Rio, S. Jangra, Clara Schulze-Schiappacasse, Gonzalo Alarcón-Andrade, M. Suthar, F. Krammer, Adolfo García-Sastre, A. Riquelme, R. Sekaly
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>110</td>
        </tr>

        <tr id="AIMS
Patients with cardiovascular disease (CVD) have an increased risk of developing severe respiratory infections, including COVID-19. However, the underlying molecular mechanisms are not completely understood. It has been previously shown that cardiovascular disease predisposes to an altered responsiveness to subsequent inflammatory triggers by an imprinted epigenetic memory in innate immune cells. Therefore, we hypothesized that patients with preexisting atherosclerotic cardiovascular disease (ASCVD) and COVID-19 display a dysregulated inflammatory response compared to patients without ASCVD due to epigenetically altered immune cells leading to increased disease severity.


METHODS AND RESULTS
Single-cell RNA sequencing revealed a dysregulated myeloid immune response with hyperinflammatory and immunosuppressive features in patients with ASCVD and moderate COVID-19. Assay for Transposase-Accessible Chromatin sequencing and in-vitro experiments with isolated monocytes infected with SARS-CoV-2 showed epigenetic priming of monocytes from patients with ASCVD towards increased expression of inflammatory mediators and type I interferon signalling. In a German nationwide cohort (NAPKON), using multiplex cytokine assays, enzyme-linked immunosorbent assays, and bulk-RNA-sequencing, we confirmed that patients with ASCVD display an exaggerated inflammatory response during moderate COVID-19.


CONCLUSIONS
This study demonstrates that patients with ASCVD show a dysregulated myeloid immune response in moderate COVID-19 disease. Mechanistically, epigenetic imprinting sensitizes myeloid cells of patients with ASCVD to an exaggerated type I interferon-associated immune response.


TRANSLATIONAL PERSPECTIVE
This study evaluates the underlying molecular mechanisms of worse outcomes of patients with atherosclerotic cardiovascular disease during respiratory infections, specifically COVID-19. Patients with atherosclerotic cardiovascular disease present with a dysregulated hyperinflammatory, type I interferon-driven immune response already during moderate COVID-19. This not only explains a major risk factor for severe COVID-19 but might also enable targeted therapies for this specific risk group.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/417901a925ab6ef7f438ab3c6409b92a5127c60d" target='_blank'>
              Atherosclerosis licenses for an exceeding immune response in COVID-19 disease by interferon priming in circulating myeloid cells.
              </a>
            </td>
          <td>
            J. Leberzammer, W. Abplanalp, Katharina Grikscheit, Emmanouil G. Solomonidis, S. Glaser, B. Schuhmacher, Maximilian Merten, Gligorije Jeremijev, A. Wilken-Schmitz, Lara Korth, David John, S. Günther, C. Kuenne, Mario Looso, C. Valasarajan, V. Beneš, Ferris Jung, Vivianne Niehaus, Gabriele Anton, Christoph Stellbrink, C. Römmele, S. Göpel, Soni S Pullamsetti, J. Vehreschild, M. Vehreschild, S. Ciesek, David M. Leistner, Andreas M. Zeiher, S. Dimmeler, S. Cremer
          </td>
          <td>2025-12-13</td>
          <td>Cardiovascular research</td>
          <td>0</td>
          <td>158</td>
        </tr>

        <tr id="Inflammation and excess cytokine release are hallmarks of severe COVID-19. While programmed cell death is known to drive inflammation, its role in SARS-CoV-2 pathogenesis remains unclear. Using gene-targeted murine COVID-19 models, we here find that caspase-8 is critical for cytokine release and inflammation. Loss of caspase-8 reduces disease severity and viral load in mice, and this occurs independently of its apoptotic function. Instead, reduction in SARS-CoV-2 pathology is linked to decreased IL-1β levels and inflammation. Loss of pyroptosis and necroptosis mediators in gene-targeted animals provides no additional benefits in mitigating disease outcomes beyond that conferred by loss of caspase-8. Spatial transcriptomic and proteomic analyses of caspase-8-deficient mice confirm that improved outcomes are due to reduced pro-inflammatory responses, rather than changes in cell death signalling. Elevated expression of caspase-8 and cFLIP in infected lungs, alongside caspase-8-mediated cleavage of N4BP1, a suppressor of NF-kB signalling, indicates a role of this signalling axis in pathological inflammation. Collectively, these findings highlight non-apoptotic functions of caspase-8 as a driver of severe COVID-19 through modulation of inflammation, not through the induction of apoptosis. During SARS-CoV-2 infection caspase-8 fuels harmful inflammation independent of apoptosis. Genetic loss of caspase-8 reduces cytokine levels, lowers viral load and mitigates disease severity, revealing non-apoptotic caspase-8 as a key driver of severe COVID-19.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/5fdd57c7d51f242c164bb60fdb057ec943038a10" target='_blank'>
              Non-apoptotic caspase-8 is critical for orchestrating exaggerated inflammation during severe SARS-CoV-2 infection
              </a>
            </td>
          <td>
            Stefanie M. Bader, Lena Scherer, Reet Bhandari, Allan J. Motyer, James P. Cooney, Liana Mackiewicz, Merle Dayton, Dylan Sheerin, David V. L. Romero, Jan Schaefer, J. Pang, Siqi Chen, Kael Schoffer, Le Wang, Xinyi Jin, D. Batey, Raymond K. H. Yip, Ishrat Zaman, P. Rajasekhar, Matthew J. Gartner, Stephen Wilcox, Lachlan L Whitehead, S. R. Georgy, Ana Maluenda, Kathryn C. Davidson, C. Allison, R. Bowden, Kerstin Brinkmann, M.-L. Asselin-Labat, B. Phipson, Maria C. Tanzer, Marco J. Herold, A. Samson, J. Vince, Andreas Strasser, Marc Pellegrini, Marcel Doerflinger
          </td>
          <td>2025-11-13</td>
          <td>Nature Communications</td>
          <td>0</td>
          <td>51</td>
        </tr>

        <tr id="


 Long COVID (LC) is a debilitating condition characterized by neurological, respiratory and/or gastrointestinal symptoms persisting after the infection with SARS-CoV-2. It has been hypothesized that LC is caused by suboptimal immune responses failing to clear SARS-CoV-2. Memory B cells and antibody-secreting plasma cells with high affinity for viruses, which confer protection from infection and contribute to viral clearance, canonically originate from germinal center (GC) reactions in lymphoid organs. By using a Fine Needle Aspirate (FNA) approach, which we previously deployed to probe GC responses to vaccination (Lederer et al. Cell 2022), we collected biopsies from cervical lymph nodes of LC and healthy COVID-19 convalescents. High-parameter flow cytometry analysis of FNA samples showed that convalescents mounted efficient GC B cell responses to SARS-CoV-2 that correlated with the generation of neutralizing antibodies. Conversely, GC responses to SARS-CoV-2 were severely hindered in LC patients and linked to a decreased production of binding and neutralizing antibodies against SARS-CoV-2 that waned faster than in convalescents. CITE-seq analysis of FNA samples also revealed transcriptional alterations in GC B and memory B cells from LC patients that were coupled to inferior clonal expansion. Overall, the direct analysis of lymph nodes uncovered major abnormalities in B cell responses to SARS-CoV-2 that might be connected to the incomplete lack of viral clearance in LC.



 This work is supported by PolyBio Research Foundation and by NIH 2U19AI082630-16 grant



 Immune Mechanisms of Human Disease (HUM)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/24f5872cdd72612847ef9e146aeeb304ba0f7497" target='_blank'>
              Alterations of B cell responses to SARS-CoV-2 in Long COVID 2566
              </a>
            </td>
          <td>
            M. Locci, Hannah Sharpe
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>21</td>
        </tr>

        <tr id="ZIKA virus (ZIKV) infections in human neonates and adults are associated with deleterious effects on brain cognition and neurological disorders. The mechanism(s) of ZIKV infection in neurons and associated neuronal antiviral responses are not fully understood. In this study, we determined the effects of ZIKV infectivity in human neuronal (SH-SY5Y) cells and mouse N2a cells/primary cultures of murine cortical neurons at early and late tested timepoints of infection. The human neuronal cells had higher ZIKV loads compared to the mouse N2a cells, but the viral loads in the murine cortical neurons were between the loads in these two in vitro cell lines. The murine cortical neurons were thought to be more permissive to ZIKV infection, but viral infection kinetics showed a declining trend like that observed in the mouse N2a cells. We noted that infectious extracellular vesicle (EV)-mediated ZIKV infection showed higher viral loads in the SH-SY5Y cells compared to direct infection with laboratory virus stocks. Similar results were obtained with ZIKV infectious EVs in the mouse N2a cells and cortical neurons. In addition, we noted that ZIKV infection significantly induced EV secretion from all three neuronal cells. Also, we found that ZIKV infection modulates the expression of type 1 interferons (IFNs) and entry receptors such as Tyro3, Axl, and MER-TK (TAM). Alongside the increased ZIKV loads in the SH-SY5Y cells, IFN-beta transcript levels and receptors Tyro3/MER-TK were upregulated at early timepoints of infection. Overall, the reduced ZIKV loads and decreasing IFN expression in the mouse neuronal cells suggested a unique murine cellular ability to restrict and limit viral replication. This could be one of the reasons for the unavailability of wild-type mouse models for ZIKV infection. Our data further shows that ZIKV may preferentially infect human rather than murine neuronal cells, and this could be the potential reason for microcephaly in newborns.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/d2bbcba835793ffe7fbf7dbdc95e5db77870ad93" target='_blank'>
              Zika Virus Infection Is More Highly Replicative and Transmissible by Extracellular Vesicles in Human than in Mouse Neuronal Cells
              </a>
            </td>
          <td>
            Kehinde D. Fasae, Md Bayzid, Girish Neelakanta, Hameeda Sultana
          </td>
          <td>2025-11-27</td>
          <td>International Journal of Molecular Sciences</td>
          <td>0</td>
          <td>24</td>
        </tr>

        <tr id="Persistent, unresolved inflammatory processes disrupt the complex homeostatic state and lead to severe disease, ultimately resulting in organ failure, shock, and death. The mediators that monitor and control the programmed mechanisms in tissue homeostasis and repair remain elusive. A recently discovered group of endogenous proteins, termed neuronal guidance proteins (NGPs), has gained attention as important mediators of immunoregulation and tissue homeostasis through their role in the complex interplay between metabolic reprogramming and immunity. In murine peritonitis, the deficiency of the NGP Plexin C1 (PLXC1−/−) led to an increase in neutrophil and Ly6Chi monocyte recruitment to the injury site and a decrease in the phagocytosis rate. This was accompanied by a decrease in the endogenous biosynthesis of specialized proresolving lipid mediators (SPMs) such as Maresin-1 and Protectin DX and finally by a lengthening of the resolution interval. Peritoneal macrophages (MΦs)PLXC1−/− followed specific strategies to adapt their metabolism to catabolic conditions, by reducing fatty acid oxidation and oxidative phosphorylation, increasing aerobic glycolysis and activation of the pentose phosphate pathway, and disrupting the tricarboxylic acid cycle. The decreased MΦsPLXC1−/− citrate levels corresponded with a lipid mediator profile in which PGD2 and PGE2 were greatly decreased in murine PLXC1−/− peritoneal exudates, indicating a lesser effect on lipid mediator class switching and ultimately the formation of SPMs. Analysis of the related signaling networks indicated mTOR and AKT2 phosphorylation pathways are critical determinants of metabolic reprogramming in activated MΦsPLXC1−/−. These findings highlight a novel role for PLXC1 in regulating the crosstalk between immunometabolism and inflammation resolution programs in severe inflammation.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/142901da389dc4e201c184a92df6289f59bd6377" target='_blank'>
              Plexin C1 modulates metabolic programming for resolution of severe inflammation
              </a>
            </td>
          <td>
            Andreas Körner, Michael Koeppen, Jasvir Kaur, Julia C Fitzgerald, S. Kostidis, Torsten Kaussen, Christoph Trautwein, M. Giera, Tamam Bakchoul, Alice Bernard, V. Mirakaj
          </td>
          <td>2025-11-25</td>
          <td>Cell Communication and Signaling : CCS</td>
          <td>0</td>
          <td>39</td>
        </tr>

        <tr id="Monkeypox, a zoonotic disease caused by the monkeypox virus (MPXV), has significant global public health implications. Inflammasomes serve as crucial components of the innate immune system, detecting pathogens and triggering cell death in infected cells to eliminate harmful agents. However, the precise molecular mechanisms governing the activation of inflammasomes during MPXV infection remain largely unclear. Using CRISPR-knockout cytosolic innate immune sensor screening, we identified AIM2 as the sensor for MPXV within the inflammasome, a trigger for inflammatory cell death. Mechanistically, AIM2 forms a complex with essential cell death molecules, including ASC and caspase-1 (CASP1), without interacting with RIPK3 or CASP8. Loss of ASC, CASP1, or gasdermin D (GSDMD) reduced cell death following MPXV infection, whereas loss of GSDME, CASP3, CASP6, CASP7, CASP9, RIPK3, or MLKL did not. Pyroptotic cell death was predominantly observed in infected cells, whereas apoptotic and necroptotic signaling pathways were primarily activated in uninfected bystander cells. Furthermore, we found that the transcription factor IRF1 serves as an upstream regulator of AIM2, controlling AIM2-dependent cell death. In experiments involving AIM2-deficient mice infected with MPXV, we observed a decrease in proinflammatory cytokines, multiple inflammatory cell death pathways, and leukocyte migration, culminating in increased viral spread. CAST/EiJ mice succumbed to high-dose MPXV infection within 8 days, whereas AIM2 inhibition increased survival, with 10% of the mice treated with an AIM2 inhibitor surviving the infection. In a low-dose infection model, AIM2 inhibition reduced IL-1β and IL-18 production, LDH release, and tissue pathology. These findings highlight the critical role of AIM2-mediated inflammasome activation, along with multiple programmed cell death pathways, in shaping the innate immune response to MPXV infection, offering valuable insights for developing therapeutic strategies targeting AIM2 and the broader innate immune response against monkeypox.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/d9255f9c0757211efce272667e049b82cca5937f" target='_blank'>
              AIM2 drives inflammatory cell death and monkeypox pathogenesis
              </a>
            </td>
          <td>
            Jueun Oh, Yun-Ho Hwang, Jihye Lee, Cheong Seok, SuHyeon Oh, Hye Yoon Kim, Nabukenya Mariam, Jaeyoung Ahn, Gyoengju Yu, Jaewoo Park, Hayeon Kim, Suhyun Kim, Seyun Shin, Min-Chul Jung, Jinwoo Gil, Joo Sang Lee, Y. Choi, Dokeun Kim, Daesik Kim, You-jin Kim, SangJoon Lee
          </td>
          <td>2025-11-12</td>
          <td>Cellular and Molecular Immunology</td>
          <td>1</td>
          <td>9</td>
        </tr>

        <tr id="Despite heavy exposure to Mycobacterium tuberculosis (Mtb), some individuals are resistant to TST and IGRA conversion (RSTRs). The functional and immunological mechanisms governing resistance are poorly understood. We hypothesized that RSTR and LTBI alveolar macrophages (AMs) respond differently to Mtb infection with transcriptional programs that are distinct from peripheral blood monocytes. We examined media and Mtb-infected AMs from bronchoalveolar lavage fluid collected from a RSTR cohort in Uganda with over 10 years of clinical follow-up. With transcriptional profiles of BAL cells analyzed immediately after collection, gene set enrichment analysis (GSEA) revealed 13 differentially expressed gene sets between RSTR (n = 19) and LTBI (n = 26) groups, including one (Hallmark E2F targets) which was positively enriched in the RSTR group (FDR < 0.3). In a subset of this cohort (n = 7 RSTR and 8 LTBI), AMs were examined with and without Mtb infection. When comparing the RSTR and LTBI groups, we identified 52 DEGs including 22 in the media condition, 15 with Mtb stimulation, and 11 with the interaction term (FDR < 0.2, Log 2-fold change > 1/<-1). Notably, RSTR AMs appear to upregulate inflammation more strongly than LTBI counterparts, including Hallmark inflammatory response (FDR < 0.2), IFNγ response (FDR < 0.1), and IFNα response (FDR < 0.1) while existing in a more non-inflammatory state at baseline (Hallmark TNF signaling via NF-kB (down, FDR < 0.1), inflammatory response (down, FDR < 0.1). In a comparison of peripheral blood monocyte gene expression profiles from the same cohort, there were both shared and AM-specific RSTR profiles detected. Together, these results suggest that RSTR and LTBI AMs have different basal and Mtb-induced transcriptional profiles, including some that differ from peripheral blood monocytes.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/74f6f6a91106ca8fedadea27abfb904beaf5f882" target='_blank'>
              Alveolar macrophage transcriptional signatures associated with resistance to TST/IGRA conversion following Mycobacterium tuberculosis exposure
              </a>
            </td>
          <td>
            Austin M. Haynes, Cristian Ovadiuc, G. Peterson, W. Worodria, Sophie Nalukwago, Timothy Muwanguzi, M. Nsereko, Catherine M. Stein, Kimberly A. Dill-McFarland, Harriet Mayanja-Kizza, W. H. Boom, R. M. Segnitz, T. Hawn
          </td>
          <td>2025-10-31</td>
          <td>BMC Genomics</td>
          <td>0</td>
          <td>36</td>
        </tr>

        <tr id="ABSTRACT Staphylococcal enterotoxins (SE) crosslink the MHC‐II on antigen‐presenting cells (APC) with the T‐cell receptor, inducing a polyclonal T‐cell response. Although APCs are the initial targets of SE and are critical in shaping subsequent T‐cell activation, the effects of SE on APC function remain poorly understood. This study investigates the immunomodulatory effects of staphylococcal enterotoxin A (SEA) on monocytes and their differentiation into monocyte‐derived dendritic cells (moDC) or macrophages (MDM). Transcriptomic analyses of human monocytes via RNA sequencing revealed SEA‐induced enrichment of gene pathways associated with inflammation, infection, and dermatitis, effects that were amplified in the presence of T cells. Phenotypic and functional characterization showed that SEA‐primed monocytes differentiated into MDM with an altered polarization, deviating from classical M1/M2 pathways. SEA‐primed MDM exhibited downregulation of key markers, including HLA‐DR, CD80, CD86, and PD‐L1. Functional assays demonstrated that SEA‐primed MDM pushed hyperinflammatory T‐cell responses, with significantly enhanced proliferation and IFN‐γ secretion. In contrast, following SEA‐priming, moDC retained robust antigen‐presenting capabilities and displayed enhanced expression of molecules involved in T‐cell interactions. These findings provide mechanistic insights into SEA‐mediated immune modulation, illustrating how SEA reprograms MDM functions and amplifies proinflammatory T‐cell responses. This advances our understanding of superantigen‐driven immune interactions, offering a foundation for developing therapeutic strategies to mitigate superantigen‐mediated immune conditions.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/31b8b3bf0438451c3b982c5f615c660d9c3ce361" target='_blank'>
              Staphylococcal Enterotoxin A Shapes Monocyte Transcription and Macrophage Polarization: Implications for Immune Responses in Infection and Inflammation
              </a>
            </td>
          <td>
            C. Arasa, Khaleda Rahman Qazi, David Brodin, Manuel Mata Forsberg, E. Sverremark-Ekström
          </td>
          <td>2025-12-01</td>
          <td>European Journal of Immunology</td>
          <td>0</td>
          <td>31</td>
        </tr>

        <tr id="ABSTRACT Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), remains a major public health threat, particularly in vulnerable populations. SARS-CoV-2 spike proteins interact with the human angiotensin-converting enzyme 2 (ACE2) receptor, together with accessory molecules that facilitate viral entry, through its spike receptor-binding domain (RBD). Although ACE2 is the primary receptor required for viral replication, its expression patterns do not fully correlate with viral distribution or tissue pathology. Moreover, SARS-CoV-2 has been shown to infect cells and tissues lacking detectable ACE2 expression. Viral entry via ACE2-independent pathways may also confer resistance to some monoclonal antibodies (Abs) targeting the spike RBD that block ACE2-mediated binding. These observations highlight the potential significance of ACE2-independent entry factors in SARS-CoV-2 infection, particularly in vaccinated individuals with Abs directed against ACE2-dependent viral entry. In this review, we discuss the emerging roles of ACE2-independent entry factors in SARS-CoV-2 infection and the immune responses. These factors include CD147, AXL, CD169/Siglec-1, CD209L, CD209, CLEC4G, ASGR1, LDLRAD3, TMEM30A, TMEM106B, transferrin receptor 1, GPR78, integrin α5β1, KREMEN1, LFA-1, and CD4. While ACE2 remains central to viral replication, ACE2-independent entry appears sufficient to elicit immune responses. Therefore, future investigations are warranted to elucidate the roles of ACE2-independent mechanisms in immune-mediated pathology and viral evolution, independent of immune pressure targeting ACE2-mediated entry in previously infected or vaccinated individuals.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/416f126df60ac30115fcfb6b97329efa70fd8c23" target='_blank'>
              ACE2-independent entry factors for SARS-CoV-2 infection and immune activation
              </a>
            </td>
          <td>
            Yiyu Sun, L. Wong, 
          </td>
          <td>2025-12-22</td>
          <td>mBio</td>
          <td>0</td>
          <td>17</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/8a2e1bb8d0dab5824b185f810e0cd5ef78deac45" target='_blank'>
              Metabolic control of macrophages in coronavirus disease 2019.
              </a>
            </td>
          <td>
            Li An, Houxi Xu, Qiaoling Fan, MengJiang Lu, Dongdong Sun
          </td>
          <td>2025-12-23</td>
          <td>Virulence</td>
          <td>0</td>
          <td>4</td>
        </tr>

        <tr id="


 Recent studies suggest respiratory infections like SARS-CoV-2 can influence brain glial cell behavior. Early-life stress, such as neonatal stress, may predispose the nervous system to an exacerbated response during immune challenges. Thus, we investigated how early-life stress modifies glial cell activation and function during Sendai virus-induced lung inflammation, and assess its impact on neuroimmune responses and susceptibility to respiratory diseases in adulthood.



 This study used a neonatal maternal separation (NMS) rat model in which Sprague Dawley rats were separated from their mother for 3 hours daily from postnatal days 3 to 12. At 8-10 weeks, rats were infected intranasally with Sendai virus, and brain glial cells were analyzed by flow cytometry post-infection.



 Activation markers of the microglia and astrocytes are modulated by Sendaï infection differently in response to stress and sex. Viral infection increased CD200 on astrocytes 4 days post-infection. At the same time, activated microglia MHCII levels were lower, with differences across sexes and between NMS and control groups.



 Respiratory viral infections may affect glial cell activation, showing a pattern aligning with human SARS-CoV-2 observations. Early-life stress may further influence the glial response to such infections, emphasizing the role of developmental factors and immune challenges in shaping neuroimmune responses.



 Supported by CIHR, FRQS, Quebec Respiratory Health Network and Fondation IUCPQ.



 Neuroimmunology (NEUR)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/bffc63259177c779d5068e71a7d6a6f22be2dddc" target='_blank'>
              Sex-specific impacts of lung viral infection on brain microglia and astrocytes 2565
              </a>
            </td>
          <td>
            J. Lauzon-Joset, Karine Bouchard, Joanny Roy, Danuzia Ambrozio-Marques, Richard Kinkead, Dany Patoine
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>11</td>
        </tr>

        <tr id="Post-COVID cardiac complications have emerged as a significant and persistent clinical concern, yet their underlying mechanisms remain poorly understood. Animal models can act as proxies to investigate the pathophysiology of the human, post-acute sequelae of SARS-CoV-2 infection (PASC). The aim of this experimental study was to evaluate the expression of inflammatory biomarkers in cardiac tissue 28 days after SARS-CoV-2 infection in a female hACE2 mouse model, with a focus on chemokine-mediated immune activation. Twelve female C57BL/6 hACE2 mice were infected with the Omicron variant (BA.1.17 lineage) of SARS-CoV-2, and eleven non-infected mice served as controls. Cardiac tissue was analyzed via Western blot for markers of innate immune activation (TLR4, MyD88, NF-κB) and pro-inflammatory cytokines (IL-6, IL-18, IL-1β, TNF-α, CD11d). Cardiac tissue injury markers (iNOS, PAI-1 and Connexin43) were also analyzed. Compared to non-infected mice, cardiac tissue from infected mice showed significantly higher expression of IL-6 (p = 0.028), indicating an inflammatory state, and CD11d (p = 0.016), suggesting an inflammatory stage accompanied by sustained activation of chemokine-mediated inflammatory signaling. No significant differences in TLR4 (p = 0.340), MyD88 (p = 0.410), NF-κB p65 (p = 0.780), IL-18 (p = 0.548), IL-1β (p = 0.455), and TNF-α (p = 0.125) expressions were observed Similarly, no changes in cardiac damage markers (iNOS: p = 0.4684; PAI-1: p = 0.5345; Connexin 43: p = 0.2879) were found. The results of this experimental study would support the hypothesis of persistent low-grade inflammation as a contributor to post-COVID cardiac sequelae in females that is not accompanied by severe tissue damage, as also observed in clinical studies. This study also reinforces the need for studies evaluating the functional and structural evolution of the myocardium after an acute SARS-CoV-2 infection.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/8c71f525771ab829c5b8bbcdcdb88fac1b05cc46" target='_blank'>
              Cardiac Tissue Damage in a Female Animal Post-COVID Model: Relevance of Chemokine-Mediated Inflammation
              </a>
            </td>
          <td>
            Silvia Flaj-Prados, Esperanza Herradón Pliego, Carlos Goicoechea Garcia, Eva M. Sánchez-Robles, L. Arendt-Nielsen, C. Fernández‐de‐las‐Peñas, Visitación López-Miranda
          </td>
          <td>2025-12-01</td>
          <td>Viruses</td>
          <td>0</td>
          <td>87</td>
        </tr>

        <tr id="


 MIS-C is a pediatric hyperinflammatory disease characterized by inflammatory shock involving multiple organ systems. MIS-C is linked with prior SARS-CoV-2 infection, approximately 4-6 weeks before symptom onset. Acute patients display distinct circulating immune cell profiles, marked by an increase in inflammatory cytokines and chemokines. Here, we used single-cell RNA- and TCR-sequencing paired with multiplexed cytokine profiling and mass cytometry to characterize the immune signatures of PBMCs and plasma in 8 acute MIS-C patients, 15 recovered MIS-C follow-ups over a range of time points (“early”: 1-3 months, “late”: 6-18 months), and 10 healthy pediatric controls. Levels of various proinflammatory cytokines and chemokines, including IL-6, IL-15, and IL-1β, were elevated in the plasma of early follow-ups; similarly, perforin, pSTAT-3, and pSTAT-4 protein expression was higher in PBMCs within this 3-month follow-up window. Multiome analysis of 151,420 PBMCs revealed an enrichment of inflammatory pathways in genes more highly expressed in early compared to late follow-ups, specifically in monocytes. Significant expansions of various paired TCR α/β-chains were also observed in acute patients, which persisted in early follow-ups. Together, our findings establish a prolonged inflammatory phenotype up to 3 months after MIS-C resolves, suggesting that the effects of SARS-CoV-2 infection-caused MIS-C may linger well after the virus is cleared despite fast clinical resolution.



 Supported by NIH/NICHD R01HD108467-01; Helen Hay Whitney Fndn. Fellowship.



 Computational and Systems Immunology (COMP)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/700fb0f1fd9b6efe4945ffb81edc27b02688ee5b" target='_blank'>
              Disseminated autoimmunity is associated with MIS-C pathogenesis 2925
              </a>
            </td>
          <td>
            Haley E. Randolph, Ashley Richardson, S. Buta, Julie Samuels, Sarah S Geisler, Mark W Russell, R. Trachtman, Dusan Bogunovic
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>16</td>
        </tr>

        <tr id="


 The immune system is essential to control and eliminate pathogens such as SARS-CoV-2, the agent of COVID-19. Studying the differential responses of individuals exposed to the same viral strain within discordant couples (one partner infected, the other not) can enhance our understanding of infection responses. This study focuses on the neutrophil response in such couples, aiming to identify and evaluate resistance and susceptibility markers through the expression of ACE2, TLR4, and TLR9 receptors, cytokine production, and NETs release following different stimuli. Our findings reveal significant differences in responses. When COVID-19-negative cells were stimulated with ODN CpG, the percentage of ACE2+ neutrophils were increased, being higher than positive individuals. COVID-19-positive individuals have higher expression of TLR4+ in neutrophils without stimulation and after stimulation with LPS, ODN CpG, and inactivated SARS-CoV-2 in different concentrations. For TLR9 expression, this behavior is maintained in COVID-19-positive groups, except for those stimulated with ODN CpG. Regarding NETs release, COVID-19-positive individuals showed higher levels of NETs produced by neutrophils, even without acute infection, mainly at serum levels. After stimulation, COVID-19 negative have the highest levels comparatively and were also able to produce more IL-8. These differences in neutrophil responses may indicate potential resistance and susceptibility factors to SARS-CoV-2 infection.



 Funding: Supported by The São Paulo Research Foundation, FAPESP (process number 2021/13354-1)



 Viral Immunology (VIR)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/dc25fff247ac3b1005ac3dd50861c2c33b641107" target='_blank'>
              Resistance and susceptibility markers of SARS-CoV-2 infection in neutrophils response from discordant couples 4014
              </a>
            </td>
          <td>
            L. A. Dias-Melicio, Thayná Ruiz Ferreira, Ana Laura Ortega Dezen, Fernando Couso Correa, Larissa Ragozo Cardoso de Oliveira, C. Simeoni, José Luiz, Proença Módena
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>19</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/275812dc3294ac678dbefad1e9f5e6d112d20c5e" target='_blank'>
              SP140 limits type I interferon–driven pathology, preserving T cell motility and promoting resistance in tuberculosis
              </a>
            </td>
          <td>
            Maxime Caouaille, Léa Fromont, Tomoyo Shinkawa, Marion Faucher, Aizat Iman Abdul Hamid, Serge Mazères, Yaël Duvergé, Yohan Lorreyte, Emmanuelle Näser, S. Behar, Emma Lefrançais, O. Neyrolles, Denis Hudrisier
          </td>
          <td>2025-12-09</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>64</td>
        </tr>

        <tr id="Abstract Background Peripheral inflammation is linked to neurodegeneration. Using Xenium spatial transcriptomics (Figure 1), we test the hypothesis that peripheral inflammation triggers transcriptional changes in microglia. Preliminary data show microglial transcriptional changes are detectable within days of the peripheral inflammatory event, and moreover, that these changes persist for months. How this impacts Aβ and tau pathology is unknown. Method 3xTg‐AD mice were exposed to a peripheral (does not directly infect the CNS) viral infection inducing systemic inflammation. At 7 days‐ and 2‐months post infection, the right and left hemispheres of the brain, respectively, were harvested for immunostaining and integrated analysis of Multiome sequencing (simultaneous single‐cell RNA‐seq and ATAC‐seq) with spatial transcriptomics. Circulating cytokine levels in the blood were measured via ELISA. Result At the 7‐day timepoint, spatial transcriptomics revealed 265 differentially expressed genes in microglia, with three unique microglial profiles present only in infected animals (Figure 2). Cluster features, such as downregulated Plcxd2 and Bhlhe40, have been associated with intracellular Aβ and pTau, as well as dysregulated lipid processing, respectively. Further, algorithmic cell sorting revealed overlap of microglia with glutamatergic neurons and endothelial cells, suggesting increased microglial engulfment of these cell types. Preliminary scRNA‐seq data at 2‐months post‐infection reveals a pro‐inflammatory microglial phenotype (Figure 3), as shown by increases in Ctss and Cd84. Genes critical for synaptic function and neuronal support (Snap25, Anks1b, Fam155a) were significantly downregulated, suggesting that microglia‐neuron interactions are influenced by peripheral inflammation. These changes correlated with global increased expression of Apoe and Psen1&2. Together, these findings show that peripheral inflammatory events induce significant deviations in microglia homeostasis. Conclusion Our preliminary findings suggest that viral‐induced peripheral inflammation alters microglia state and homeostasis in a 3xTg‐AD model. Despite the clearance of systemic inflammation, the transcriptional profile of microglia remains different in infected vs mock‐infected mice. The data suggest peripheral inflammatory stress events alter microglial transcriptional profiles and a “reset” to the original baseline profile is not immediate. The implications on neurodegeneration are being explored.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/79f5f8c0e4dfe741508526e81fb59b5018895daf" target='_blank'>
              Multiomic Insights into Inflammation‐Driven Microglial Dysregulation in AD
              </a>
            </td>
          <td>
            Stella R Wroblewski, Sara Morris, Gabrielle Blahusiak, Vivianne E. Morrison, Elizabeth Engler-Chiurazzi, Kevin J. Zwezdaryk
          </td>
          <td>2025-12-01</td>
          <td>Alzheimer's & Dementia</td>
          <td>0</td>
          <td>4</td>
        </tr>

        <tr id="


 Our goal was to understand the host immune response following the SARS-CoV-2 infection and finding an effective immune-therapeutic intervention. Mice infected with a mouse-adapted strain of SARS-CoV-2 (MA-10) showed increased CXCR3 signaling compared to sham-challenged mice, as observed by the increased expression of CXCR3 and its ligands CXCL9, CXCL10, and CXCL11 in lungs. Flow cytometry revealed that CXCR3+ T cells, Innate lymphoid cells, and macrophages were associated with the recovery following MA-10 infection. Interestingly, blocking CXCR3 signaling with monoclonal antibodies worsened disease outcomes measured by survival (P = 0.02), clinical scores (P = 0.006 on day 5 pi), and weight loss (P = 0.002 on day 5 pi). A plaque assay of lung lysates showed that aCXCR3 treated mice had impaired viral clearance (P = 0.02). Administering aCXCR3 showed a similar phenotype in Rag2-/- mice, suggesting that the CXCR3-mediated protection was conferred by innate immune cells. To investigate the role of alveolar macrophages, we stained for CD169, CD11c, and the SARS-CoV2 nucleocapsid. Immunostains confirmed that aCXCR3-treated mice had higher viral loads in the lungs. Although CD169+CD11c+ alveolar macrophages were comparable between the groups, the number of alveolar macrophages that phagocytosed viruses were significantly lower in aCXCR3 treated mice (P < 0.0001). We conclude that CXCR3 signaling in alveolar macrophages is indispensable to clear viral load during SARS-CoV2 infection.



 Innate Immune Responses and Host Defense: Cellular Mechanisms (INC)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c93327417a4edf7f16144b0bb41ca1916c870d3f" target='_blank'>
              CXCR3+ Alveolar macrophages help to clear viral load during SARS-CoV-2 infection 9049
              </a>
            </td>
          <td>
            Md Jashim Uddin
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>4</td>
        </tr>

        <tr id="Cerebral malaria (CM), a lethal neurological complication of Plasmodium falciparum, is characterized by blood–brain barrier (BBB) disruption. Although astrocytes constitute essential components of the BBB neurovascular unit, their immunoregulatory functions during CM pathogenesis remain elusive. Clinical evidence of altered copper homeostasis in patients with CM, coupled with known associations between copper dysregulation and astrocyte reactivity, prompted investigation of cuproptosis—a copper-dependent programmed cell death pathway—in the disease progression of CM. Using a P. berghei ANKA (PbA)-induced experimental CM (ECM) model in C57BL/6 mice, we evaluated pharmacological modulation with copper ionophore disulfiram (DSF) versus copper chelator tetrathiomolybdate (TTM). Parallel in vitro experiments assessed astrocytes stimulated by PbA-infected red blood cells (iRBCs)/blood-stage soluble antigen (PbAg) under DSF-CuCl2 or TTM-CuCl2 treatment. ECM mice demonstrated significant cerebral copper accumulation with concomitant upregulation of cuproptosis markers (SLC31A1, FDX1, DLAT, and DLST) and downregulation of ATP7A copper transporter. DSF administration exacerbated ECM progression through amplified parasitemia, aggravated BBB permeability, cerebral edema, and neuroinflammatory responses, whereas TTM treatment counteracted these pathological manifestations. Immunohistochemical analysis revealed DSF-induced astrocyte reactivity (GFAP+/Serping1+) with colocalization of cuproptosis markers (GFAP+-SLC31A1+/FDX1+/DLAT+/DLST+), contrasting with TTM-mediated suppression. In vitro, DSF-CuCl2 treatment augmented iRBC-stimulated astrocyte expression of reactivity markers (GFAP and Serping1), cuproptosis regulators (SLC31A1, FDX1, DLAT, and DLST), and proinflammatory mediators (CXCL10, tumor necrosis factor (TNF)-ɑ, interleukin (IL)-1β, and IL-6), but conversely reduced PbAg-stimulated cell viability. These effects were reversed by TTM-CuCl2 treatment. These findings establish that cuproptosis exacerbates ECM pathogenesis by promoting astrocyte reactivity, highlighting copper homeostasis modulation as a potential therapeutic strategy for CM.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/3aedf7f33675e0c556ca99fbe3a185fc9a211848" target='_blank'>
              Cuproptosis-driven astrocyte reactivity exacerbates experimental cerebral malaria pathogenesis
              </a>
            </td>
          <td>
            Xinpeng Hou, Xiumei Mo, Xiaoran Zhang, Qi Wang, Xiaoyan Chen, Chufang Lai, Jiamei Gao, Lirong Wu, Wenbin Liu, Jiajing He, Xingda Zeng, Hui Yin, Zujun Deng, Tao Liu, Minqiu Ye, Zhenlong Liu, Xiaobao Jin, Jianping Song, Jie Wang, Bo Huang
          </td>
          <td>2025-11-10</td>
          <td>Parasites & Vectors</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="Long COVID has emerged as a major global health concern, yet the long-term trajectory of immune recovery and its contribution to persistent symptoms remain to be elucidated. Here, we conducted a three-year longitudinal follow-up of the 47 COVID-19 patients and applied single-cell RNA sequencing (scRNA-seq) and multiplex cytokine profiling to comprehensively characterize the peripheral immune landscape during convalescence. We observed persistent immune dysregulation up to three years post-infection, characterized by chronic inflammation and impaired restoration of naïve CD4⁺ T cells, naïve CD8⁺ T cells, and SLC4A10⁺ MAIT cells—features reminiscent of immunosenescence. Notably, Th17 cells, rather than monocytes, emerged as key drivers of chronic inflammation beyond one year. We identified two distinct Th17 subsets: RORC⁺ Th17 cells and LTB⁺ Th17 cells. While RORC⁺ Th17 cells were negatively correlated with inflammatory cytokine levels, LTB⁺ Th17 cells showed proinflammatory features and were positively associated with long COVID symptoms. Sustained elevation of S100A8 and IL-16 in follow-up patients may contribute to the persistent presence of LTB⁺ Th17 cells. Together, our study provides an in-depth longitudinal map of immune remodeling in COVID-19 convalescents, revealing key cellular and molecular drivers of sustained inflammation up to three years post-infection.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f682ef5df5972e318b0093c3cf2459508e92d089" target='_blank'>
              T cell-driven sustained inflammation and immune dysregulation mimicking immunosenescence for up to three years post-COVID-19
              </a>
            </td>
          <td>
            Tian Zheng, Ru Gao, Yiwei Liu, Ye-ming Wang, Chao Wu, Li Guo, Lan Chen, Xinming Wang, Yan Xiao, Jingchuan Zhong, Rongling Zhang, Ying Wang, Xianwen Ren, Bin Cao, Lili Ren, Jianwei Wang
          </td>
          <td>2025-11-20</td>
          <td>Immunity & Inflammation</td>
          <td>0</td>
          <td>33</td>
        </tr>

        <tr id="Background Severe COVID-19 is frequently associated with acute respiratory distress syndrome (ARDS) and prolonged pulmonary sequelae. Persistent immune activation, including dysregulated B cell responses and increased proinflammatory chemokines, has been linked to the post-acute sequelae of SARS-CoV-2 infection. However, the mechanisms linking these factors remain poorly defined. Methods Sixty patients were studied four months after acute COVID-19, including 34 who developed ARDS, 26 who did not develop ARDS, and 12 healthy controls. Clinical, computed tomography scan (CT), and diffusion capacity of the lungs for carbon monoxide (DLCOc) assessments were performed. Anti-SARS-CoV-2 IgM/IgG levels were quantified, circulating B cell subsets were characterized, and circulating cytokines and chemokines were measured. CXCR3 expression on B cells was analyzed by spectral flow cytometry. In vitro assays were performed to evaluate the effects of CXCL9 and CXCL10 on B cell activation, plasma cell differentiation, IgG production, and CD40L expression on CD4+ T cells. Associations between immunological markers and pulmonary sequelae were assessed. Results IgG, but not IgM, levels were significantly higher in patients with ARDS than in patients without ARDS. Both COVID-19 groups showed a reduction in CD19+CD20+ B cells and an increase in plasmablasts compared to controls. Serum levels of CXCL9 and CXCL10, but not other cytokines, positively correlated with IgG levels. In vitro, CXCL9 increased CD86 expression on B cells, while both chemokines promoted plasma cell differentiation (CD27+CD38+, CD138+) and increased total IgG secretion. CXCL9 also increased the expression of CXCR3 and CD40L on activated CD4+ T cells. Clinically, patients with combined CT abnormalities and reduced DLCO had the highest levels of IgG, CXCL9, and CXCL10. Conclusion Four months after COVID-19, patients with prior ARDS and persistent pulmonary sequelae exhibit sustained elevations of anti-SARS-CoV-2 IgG and chemokines CXCL9 and CXCL10. Both chemokines directly enhance B cell differentiation into IgG-secreting plasma cells in vitro, while CXCL9 also increases CD4+ T cell help, suggesting a mechanistic link between chronic inflammation, increased humoral responses, and long-term lung impairment. Targeting CXCL9/CXCL10–CXCR3 signaling could offer therapeutic potential to mitigate post-COVID pulmonary complications.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1f87e4a08188abb1875547220225dd7d5712072b" target='_blank'>
              CXCL9 and CXCL10 support the exacerbated humoral response in recovered COVID-19 patients who developed acute respiratory distress syndrome by promoting plasma cell differentiation, whereas CXCL9 also induces CD40L and CXCR3 upregulation on T helper cells
              </a>
            </td>
          <td>
            R. Quiroga, Sergio Sanhueza, Catalina Sepúlveda, Bárbara Antilef, C. Munoz, Camilo Cabrera, M. Fraga, Faryd Llerena, L. Lamperti, M. I. Barria, Alicia Colombo, Gonzalo Labarca, Mario Henriquez-beltran, Luciano Ferrada, Estefanía Nova-Lamperti
          </td>
          <td>2025-12-04</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>17</td>
        </tr>

        <tr id="


 Obesity is a significant risk factor for worse clinical outcomes in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection. Although obesity is known to alter immune function, the mechanisms by which it affects local and systemic SARS-CoV-2 immunity and worsens disease severity remain unclear. Here, we compared virus–host dynamics in genetically obese Lepob (ob/ob) mice and lean control mice after intranasal infection with SARS-CoV-2 Beta (B.1.351). Obese mice exhibited delayed viral clearance from the lungs, worse histopathologic pulmonary injury, and worse clinical outcomes compared with infected lean mice. Pulmonary CD8+ T cells in obese mice displayed an exaggerated SARS-CoV-2-specific cytokine response and a marked shift in energy metabolism towards preferential fatty acid utilization. SARS-CoV-2 clearance from the lungs of obese mice was normalized by adoptive transfer of CD8+ T cells from SARS-CoV-2-immune lean mice. Collectively, these data suggest that obesity is associated with cell-autonomous metabolic and immunologic abnormalities in pulmonary SARS-CoV-2-specific CD8+ T cells that contribute to delayed viral clearance and worse clinical outcomes in infected obese mice.



 This study was funded by National Institutes of Health grants U19 AI142790-02S1 (to SS and EOS), the GHR Foundation (to SS and EOS), the Arvin Gottleib Foundation (to SS), and the Overton family (to SS and EOS). This research was also supported by a La Jolla Institute for Immunology (LJI) /Kyowa Kirin Inc. (KKNA) Interactive Fund.



 Viral Immunology (VIR)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/fa87bcd3d35d948a0e1cb2e9e259c54c267d8b95" target='_blank'>
              Obesity Alters the Metabolic and Immunologic Response of Pulmonary T Cells to SARS-CoV-2 Infection 2143
              </a>
            </td>
          <td>
            Shailendra Kumar Verma, Julia Timis, Erin Maule, A. E. Ngono, Fernanda Ana-Sosa-Batiz, Robyn Miller, Kathryn Hastie, E. Saphire, Kenneth Kim, Thomas Riffelmacher, S. Shresta
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>54</td>
        </tr>

        <tr id="This study investigated how prolonged aggression in male CD1 mice alters responses to chronic LPS (lipopolysaccharide)-induced inflammation. Experience of aggression induced pathological aggression in 36% of mice. Following LPS, aggressors resolved systemic inflammation within five days—evidenced by normalized locomotor activity, WBC (white blood cells), and lymphocyte counts—while controls remained inflamed. LPS did not alter established aggression or anxiety. Furthermore, aggressors demonstrated accelerated inflammation resolution in the brain, showing a higher proportion of resting microglia and a lower percentage of activated microglia following LPS-induced inflammation compared to control animals. Gene expression analysis revealed a more pronounced inflammatory response in the hypothalamus than in the nucleus accumbens. Aggressive mice exhibited a profile associated with inflammation resolution, indicated by increased expression of the Trem2 gene. These differential immune responses may be modulated by the dopaminergic system. Elevated Drd1 gene expression in the hypothalamus could possibly contribute to the anti-inflammatory signaling, while changes in nucleus accumbens dopaminergic activity, involving D2 receptor activation, appear linked to the development of pathological aggression. Thus, this study demonstrates that prolonged aggression induces persistent changes in behavioral, neuroimmune, and neuroendocrine systems in male CD1 mice. Aggressive animals develop a distinct neuroimmune phenotype characterized by accelerated resolution of both systemic and brain inflammation following LPS challenge.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e8af717818ae65429c337dd3a00e34367f6925bd" target='_blank'>
              Prolonged Aggressive Experience Accelerates Resolution of Inflammation in Blood and Microglia After Repeated LPS Treatment
              </a>
            </td>
          <td>
            Anastasia Mutovina, A. Sapronova, Kseniya Ayriyants, Yulia Ryabushkina, Julia Khantakova, Polina Mezhevalova, Polina Ritter, Natalya Bondar
          </td>
          <td>2025-12-01</td>
          <td>International Journal of Molecular Sciences</td>
          <td>0</td>
          <td>4</td>
        </tr>

        <tr id="Background. Asthma is a chronic progressive heterogeneous respiratory disease accompanied by the development of a systemic inflammatory response. Due to the widespread prevalence of the novel coronavirus infection, there is concern about the impact of COVID-19 on patients with asthma. Current evidence suggests that SARS-CoV-2 activates the inflammasome response, triggering a hyperinflammatory reaction in patients with asthma, but the long-term consequences are still insufficiently studied. 
Purpose. To study the features of the systemic inflammatory process over six months after SARS-COV-2 infection in individuals with asthma. 
Materials and methods. In patients with mild, partially controlled asthma after mild COVID-19 infection (n = 52) and individuals with asthma (n = 34) who did not contract COVID-19, an assessment of inflammatory markers in peripheral blood was performed. Patients were examined immediately after recovery and confirmation of a negative SARS-COV-2 test result; one month, three months, and six months after the infection. The control group included conditionally healthy volunteers (n=15) who did not contract COVID-19. The cellular composition of peripheral blood, ESR, CRP, D-dimer levels were determined by classical methods; interleukin concentrations: (IL)-1β, IL-6, IL-18, NOD-like receptor protein 3 (NLRP3) inflammasome, gasdermin D (GSDMD) were measured by ELISA methods. 
Results. It was revealed that for all studied parameters, there is a slow decrease in the level of indicators by six months. The levels of GSDMD, platelets, IL-1β, D-dimer, ESR, IL-6, NLRP3 after six months do not reach the values of the control group, which indicates a persistent hyperinflammatory response of the immune system. 
Conclusion. Activation of NLRP3 and gasdermin D by the SARS-CoV-2 virus directly or indirectly can lead to dysregulation of inflammasome-mediated mechanisms, triggering and maintaining a hyperinflammatory reaction for six months, prolonging the recovery process in patients with asthma. The study of these processes will expand the understanding of the pathological mechanism. This will allow the development of new therapeutic strategies for asthma patients who have suffered from the novel coronavirus infection.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/4989330952617c30321fd95e1d3a822ad386e019" target='_blank'>
              Dynamics of inflammatory markers over six months in patients with asthma who underwent COVID‑19
              </a>
            </td>
          <td>
            T. G. Lobova, T. Vitkina
          </td>
          <td>2025-10-31</td>
          <td>Siberian Journal of Life Sciences and Agriculture</td>
          <td>0</td>
          <td>10</td>
        </tr>

        <tr id="Alcohol use disorder (AUD) is associated with significant neuroimmune dysregulation, with microglia emerging as a potential pathological driver of neurotoxicity. However, the molecular landscape driving this alcohol-induced reactivity has yet to be uncovered, especially in the context of human microglia. Here, we comprehensively characterized global-scale molecular changes of human stem cell-derived microglia (iMGLs) after exposure to ethanol and inflammatory mediators lipopolysaccharide (LPS) and TNFα using mass spectrometry-based proteomics. KOLF2.1J hiPSCs were differentiated to iMGLs utilizing commercially available kits and treated with multiple ethanol exposure paradigms, LPS, and TNFα. Proteomic profiles were assessed by data-independent acquisition (DIA) mass spectrometry, followed by a Luminex cytokine assay and a functional phagocytosis assay. Ethanol produced distinct, temporally dependent proteomic changes that differed markedly from the robust proinflammatory responses induced by LPS and TNFα. Cytokine measurement confirmed an overall lack of proinflammatory responses of iMGLs treated with ethanol in contrast to the elevated levels in LPS- and TNFα-treated cells. However, Ingenuity Pathway Analysis and flow cytometry revealed an increase in phagocytosis of iMGLs treated with ethanol for 48 hours. Our findings demonstrate that ethanol exposure induces distinct and temporally dependent molecular phenotypes in human iMGLs, which differ markedly from the robust proinflammatory responses elicited by LPS and TNFα. The novel pathways identified in this study will provide new insights into the human-specific response to ethanol and emphasizes the importance of utilizing human-specific models for neuroimmune interactions in AUD.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/243231cde6c0b823c9ec42396c1fb1a29f3ae249" target='_blank'>
              Deep Proteomic Profiling of Human Stem Cell-Derived Microglia: Insights Into Inflammatory and Alcohol-Induced Reactivity
              </a>
            </td>
          <td>
            Tiara Wolf, Jessica Wohlfahrt, Jennifer Guergues, Stanley M. Stevens
          </td>
          <td>2025-11-17</td>
          <td>Research Square</td>
          <td>0</td>
          <td>6</td>
        </tr>

        <tr id="Background
Little information is available on the immune signaling pathway that drives severe COVID-19 in asthma. Our study evaluates the association between immune dysfunction and progression to severe COVID-19 in asthma using single-cell RNA sequencing.


Methods
Four patients with asthma and eight patients without asthma from three centers in South Korea were used for this analysis. For each patient, samples were collected over three-time points: at the time of COVID-19 infection, one week later, and two weeks later.


Results
They were classified into four groups according to the presence or absence of asthma and COVID-19 severity; non-asthma/mild COVID-19 (n=5), non-asthma/severe COVID-19 (n=3), asthma/mild COVID-19 (n=3), and asthma/severe COVID-19 (n=1) groups. A high-quality scRNA-seq dataset composed of 155,565 cells was generated that characterized peripheral immune cells. When the proportion of cell type was analyzed by time points, a decrease in T-cells was shown at the second time point in asthma/severe COVID-19 group compared to other groups. When the proportion of T-cell subtype was analyzed by time points, an increase in the proportion of CD8+ T cell was shown at the second time point in asthma/severe COVID-19 group than in other groups: in DEG analysis, notably, we observed relatively higher levels of cytotoxicity-related genes in asthma/severe COVID-19 compared to other groups.


Conclusion
Our study provides new insights into the mechanisms underlying the progression of COVID-19 infection in patients with asthma. A reduction in the proportion of T cells while expanding cytotoxic CD8+ T cell proportion was associated with severe COVID-19 presentation in asthma.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/024d563473f02b1257c1b2dc0e7510521f7669e6" target='_blank'>
              T cell immune dysfunction and progression to severe COVID-19 in asthma revealed by single-cell RNA sequencing.
              </a>
            </td>
          <td>
            B. Kim, Youlim Kim, Sang Hoon Lee, Siyoung Lee, Minjun Choi, Byeongchan Lee, Jae Seok Jeong, Sang-Heon Kim, Hyun Lee, Kwang Ha Yoo
          </td>
          <td>2025-11-18</td>
          <td>Tuberculosis and respiratory diseases</td>
          <td>0</td>
          <td>11</td>
        </tr>

        <tr id="Parkinson’s disease (PD) is increasingly recognized as a multisystem disorder involving pathological α-synuclein (α-syn) accumulation and widespread neuroimmune dysregulation. Microglia, the resident immune cells in the central nervous system (CNS), are pivotal mediators of the bidirectional communication between the CNS and peripheral systems. In addition to sensing neuronal injury and α-syn pathology, microglia dynamically respond to peripheral immune signals, including circulating cytokines, immune cell infiltration, and microbial metabolites, through pattern recognition receptors such as Toll-like and NOD-like receptors. Furthermore, microglia regulate blood–brain barrier integrity, modulate peripheral immune cell recruitment, interact with meningeal lymphatic vessels, and contribute to the propagation of α-syn within the CNS and along the gut–brain axis. However, a comprehensive framework encompassing their diverse roles in peripheral–central immune crosstalk remains underdeveloped. This review synthesizes recent advances elucidating how microglia link the CNS to peripheral immune and metabolic signals in PD. We further highlight microglial contributions to α-syn propagation along the gut–brain axis and discuss how their functional states influence disease progression. A deeper understanding of microglial involvement in this complex neuroimmune interface may inform the development of effective and system-level therapeutic strategies for PD.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/40b4787f9c236f2822ea4097343456b74122cbca" target='_blank'>
              Microglia in the crosstalk between peripheral and central nervous systems in Parkinson’s disease
              </a>
            </td>
          <td>
            Tianbai Li, Tao Qiu, Fei Jiang, Huaibin Cai, Weidong Le
          </td>
          <td>2025-12-01</td>
          <td>Translational Neurodegeneration</td>
          <td>0</td>
          <td>16</td>
        </tr>

        <tr id="Sepsis remains a leading global cause of death, with immune heterogeneity’s molecular mechanisms poorly understood. This study analyzed 1,862 human peripheral blood samples, constructing a molecular interaction disturbance network that first revealed the network biology underlying sepsis immune heterogeneity. We identified 3 sepsis subtypes with marked different prognostic characteristics, with the C1 subtype showing the worst prognosis characterized by severe CD4+ T cell exhaustion—validated across 10 independent cohorts. Integrating single-cell transcriptomics from over 450,000 cells, proteomics, and functional validation, we identified monocyte-derived matrix metalloproteinase-9 (MMP9) as a key regulator driving CD4+ T cell dysfunction. Mechanistically, MMP9 modulates T cell exhaustion through dual mechanisms: promoting leukocyte-associated immunoglobulin-like receptor-1 (Lair-1) aggregation on T cell membranes, directly inhibiting zeta chain of T cell receptor associated protein kinase 70 (ZAP70) phosphorylation in T cell receptor signaling, while impairing Ca2+-release-activated Ca2+ channel function and intracellular calcium clearance, causing calcium dysregulation that blocks nuclear factor of activated T cells (NFAT) activation and nuclear translocation. The selective MMP9 inhibitor MMP9-in-1 effectively reversed T cell dysfunction, restored calcium homeostasis and NFAT nuclear translocation, markedly enhanced CD4+ T cell interleukin-2 and interferon-γ production, and reduced programmed cell death protein 1 expression. This work establishes a comprehensive translational framework from molecular network disturbances to clinical phenotypes, advancing sepsis immunopathophysiology understanding and providing effective targets for the treatment of sepsis patients.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/669347da1bb81250d0a1cfa9e2302d53bc332296" target='_blank'>
              Targeting Matrix Metalloproteinase-9 to Alleviate T Cell Exhaustion and Improve Sepsis Prognosis
              </a>
            </td>
          <td>
            Xuan Wang, Jingyuan Ning, Liang Zhou, Hongru Li, Jinlei Cui, Jiachao Wang, Xiangyang Liang, Jinquan Li, Miao Li, Xue Gao, Wen-jian Li, Xing Chen, Fei Yu, Lin Wei, Cuiqing Ma
          </td>
          <td>2025-11-02</td>
          <td>Research</td>
          <td>0</td>
          <td>8</td>
        </tr>

        <tr id="Background Recurrent miscarriage (RM), characterized by the loss of two or more consecutive pregnancies, is a significant challenge in reproductive medicine. While immunological dysregulation is increasingly recognized as a key contributor, the role of innate immunity, particularly neutrophils, remains underexplored. Understanding neutrophil-driven immune mechanisms may provide novel diagnostic and therapeutic insights for RM. Methods We integrated bulk transcriptomic datasets from RM, autoimmune diseases, and decidua single-cell RNA sequencing data. Differentially expressed genes (DEGs) and enriched pathways were identified, and intercellular communication was analyzed using CellChat. Key genes (KGs) were validated through ROC analysis, nomogram modeling, and experimental validation in trophoblast cells. Results Single-cell profiling revealed increased neutrophil proportions and distinct activation states in RM. Neutrophils exhibited a TNF-α-driven polarized phenotype with upregulated oxidative stress and antigen presentation. Intercellular communication analysis identified the APP-CD74 axis as a key signaling pathway. CXCL1 and related genes were consistently upregulated and showed strong diagnostic performance. Molecular docking identified potential therapeutic compounds targeting CXCL1, and in vitro assays confirmed immune-mediated trophoblast injury. Conclusions Neutrophil-driven immune dysregulation, with TNF-α-polarized neutrophils and APP–CD74 signaling, contributes to RM pathogenesis. CXCL1 and related genes serve as promising biomarkers, offering new opportunities for early diagnosis and therapeutic intervention.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/260d710e2e29f18d73188670fe733dcdddcf047d" target='_blank'>
              Neutrophil-mediated immune dysregulation in recurrent miscarriage: implications of APP–CD74 signaling and CXCL1 as diagnostic biomarkers
              </a>
            </td>
          <td>
            Shan He, Fei Ma, Meng Yu, Jia-man Wu, , Ke-wang Luo, Hong Chang, Qi Liang, Yan Ning
          </td>
          <td>2025-12-04</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="The effects of antiretroviral therapy (ART) and treatment interruption on myeloid cell egress from the central nervous system (CNS) during human immunodeficiency virus (HIV) and simian immunodeficiency virus (SIV) infection remain poorly defined. We hypothesized that CNS macrophages normally traffic out of the CNS, accumulate during viral infection and inflammation, and are released as inflammation resolves. To test this, we administered intracisternal (i.c.) injections of two different colored fluorescent superparamagnetic iron oxide nanoparticles (SPION) to SIV-infected macaques either early in infection (12–14 dpi) or 30 days before necropsy. SPION are preferentially taken up by perivascular, meningeal, and choroid plexus macrophages, enabling us to track macrophage turnover, infection, and migration. In non-infected macaques, SPION+ macrophages trafficked from the CNS to peripheral sites including the deep cervical lymph node (dCLN), lumbar lymph nodes, spleen, and dorsal root ganglia (DRG). With SIV infection, these cells accumulated in the CNS and showed reduced peripheral trafficking. ART decreased the number of SPION+ perivascular macrophages, and to a lesser extent, meningeal or choroid plexus macrophages. After ART interruption, SPION+ perivascular and choroid plexus macrophage numbers remained stable, whereas SPION+ meningeal macrophages increased. ART eliminated SIV-RNA+ perivascular macrophages, leaving few- scattered SIV-RNA+ cells in the meninges and choroid plexus. Following ART interruption, perivascular macrophages remained virus-negative, but scattered viral RNA+ meningeal macrophages persisted. In non-infected macaques, SPION+ macrophages trafficked to the dCLN, spleen, and DRG, but this trafficking diminished with SIV infection and AIDS with SIVE. Importantly, SIV-RNA+ SPION+ macrophages that exited the CNS were cleared by ART and did not reappear after treatment interruption. Using two differently colored SPION to assess establishment of CNS viral reservoirs, we observed higher numbers of early-labeled macrophages within and outside the CNS in animals with AIDS and SIVE, ART treatment, and ART interruption. These findings support a model in which SIV-infected perivascular macrophages seed an early CNS viral reservoir, while the meninges and choroid plexus undergo continual viral seeding during infection. ART reduces trafficking of infected macrophages out of the CNS and clears the perivascular macrophage reservoir, but SIV-RNA+ meningeal macrophages can persist, in low numbers, and can rebound after ART interruption.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/978817c1cd51902524161c071846dc82c1a681a8" target='_blank'>
              Resolving inflammation: The impact of antiretroviral therapy on macrophage traffic in and out of the CNS
              </a>
            </td>
          <td>
            Zoey K. Wallis, C. Midkiff, Miaoyun Zhao, P. Autissier, Soon Ok Kim, Addison Q. Amadeck, Yiwei Wang, M. Jakubowski, Tricia H Burdo, Andrew D. Miller, Qingsheng Li, Xavier Alvarez, Robert V. Blair, Kenneth C Williams
          </td>
          <td>2025-12-01</td>
          <td>PLOS Pathogens</td>
          <td>0</td>
          <td>22</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c50d95b7ee1f0918516a315eb52760cde23237c7" target='_blank'>
              Ferrapoptosis: Discovery of a Hybrid Programmed Cell Death
              </a>
            </td>
          <td>
            Qiuyun Yang, Yang Chen, Yang Shen, Xiao Zhang, Xianliang Chen, Xinnan Zhao, Ruixuan Yuan, Manrui Li, Yang Xu, Xilong Lin, Yihan Sun, Shengyuan Zuo, Xinyang Liu, Zhuo Li, Ying Chen, Shichun Wang, Meili Lv, Lin Zhang, Weibo Liang, Xiameng Chen
          </td>
          <td>2025-11-27</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>10</td>
        </tr>

        <tr id="Neurotropic viruses, such as Japanese encephalitis virus (JEV), trigger central nervous system (CNS) inflammation primarily through disruption of the blood–brain barrier (BBB) and infiltration of peripheral immune cells. Although the gut microbiota is known to regulate diverse immunopathological processes, its contribution to CNS neuroinflammation and systemic immune responses during neurotropic viral infection remains poorly understood. Here, we show that depletion of gut microbiota by antibiotic cocktail treatment markedly increases susceptibility to CNS neuroinflammation following JEV infection. Loss of microbiota promoted viral dissemination into extraneural tissues, aggravated systemic inflammation and organ damage, and impaired tonic type I interferon (IFN-I) responses and hematopoietic differentiation during disease progression. Remarkably, fecal microbiota transplantation (FMT) restored resistance to CNS neuroinflammation, highlighting the protective role of the microbiota. Moreover, ampicillin-mediated depletion of specific gram-positive bacteria—including Bifidobacterium, Faecalibaculum, Ligilactobacillus, and Turicibacter—was associated with enhanced viral spread, systemic inflammation, and organ injury, accompanied by distinct shifts in fecal metabolites. Collectively, these findings demonstrate that gut microbiota–driven tonic IFN-I responses limit viral dissemination in extraneural tissues, thereby attenuating systemic inflammation and protecting against CNS neuroinflammation, particularly viral encephalitis.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/05dc7ecb536c1f8f63866db104e2581d4fc3e266" target='_blank'>
              The gut microbiota limits systemic inflammation during neurotrophic viral CNS infection by priming tonic type I interferon signaling
              </a>
            </td>
          <td>
            Hye Won Cho, Hee Won Byeon, S. Park, Erdenebileg Uyangaa, Jin Young Choi, Koanhoi Kim, S. Eo
          </td>
          <td>2025-11-04</td>
          <td>Journal of Neuroinflammation</td>
          <td>0</td>
          <td>28</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/96d3861c110e5ae3f35e700cedd4412c7f059c98" target='_blank'>
              T-cell Multiomic Analysis Identifies Subsets and Mechanisms of Interaction with Epithelial Cells in Idiopathic Pulmonary Fibrosis
              </a>
            </td>
          <td>
            A. Serezani, Julia M. R. Bazzano, B. Pascoalino, Ludmilla da Silva, Abigail J. Dietrich, Chase J. Taylor, T. Sherrill, C. Calvi, Paula I. Gonzalez-Ericsson, E. Wilfong, Matthew D Bacchetta, C. Shaver, Lorraine B. Ware, M.L. Salisbury, Luc Van Kaer, N. Banovich, JA Kropski, Timothy S. Blackwell
          </td>
          <td>2025-11-19</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>31</td>
        </tr>

        <tr id="


 Peroxisomes are vital yet often overlooked metabolic organelles. Here we demonstrate that exuberant interferon signaling remodeled the macrophage peroxisome compartment after severe COVID-19. Lack of macrophage peroxisomes resulted in impaired inflammation resolution and defective lung repair, causing heightened acute morbidity and mortality during SARS-CoV-2 infection. Peroxisomes exhibited cell-type specific modulation of lipid metabolism, enhancing mitochondrial health critical for lung macrophage repair program and alveolar cell self-renewal. Peroxisomes also prevented excessive inflammasome activation and IL-1β release, thereby limiting the accumulation of KRT8high dysplastic epithelial progenitors and facilitating their proper differentiation into functional alveolar cells post viral injury. Dysfunction in macrophage peroxisomes contributed to chronic lung pathology and fibrosis post SARS-CoV-2 infection. Furthermore, pharmacologically enhancing peroxisome biogenesis mitigated acute symptoms and limited chronic sequelae post SARS-CoV-2 infection (PASC). Our data reveal a peroxisome-centric pro-recovery therapeutic strategy for managing both acute and chronic conditions after respiratory viral infections.



 The study was in part supported by the US National Institutes of Health grants AI147394, AG069264, AI112844, HL170961, AI176171 and AI154598 to J.S, R01HL132287, R01HL167202 and R01HL132177 to Y.M.S, F31HL170746 and T32AI007496 to H.N, R01HL155759 and R01HL159953 to P.C, P01-HL108793 to D.J, and HL159675, HL152293 and AI163753 to J.Q.



 Viral Immunology (VIR)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/31916c623de231a4bb589cd8541da198e144c336" target='_blank'>
              Macrophage peroxisomes guide alveolar regeneration and limit post-acute sequelae of SARS-CoV-2 infection (PASC) 2101
              </a>
            </td>
          <td>
            Xiaoqin Wei, Jie Sun
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>4</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/ff36a4b1a6924bc75f6af8503f56e2c97056bea0" target='_blank'>
              Dormant viral pathways underlie space-induced neural senescence – a neuroprotective strategy for spaceflight and neurological diseases
              </a>
            </td>
          <td>
            A. M. Martins, Hideyuki Nakashima, Angela Macia, Taichi Umeyama, Satoshi Miyashita, Livia Luz de Souza Nascimento, Luisa Bulcao Vieira Coelho, Pinar Mesci, Erik Viirre, Nicole Suarez, Aurian Saleh, Alex Savchenko, Beatriz Freitas, Aline L. Leite, Diego M. Assis, Masataka Ishizu, Tomoo Owa, Mikio Hoshino, John R. Yates, Kinichi Nakashima, A. Muotri
          </td>
          <td>2025-11-04</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>68</td>
        </tr>

        <tr id="A major health challenge resulting from the COVID-19 pandemic is the manifestation of post-acute sequelae of SARS-CoV-2 (PASC). PASC (or long COVID) is a collective term used for clinical symptoms, various pathologies, and life-quality-changing functional impairment that persist for months to years after the initial SARS-CoV-2 infection. The mechanisms underlying PASC are not understood, although advances have been made in identifying factors that may contribute to long-term pathology. Recent data have emerged, showing an association between SARS-CoV-2 viral persistence and non-SARS-CoV-2 infections (pre-existing, viral reactivation, or new infections) in facilitating or mediating PASC. However, the heterogeneous nature and timing of co-infections have made it challenging to understand, interpret, and contextualize their contribution to PASC. Here, we summarize the impact of potential viral, bacterial, and fungal infections on SARS-CoV-2 pathogenesis, with a focus on their possible roles in the development of PASC. We also provide a framework to understand the mechanisms of PASC and inform basic, translational, and clinical research initiatives, including RECOVER, a large and ongoing research initiative to understand, treat, and prevent long COVID.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/000f98d578723e631538234351febf6a80fd995b" target='_blank'>
              The role of co-infection in the pathogenesis of acute SARS-CoV-2 infection and development of post-acute sequelae: A perspective
              </a>
            </td>
          <td>
            T. Henrich, Christopher P Montgomery, Joerg Graf, Nahed Ismali, S. Mohandas, Mehul Suthar, Hassan Brim, John M Coffin, Aayush Pagaria, Jeisac Guzmán Rivera, Urmila Vudali, P.S. Keim, Guangming Zhong, Rebecca McGrath, Belinda Edwards, Adolfo García-Sastre, M. Gennaro
          </td>
          <td>2025-11-17</td>
          <td>eLife</td>
          <td>0</td>
          <td>47</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/730bda77c6f77da1330b66ac6126520d39d7c77d" target='_blank'>
              Longitudinal gene expression analysis in COVID-19 sepsis highlights dynamic immune, cellular, and metabolic dysfunction in high severity patients.
              </a>
            </td>
          <td>
            Andy An, Arjun Baghela, Peter Zhang, Travis M. Blimkie, Jeff Gauthier, Daniel E Kaufmann, E. Acton, Amy H. Lee, Roger C. Levesque, Robert E. W. Hancock
          </td>
          <td>2025-12-19</td>
          <td>Scientific reports</td>
          <td>0</td>
          <td>9</td>
        </tr>

        <tr id="Greater than a hundred genetic risk factors for Alzheimer’s disease (AD) have been identified by genome-wide association studies (GWAS), many of which are primarily expressed in microglia. However, the pathogenic role for most of them remains unclear. We sought to assess at scale how AD GWAS hits influence human microglial inflammatory responses. Thus, we conducted CRISPR inhibition (CRISPRi) screens of 119 AD GWAS hits in hiPSC-derived microglia (iMGLs), with reactive oxygen species (ROS) produced in response to the viral mimic poly(I:C) as a readout. Top hits that either decreased or increased ROS in response to poly(I:C) when knocked down were then interrogated in CROP-seq experiments, where CRISPRi was combined with single cell RNA-sequencing (scRNA-seq). These analyses identified 9 unique microglial clusters, including a poly(I:C)-driven inflammatory cluster (2). Emerging evidence supports a pathogenic role of viral infections in AD and our scRNA-seq showed significant overlap with AD-relevant microglial clusters. Knockdown (KD) of two hit genes, MS4A6A and EED, which lead to high levels of ROS in the presence of poly(I:C), increased the proportion of inflammatory cluster 2 cells and led to functionally related changes in gene expression. In addition, KD of MS4A6A reduced the proportion of iMGLs in the disease-associated microglia (DAM) cluster under all conditions, suggesting that MS4A6A may modulate the DAM response. In contrast, KD of hit genes, INPP5D or RABEP1 which led to low levels of ROS in the presence of poly(I:C), did not significantly affect the proportion of cells in inflammatory cluster 2 but rather shaped the inflammatory response. This included upregulation of a poly(I:C)-independent HLA inflammatory cluster (6) by INPP5D KD under all conditions. Despite INPP5D or RABEP1 being involved in disparate biological processes, their perturbation led to similar changes in gene expression, which included changes in genes related to metabolism such as oxidative phosphorylation, suggesting a shared conversion point by which AD GWAS hits affect cell state. Overall, our data begin to elucidate the functional roles played by various AD GWAS hits, including how they regulate and shape inflammatory responses such as those observed in AD. Supplementary Information The online version contains supplementary material available at 10.1186/s12974-025-03562-9.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/497cdf48270eb7ac4fe84bee351f4625ecdcfd71" target='_blank'>
              High throughput identification of genetic regulators of microglial inflammatory processes in Alzheimer's disease
              </a>
            </td>
          <td>
            Christopher L. Cardona, Lai Wei, Joonwon Kim, Ellen Angeles, Gunjandeep Singh, Shiye Chen, Ronak Patel, Nkechime Ifediora, Peter Canoll, A. Teich, Gunnar Hargus, Alejandro Chavez, Andrew A. Sproul
          </td>
          <td>2025-12-03</td>
          <td>Journal of Neuroinflammation</td>
          <td>0</td>
          <td>28</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/29fe25ea72e27bc7febd50ceacab0f0b8d2a1098" target='_blank'>
              SARS-CoV-2 infection and gut-lung axis: the potential role of rifaximin.
              </a>
            </td>
          <td>
            T. N. Almanaa, H. Al-kuraishy, A. Al-Gareeb, Maii A. Abdelnaby, A. Alexiou, M. Papadakis, Islam E Abo-ElFetoh, G. Batiha
          </td>
          <td>2025-12-18</td>
          <td>Inflammopharmacology</td>
          <td>0</td>
          <td>52</td>
        </tr>

        <tr id="Influenza A virus (IAV) is a prevalent pathogen that causes severe respiratory infections worldwide. Currently, the incidence of coinfections between IAV and Gram-negative bacteria has been steadily increasing, and the synergistic interaction between IAV infection and bacterial exposure represents a pivotal risk factor for disease exacerbation. Lipopolysaccharide (LPS), a major Gram-negative bacterial virulence factor, is hypothesized to regulate IAV-induced immune response intensity and disease severity by reshaping the pulmonary immune microenvironment. Here, we established an in vivo coadministration model via intratracheal instillation of low-dose LPS and H1N1 to dissect their synergistic pathogenesis. LPS exposure potentiated H1N1-induced severe lung injury, manifested as persistent neutrophil and monocyte infiltration, elevated levels of cytokines (e.g., CXCL1, CCL2, and IL-6), and alveolar damage without affecting viral replication. Mechanistically, LPS triggered immune hyperactivation through early neutrophil recruitment, neutrophil extracellular trap (NET) formation, and a self-sustaining positive feedback loop. Intervention experiments revealed that the degradation of NETs by DNase I or neutrophil inhibition significantly alleviated lung damage and systemic inflammatory responses. This study establishes NET-driven innate immune amplification as a key mechanism underlying LPS-enhanced H1N1 pathogenicity, offers an immunomodulatory approach for severe bacterial-viral coinfections, and underscores the parity of immunomodulatory therapy with anti-infective treatment.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/8a8204eba4e3f2c05f83c187d56985bc21d9c8f7" target='_blank'>
              Exposure to bacterial lipopolysaccharide aggravates H1N1-mediated lung immunopathology via neutrophil extracellular trap formation
              </a>
            </td>
          <td>
            Guiling Yan, Zhongwen Hu, Yuanyuan Peng, Yuqin Tu, Jingling Xie, Yuchao Zhong, Changchun Niu, Yang Luo
          </td>
          <td>2025-11-18</td>
          <td>Scientific Reports</td>
          <td>0</td>
          <td>1</td>
        </tr>

        <tr id="


 Vaccination is essential for preventing viral infections and promoting public health; however, its efficacy may vary due to factors such as the nature of the pathogen, vaccine type, and individual immune response. It is known that intranasal immunizations can enhance the immune response by stimulating tissue-resident memory T cells (TRMs), which promote early viral clearance at the infection site. Our study aims to optimize the generation and maintenance of TRMs in the lungs using purinergic signaling components as adjuvants. For this, we crossed B knockout mice with hACE2 mice, generating a B cell-deficient lineage capable of internalizing active SARS-CoV-2 (BKO-hACE2). C57BL/6 and BKO-hACE2 mice were immunized with inactivated SARS-CoV-2 receiving one intravenous dose followed by three intranasal booster doses. After 30 days, lungs were analyzed by flow cytometry and histopathology. Additionally, we evaluated the effects of ATP (0.5 mM to 10 mM) during immunizations, finding that lower doses (0.5 mM) increased the frequency of TRMs (CD4+ and CD8+), while higher doses reduced this population. This suggests that ATP may interact with the P2X7 receptor, promoting either proliferation or cell death. Although infection data did not provide conclusive evidence of T cell-mediated protection in the absence of antibodies, the potential of ATP as a possible adjuvant opens new avenues for enhancing immune responses in experimental models.



 FAPESP - 2023/15373-9



 Viral Immunology (VIR)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/988c1a539848238549c2d61fd24576f4f991f375" target='_blank'>
              Enhancing lung immunity against COVID-19: the role of ATP in TRM cell generation 9389
              </a>
            </td>
          <td>
            Marcos Vinícios Pinheiro Cione, Igor Santiago-Carvalho, Luciana dos Santos Barros Manhaes, Rodrigo Jose Rocha Xavier Freitas, Rogério Silva do Nascimento, Viviane Fongaro Botosso, Ana Marcia Sá Guimarães, Henrique Borges da Silva, Jose Maria Alvarez Mosig, M. R. D'Império Lima
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>24</td>
        </tr>

        <tr id="Respiratory syncytial virus (RSV), a filamentous, enveloped, negative-sense, single-stranded RNA virus, is a common cause of respiratory infections in pediatric and elderly populations, often leading to severe inflammation and lung damage. To date, there is no effective treatment for RSV infection. Therefore, elucidating the antiviral mechanism in RSV infection is critical for identifying potential effective therapeutic targets. Type I interferons (IFN-Is), especially IFN-β, play a key role in the immediate immune response against viral infection by inhibiting viral load and spread. Current studies have shown that ARCN1 (archain 1), the δ subunit of the coat protein complex I complex, is involved in intra-Golgi trafficking and protein transport from the Golgi apparatus back to the endoplasmic reticulum. In this study, we demonstrate that ARCN1 suppresses the anti-RSV innate immune response by promoting E3 ubiquitin ligase STUB1-mediated K48-linked polyubiquitination and subsequent proteasomal degradation of IKKε. Mechanistically, ARCN1 recognizes and binds to the δL motif of STUB1 via its flexible MHD domain while interacting with IKKε. This finding provides a theoretical basis for the development of new antiviral treatment strategies targeting ARCN1.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/32c87ced4d49da7da6a4806fe632d757e2e9e8ee" target='_blank'>
              ARCN1 suppresses innate immune responses against respiratory syncytial virus by promoting STUB1-mediated IKKε degradation
              </a>
            </td>
          <td>
            Jiamin Cai, Yunfei Ye, Zhengrong Chen, Fei Xu, Xiaoping Li, Mengyun Wu, Ji Zhou, Yuanyuan Shao, Peijie Zhu, Jing Zhao, Jingjing Hu, Yufeng Wang, Cancheng Li, Xiaoyu Tian, Beibei Huang, Tian Xia, Wenjun Wang, Chuangli Hao, Yi Yang, Jinping Zhang
          </td>
          <td>2025-12-01</td>
          <td>PLOS Pathogens</td>
          <td>0</td>
          <td>13</td>
        </tr>

        <tr id="


 The COVID-19 pandemic remains a significant global challenge, with comorbidities like obesity and diabetes exacerbating the severe outcomes. However, the mechanisms driving heightened susceptibility in these populations are poorly understood. SARS-CoV-2 infection disrupts lipid metabolism pathways regulated by Phospholipase A2 and 12-Lipoxygenase (12-LOX), an enzyme producing pro-inflammatory lipids such as 12-S-hydroxy eicosatetraenoic acid (12-HETE). This study examined the role of 12-LOX in severe COVID-19-associated hyperinflammation and evaluated the therapeutic potential of 12-LOX inhibition. We found elevated 12-LOX expression in lung and pancreatic tissues of diabetic COVID-19 decedents compared to the diabetic individuals with non-COVID-respiratory deaths. In SARS-CoV-2-infected K18-hACE2 mice, 12-LOX expression increased in lung and pancreatic tissues, even without diabetes, mirroring human findings. Treatment with the 12-LOX inhibitor VLX-1005 improved survival in mice receiving high-challenge doses of SARS-CoV-2. VLX-1005 treatment downregulated 30 pro-inflammatory cytokine and chemokine genes while upregulating four anti-inflammatory genes. Treated mice exhibited reduced inflammation and lower viral loads in the lungs. Notably, 12-HETE was undetectable in VLX-1005-treated mice but significantly elevated in controls. These findings demonstrate that 12-LOX inhibition mitigates hyperinflammation and improves survival against severe COVID-19 infection.



 Veralox Therapeutics funded this research.



 Viral Immunology (VIR)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f3243933421cc39c9103bb70aec0f64509f1226f" target='_blank'>
              12-Lipoxygenase Drives Hyperinflammatory Responses and Enhances COVID-19 Severity 9032
              </a>
            </td>
          <td>
            Chandra Shekhar Bakshi, M. D'Silva, Jerry L. Nadler, Dave Meloney
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>4</td>
        </tr>

        <tr id="


 Recent advances in single-cell transcriptomics have revealed significant heterogeneity in microglia, brain-resident macrophages that monitor the brain microenvironment. Disease-associated microglia (DAM), a unique transcriptional state, have been implicated in neurodegeneration and aging. Despite their critical role, the signaling pathways regulating DAM development and their function remain unclear. By overexpressing α-synuclein in neurons, our lab established a mouse model of Parkinson’s Disease (PD) that recapitulates microglial activation, immune cell infiltration, and dopaminergic neuron loss. In our model, we observed an expansion of the DAM transcriptional state and successfully characterized DAM accumulation at the protein level throughout PD progression. This accumulation coincides with reduced immune cell infiltration, linking DAM to chronic neuroinflammation. Using scATAC-seq, we identified transcription factors enriched in distinct microglial states: RelA motifs in acutely activated microglia and Irf4 motifs in DAM. Conditional knockout (cKO) of RelA in microglia reduced immune cell infiltration, whereas IRF4 cKO reduced protein expression of Clec7a, a DAM marker. By blocking transitions between different microglial states, our research aims to elucidate the function and role of α-synuclein-mediated DAM in PD progression and potentially establish DAM as a therapeutic target in neurodegenerative disorders.



 Aligning Science Across Parkinson’s: ASAP



 Neuroimmunology (NEUR)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/4da3d370218c60ccf242a6e1d980c70ae41a4936" target='_blank'>
              The role of α-synuclein-mediated disease-associated microglia in Parkinson’s disease 3319
              </a>
            </td>
          <td>
            Ya-Ting Yang, David A. Figge, Jhodi M. Webster, Aidan T. Miller, Asta Zane, A. Harms
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>24</td>
        </tr>

        <tr id="

 The role of Regulatory T cells (Tregs) in severe COVID-19 remains unclear. Some authors reported that Tregs increased in peripheral circulation, while other investigators reported that these cells decreased in severe COVID-19 patients. The expression of FoxP3 in Tregs remains inconsistent and controversial. These observations have been made using immune phenotyping via flow cytometry and T-cell sequencing; however, none of these data provide a clear indication of what Tregs are doing in this chaotic hyperactivated immune response.



 We conducted a comprehensive characterization of the Treg compartment in a longitudinal cohort of patients with acute COVID-19, including individuals with mild or severe disease. Using RNA-seq, we analyzed gene expression across the cohort, while flow cytometry enabled us to determine Treg phenotype and observe changes during disease progression. Furthermore, we assessed Treg activity through a suppression assay.




 Gene expression analysis revealed significant downregulation of genes involved in regulatory pathways supporting T regs' functional activities, consistent across the severe patients analyzed. In contrast, we found increased expression of these genes in patients with mild disease. This finding was further confirmed by phenotyping analysis, which showed significant differences in CD25
 +
 CD127
 -
 Treg cells between mild and severe patients, positively associated with CTLA-4 and PD-1 inhibitory markers. Surprisingly, these results did not correlate with FoxP3 expression. Furthermore, a high frequency of CD25
 +
 CD127
 -
 Treg cells was associated with young, mild patients. In contrast, a lower frequency of CD25
 +
 CD127
 -
 cells and a higher frequency of FoxP3+ cells were associated with elderly patients. Finally, a Treg functional assay showed a lower capacity for suppression in Tregs obtained from severe patients compared to those from mild patients in the acute phase of the disease.




 Our findings offer critical insights into the role of Tregs in SARS-CoV-2, with implications that extend beyond this viral infection. Understanding how Tregs contribute to immune responses in COVID-19 could inform therapeutic strategies to modulate immune regulation in infectious diseases more broadly.
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/375e622ef27c7342cf0c8ff5baa1cafe0077df24" target='_blank'>
              Longitudinal immune profiling uncovers regulatory T cell signatures associated with the progression of COVID-19
              </a>
            </td>
          <td>
            Camila Kossack, Felipe Bravo, Francisco Fuentes-Villalobos, Claudio Quevedo, Matias A. Medina, Raúl Riquelme, M. Rioseco, Mario Calvo, Karina Pino-Lagos, Felipe Aguilera, M. I. Barria, J. Garrido
          </td>
          <td>2025-12-19</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>17</td>
        </tr>

        <tr id="


 Pathogenic human coronaviruses (hCoVs) cause severe respiratory illness and continue to challenge global public health. These hCoVs suppress anti-viral immunity and elicit excessive inflammation (dysregulated immunity) resulting in acute lung injury and fatal pneumonia. However, the key PAMPs and host factors that facilitate dysregulated immunity are not well understood. Therefore, using murine bone-marrow derived macrophages, we evaluated the mechanistic basis of SARS-CoV-2-induced dysregulated immunity. In novel findings, we show that SARS-CoV-2 structural protein- and viral-RNA-induced toll-like receptor (TLR)-extracellular regulated kinase (ERK)1/2 activity promotes dysregulated immunity in macrophages. Notably, blocking ERK1/2 activity not only reduced inflammatory cytokine response in viral RNA mimic and SARS-CoV-2 structural proteins-stimulated macrophages but also enhanced antiviral IFN-I response, whereas blocking other key inflammatory pathways such as p-38 MAPK, NF-kB, and JNK only suppressed inflammation, highlighting the unique role of ERK1/2 in facilitating hCoV-induced dysregulated immunity. We further show that inhibiting ERK1/2 activity reduced viral titers in SARS-CoV-2 infected human airway epithelial cells and improved survival in MA-CoV-2 infected mice. Collectively, we identify TLR-ERK1/2 signaling as novel pathway that drives SARS-CoV-2-induced dysregulated immunity and blocking this pathway will likely facilitate protective immunity to hCoV infections.



 NIH R21AI186028-01; NIH R01HL165423-01A1; NIH: P30GM149368-02



 Innate Immune Responses and Host Defense: Cellular Mechanisms (INC)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/6727d234f219dfc749f31f2e6c430b70223abdc8" target='_blank'>
              Novel role of TLR-ERK1/2 activation in SARS-CoV-2-induced dysregulated immunity 3869
              </a>
            </td>
          <td>
            Rakshya Shrestha, Roshan Ghimire, Cody Whitley, P. Johnson, Rudra Channappanavar
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>4</td>
        </tr>

        <tr id="Abstract Introduction. Six to seven million individuals are infected with Trypanosoma cruzi, the causative agent of Chagas disease. With 12,000 deaths annually, chronic Chagas disease remains a significant global health challenge due to persistent vector transmission, increasing non-vector transmission and limited therapeutic options. Chronic Chagas cardiomyopathy is a leading cause of morbidity and mortality, yet the underlying mechanisms remain poorly understood. Gap Statement. Since its initial description more than 100 years ago, research efforts into the cardiomyopathy found in chronic Chagas disease have primarily focused on the contributions of immune cells, cardiomyocytes and cardiac fibroblasts, leaving a significant gap in understanding the role of microvascular endothelial dysfunction in disease progression. Aim. The aim of this study was to identify any morphological or functional changes to cardiac microvascular endothelial cells induced by T. cruzi infection with the potential to contribute to the pathologies found in chronic Chagas disease. Methodology. We cultured primary cardiac microvascular endothelial cell monolayers in vitro and infected them with T. cruzi trypomastigotes or exposed them to conditioned media collected from control or infected endothelial cells. Cells were analysed for changes in morphology and proliferation, by wound healing assays for measurements of migratory capacity and by tube-forming assay to characterize their ability to form capillary-like structures. Results. We show that T. cruzi infection leads to the development of hypertrophic multinuclear cells, inhibits endothelial proliferation, increases endothelial migration and results in changes in several aspects of angiogenesis. Conclusion. We present data to demonstrate morphological and functional changes in cardiac endothelial cells that occur as a result of T. cruzi infection and propose that these changes may contribute to endothelial dysfunction and the development of chronic Chagas cardiomyopathy.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/4d363cfd484de981cde91418bbc3b956d87c21a2" target='_blank'>
              Trypanosoma cruzi infection-induced changes in cardiac microvascular endothelial cell morphology and function
              </a>
            </td>
          <td>
            Lyndsey N Gisclair, Douglas A Johnston
          </td>
          <td>2025-11-01</td>
          <td>Journal of Medical Microbiology</td>
          <td>0</td>
          <td>0</td>
        </tr>

        <tr id="Acute neuroinflammation rapidly activates brain immune responses, but its lasting effects on microglia are unclear. Using systemic LPS administration and LCMV-Armstrong infection, we found that blood–brain barrier disruption and cytokine shifts resolved within 30 days, yet microglial recovery was incomplete—marked by persistent numerical loss and an IFN-γ–low phenotype in the LPS model and reduced relative abundance in the LCMV model. Single-cell RNA sequencing revealed sustained transcriptional alterations, including disease-associated microglia (DAM) features and a distinct recovery-biased population. These acute signatures overlapped with profiles from Alzheimer’s model mice and were enriched in human microglia from multiple sclerosis, Alzheimer’s disease, and other neuroinflammatory conditions. Although our observation period was shorter than the chronic course of these diseases, the persistence of disease-like microglial states suggests that transient inflammation can prime the brain for long-term vulnerability. Targeting this primed state may offer new strategies to prevent or mitigate neurodegenerative pathology. Supplementary Information The online version contains supplementary material available at 10.1186/s12974-025-03572-7.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/8721848b4335622c9d56e1c1301ae59339a8f8e0" target='_blank'>
              Acute neuroinflammation induces prolonged transcriptional reprogramming in microglia
              </a>
            </td>
          <td>
            Sehoon Moon, Cheol Gyun Kim, Young-Kwang Kim, Cheol-Heui Yun, Min-Kyoo Shin, Hyungseok Seo
          </td>
          <td>2025-12-10</td>
          <td>Journal of Neuroinflammation</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="Post-viral neuroinflammatory syndromes, particularly those occurring after SARS-CoV-2 infection, have received increasing attention due to their complex and persistent neurological manifestations. The aim of this narrative review is to integrate current evidence on the molecular and cellular mechanisms underlying chronic neuroinflammation following viral infections, with a focus on dysregulated innate immune responses, macrophage–microglia interactions, oxidative–mitochondrial stress, and impaired inflammation resolution pathways. Our synthesis shows that prolonged activation of macrophages and glial cells promotes the continuous release of pro-inflammatory mediators, while defective phagocytosis and inadequate clearance of cellular debris maintain an inflammatory microenvironment. Mitochondrial dysfunction further amplifies immune activation by stimulating metabolic stress and reactive oxygen species production. In parallel, deficiencies in mediators specialized in inflammation resolution impede the transition from inflammation to resolution, allowing neuroimmune imbalance and nociceptive sensitization to persist long after virus clearance. Key conclusions indicate that these interconnected mechanisms collectively contribute to the long-term neurological symptoms observed in post-viral states, including cognitive impairment, neuropathic pain, and fatigue. Emerging therapeutic strategies targeting cytokine signaling, microglial reactivity, mitochondrial function, and resolution pathways are promising, but remain insufficiently validated in clinical practice. Overall, evidence suggests that post-viral neuroinflammation results from the convergence of sustained immune activation and failure of endogenous resolution mechanisms, highlighting the need for further mechanistic studies and targeted interventions.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1486b2a0665ed52ccf9a17b86e0809646ad8755a" target='_blank'>
              Dysregulated Resolution of Inflammation After Respiratory Viral Infections: Molecular Pathways Linking Neuroinflammation to Post-Viral Neuropathic Pain—A Narrative Review
              </a>
            </td>
          <td>
            A. Popa, Elena Popa, Tatiana Dramba, Elena-Adorata Coman, Mihaela Poroch, M. Ungureanu, A. Bacușcă, Ana-Maria Slanina, Gema Bacoanu, V. Poroch
          </td>
          <td>2025-11-25</td>
          <td>International Journal of Molecular Sciences</td>
          <td>0</td>
          <td>10</td>
        </tr>

        <tr id="Introduction Aging increases vulnerability of the elderly to influenza, but the mechanisms have not been fully understood. Although lethally infected aged mice are frequently used as models of influenza infection in the elderly, they are more suitable for studying mortality rather than the increased disease severity frequently observed in non-lethal infections. Therefore, understanding age-related differences under sublethal infection conditions is crucial. Methods Adult (8–12 months) and aged (22–24 months) mice were infected with a sublethal dose of H1N1 (PR8). Body weight loss, lung viral titers, pulmonary innate immune cell composition, and transcriptional levels of key inflammatory cytokines were assessed. Results Despite similar body weight loss, the aged mice showed significantly higher lung viral titers at day 8. Notably, key innate immune populations, including alveolar macrophages, neutrophils, and eosinophils, showed distinct age-related patterns. In the adult mice, alveolar macrophages negatively correlated with weight loss, whereas no protective immune factor was identified in the aged mice. Moreover, our data showed that persistent viral replication led to distinct innate immune cell composition in the adult and aged mice despite comparable transcription levels of inflammatory cytokines. The numbers and frequencies of both the neutrophils and eosinophils were significantly higher in the virus-persistent adult mice than those in the virus-persistent aged mice. Discussion Our findings reveal skewed acute immune responses to influenza in aged mice, which may partially account for their mild weight loss despite delayed viral clearance and highlight age-related impairments in early antiviral immunity.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/5c351ed0e5d3df4fe77cb078ab0d2b65afface5c" target='_blank'>
              Skewed pulmonary innate immune cell composition underlies the delayed influenza clearance in aged mice
              </a>
            </td>
          <td>
            Xiaoyang Cheng, Fang Zhao, Jing Wu, Yanmin Wan, Zhaoqin Zhu, Jialin Jin
          </td>
          <td>2025-12-10</td>
          <td>Frontiers in Microbiology</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="Severe dengue virus (DENV) infection is characterised by vascular leak and can lead to shock and death. The virus-derived non-structural protein 1 (NS1), which is released into the circulation as a lipoparticle, has been implicated in exacerbation of inflammation through activation of Toll-like receptor 4 (TLR4), and in disruption of endothelial monolayer integrity. We sought to identify the component of the NS1 lipoparticle that activates TLR4. Native and C-terminally His-tagged recombinant NS1 were produced in suspension HEK293 cells and formed hexamers indicating structural integrity. However, neither the recombinant NS1 nor NS1 secreted by DENV-infected Vero or K562 cells activated TLR4. Thus, the NS1 apoprotein itself does not activate TLR4, although it could potentially associate with inflammatory lipids as a lipoparticle. Notably, the lack of TLR4 stimulation by NS1 protein does not exclude a role for TLR4 in dengue disease as it may be activated by LPS influx from the gut or by putative endogenous stimulatory lipids. Furthermore, purified His-tagged NS1, at a biologically relevant concentration, only had a modest effect on endothelial monolayer integrity as assessed by changes in the electrical impedance of an endothelial monolayer. In contrast TNF, a cytokine with an established role in vascular leak, had a potent effect when used at a concentration seen in severe dengue disease. Medium from DENV-infected human macrophages also had a potent disruptive effect. This medium had low NS1, compared to that encountered in some patients, but high TNF concentration and its effect on endothelial monolayers was mostly ablated by an anti-TNF antibody. While multiple factors are likely to contribute to DENV-associated vascular leak in vivo, our data support a key role for TNF. Importantly, our data indicate that while NS1 has a modest effect on endothelial monolayer integrity there is no evidence for it activating TLR4.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/9c3b516269fec900b4ff396c332b0fce4822b689" target='_blank'>
              Dengue virus NS1 protein does not activate TLR4 and has a modest effect on endothelial monolayer integrity compared to TNF
              </a>
            </td>
          <td>
            P. Vajjhala, Jaehyeon Kim, Adriana Pliego Zamora, Helen Mostafavi, Larisa I. Labzin, K. Stacey
          </td>
          <td>2025-11-01</td>
          <td>PLOS Pathogens</td>
          <td>0</td>
          <td>50</td>
        </tr>

        <tr id="Background Many patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection experience neurologic changes post-infection, which has been hypothesized to be due to dysregulation in the infectious-immune axis that leads to a neuro-immune response. This immune dysfunction has been termed “Alzheimer’s of the Immune System” or AIS and there are several immune factors that may play a key role. These include, among others, complement activation due to low levels of C1-esterase inhibitor (C1-INH) and function, and a decrease in signaling of Toll-like receptor (TLR)-3. We propose that C1-INH replacement may upregulate the immune dysfunction, thereby improving neurological symptoms. Methods In this randomized, double-blind, placebo-controlled, crossover, proof-of-concept study, adults experiencing SARS-CoV-2 post-viral fatigue syndrome for >4 weeks post-recovery from coronavirus disease 2019 (COVID-19) infection were randomized 1:1 to two arms: Arm 1 (C1-INH for 8 weeks, then placebo for 8 weeks) or to Arm 2 (placebo for 8 weeks, then C1-INH for 8 weeks). Patients were assessed for adult executive function, abnormal cognitive decline, depression [Beck Depression Inventory-II (BDI-II)], migraine, fatigue [Fatigue Severity Scale (FSS)] and pain (Short-form McGill Pain Questionnaire). Percent change in TLR signaling in response to zymosan was compared with controls at baseline, Week 8 and Week 16. Safety was assessed throughout. Results At this interim analysis, 36 patients with SARS-CoV-2 post-viral fatigue syndrome had completed the two 8-week treatment periods. In Arm 1, trends toward improvements from baseline at Week 8 of C1-INH therapy were observed in BDI-II score (−8.7 points), mean FSS score (0.6 points), and mean McGill Pain Questionnaire score (−0.4 points). These improvements were either sustained or worsened at Week 16, following crossover to placebo. The outcomes in Arm 2 were compatible with those in Arm 1. Patients with SARS-CoV-2 post-viral fatigue syndrome had low levels of TLR-related signaling biomarkers compared with healthy controls. Conclusion This proof-of-concept study demonstrates sustained dysregulation of the immune system after COVID-19 infection. Improvements in depression, fatigue, and pain were observed with C1-INH treatment in patients with SARS-CoV-2 post-viral fatigue syndrome, indicating C1-INH may be a potential therapeutic target. Clinical trial registrationThe study was registered on September 21, 2024, with the identifier number NCT04705831.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/5216336754bb129297f909c59c4917e2881d5491" target='_blank'>
              Does C1 esterase inhibitor play a role in post COVID-19 neurological symptoms? A randomized, double-blind, placebo-controlled, crossover, proof-of-concept study
              </a>
            </td>
          <td>
            Isaac Melamed, Caley Buckley, Mary Ellen Bayko, Joe Lynn Williams, Noga Or-Geva
          </td>
          <td>2025-11-06</td>
          <td>Frontiers in Neurology</td>
          <td>0</td>
          <td>1</td>
        </tr>

        <tr id="SARS-CoV-2 disrupts cellular homeostasis, including the autophagy-lysosome pathway (ALP), a critical component of innate immunity and viral clearance. By subverting autophagy, SARS-CoV-2 proteins such as ORF3a, ORF7a, and NSP6 inhibit autophagosome-lysosome (APG-L) fusion, generating “incomplete autophagy” that permits viral persistence and drives hyperinflammation. Transcription factor EB (TFEB), a master regulator of lysosomal biogenesis and autophagy, has emerged as a central player in the host response to coronavirus infection. TFEB orchestrates the expression of genes required for lysosomal function and autophagic flux while also shaping immune processes, including cytokine production, interferon-stimulated gene expression, and inflammasome clearance. This mini review synthesizes current knowledge on the TFEB-ALP axis in COVID-19 pathogenesis, highlighting its influence on acute immunopathology and its potential contribution to post-acute sequelae (Long COVID). Restoring TFEB activity and autophagic flux may counteract SARS-CoV-2 evasion strategies and restrain aberrant inflammatory responses. Harnessing the TFEB-autophagy pathway as a host-directed therapeutic strategy could help rebalance immune homeostasis, limit tissue damage during acute infection, and mitigate persistent inflammatory sequelae in Long COVID.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/16fa03377df001310b096f5bc84f1cdb14cf36a8" target='_blank'>
              Dysregulated TFEB–autophagy-lysosome pathway links acute COVID-19 immunopathology to Long COVID sequelae
              </a>
            </td>
          <td>
            Magdalena Gabig-Cimińska
          </td>
          <td>2025-11-28</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>0</td>
        </tr>

        <tr id="Severe Coronavirus disease 2019 (COVID-19) is associated with abnormal innate and adaptive immune responses, as well as systemic alterations, including a shift in lipid network. A case–control study was conducted to describe the systemic lipidomic profile in COVID-19 according to disease severity. Selected polyunsaturated fatty acids (PUFAs), oxylipins, and endocannabinoids were analysed using a targeted liquid chromatography coupled to mass spectrometry in tandem method. Multivariate receiver operating characteristic curve-based model evaluation was performed to define a lipidomic signature for the disease. A total of 135 hospitalized COVID-19 patients, of whom 85 had severe form, and 134 healthy individuals were included. Patients exhibited increased levels of free PUFAs, proinflammatory and pro-resolving oxylipins, and endocannabinoids compared to controls. A combination of five lipid mediators, i.e., prostaglandin D2, prostaglandin E2, thromboxane B2, lipoxin B4, and 2-archidonylglycerol, discriminates patients from control individuals with excellent accuracy [AUC, 0.977 (0.950–0.995)]. The severe form is characterized by an imbalance between proinflammatory and pro-resolving oxylipins and increased endocannabinoids. COVID-19 is associated with a lipid storm that conditions disease severity. Targeting lipid mediators-related metabolic and signalling pathways could be an interesting therapeutic option in severe forms.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a5fb8bf52683c50e4277c9e8f4f3b1e200f52531" target='_blank'>
              COVID-19 is Associated with a Lipid Storm that Worsens in Cases of Severe Pneumonia
              </a>
            </td>
          <td>
            A. Bouabdallah, M. K. Ben-Fradj, Mohamed Bessem Hammami, Rim Abdelmalek, H. Sanhaji, T. Klopfenstein, Moncef Feki
          </td>
          <td>2025-11-01</td>
          <td>Microorganisms</td>
          <td>0</td>
          <td>17</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a860b1f890cd6919e6ed4f49c16018a6906fcd8a" target='_blank'>
              Exaggerated IFN-I Response in Long COVID PBMCs Following Exposure to Viral Mimics.
              </a>
            </td>
          <td>
            Bart Humer, J. Berentschot, C. V. van Helden-Meeuwsen, L. Bek, Maaike de Bie, Tobias M Defesche, Chantal A Boly, Manon Drost, M. Hellemons, W. Dik, M. Versnel
          </td>
          <td>2025-12-10</td>
          <td>Journal of clinical immunology</td>
          <td>0</td>
          <td>45</td>
        </tr>

        <tr id="Abstract Background Alzheimer's Disease (AD) is characterised by the accumulation of aggregated β‐amyloid and neurofibrillary tangles, with the immune system being a key driver of AD pathology and progression. Systemic infections can worsen cognitive decline in patients, possibly due to cerebrovascular dysfunction and exaggerated neuroinflammation, but the underlying mechanisms are not fully understood. Modelling systemic infection in animal models has classically been carried out using lipopolysaccharide (LPS) to mimic a systemic bacterial infection. LPS activates the innate immune compartment of the immune system but does not accurately represent the chronic low grade inflammatory changes observed during a real bacterial infection. In this study, we investigate the inflammatory and vascular effects following exposure to a live, attenuated bacterial strain Salmonella Typhimurium in APP/PS1 and WT mice. Method APP/PS1 mice and WT littermates were infected with 1x106 CFU Salmonella Typhimurium (SL3261) or sterile saline control by intraperitoneal injection and tissue from perfused mice was collected at 7 and 28 days post‐infection. Liver and brain tissue were analysed for systemic inflammation, cerebrovascular dysfunction and neuroinflammation using immunofluorescence. Result We report that systemic infection with Salmonella Typhimurium induces fibrin(ogen) deposition in the liver accompanied by the formation of FcγRI and CD11b positive inflammatory lesions. Cerebrovascular activation, measured by increased expression levels of VCAM and ICAM, is observed 7 days post infection, which is accompanied by extravasation of fibrin(ogen) and IgG into the brain parenchyma. Microglial activation, measured by expression of MHC‐II and FcγRI, revealed an exaggerated microglial response in APP/PS1 mice when compared to WT littermates. The cerebrovascular dysfunction following exposure to Salmonella Typhimurium may have contributed to this exaggerated neuroinflammatory response. Conclusion This study shows that APP/PS1 mice with a systemic bacterial infection have exaggerated microglial neuroinflammatory response. The cerebrovascular dysfunction and fibrin‐ mediated activation of microglia following exposure to Salmonella Typhimurium may have contributed to this exaggerated neuroinflammatory response.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/86a90de9ba1de1a8e1a7af0b9cbc74a9513897ea" target='_blank'>
              Systemic bacterial infection induces cerebrovascular dysfunction and exaggerated neuroinflammation in APP/PS1 mice
              </a>
            </td>
          <td>
            Matthew P Colley, A. B. Kantor, Jessica Teeling
          </td>
          <td>2025-12-01</td>
          <td>Alzheimer's & Dementia</td>
          <td>0</td>
          <td>1</td>
        </tr>

        <tr id="Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), has led to a global health crisis by triggering extensive systemic and immune dysregulation. Granulocytes, including neutrophils, eosinophils, and basophils, are critical components of the innate immune system that play dual roles in protection and pathogenesis during infection. In this review, we examine the multifaceted roles of granulocytes in COVID-19 and their impact on disease severity through excessive inflammation, cytokine storm, and tissue damage. Neutrophil extracellular traps (NETs) and the overactivation of neutrophil subtypes contribute to the development of thrombosis and acute respiratory distress syndrome. In contrast, eosinophils and basophils modulate T helper 2-type and allergic responses that may influence recovery or disease progression. We further summarize the therapeutic strategies targeting granulocyte activation and signaling pathways, including IL-1, IL-6, IL-17, IL-5 receptor, granulocyte-macrophage colony-stimulating factor inhibitors, and antihistamines, emphasizing their clinical outcomes, approval status, and the global regions in which they are studied. Understanding the regulatory mechanisms of granulocyte activation and inhibition provides new insights into COVID-19 immunopathology and opens pathways for targeted immunomodulatory therapy. These findings underscore the importance of balancing protective immune functions with controlled anti-inflammatory interventions to mitigate the severe complications of SARS-CoV-2 infection.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c1949f61557e86e96575d6b1c878127a5eaa2ccc" target='_blank'>
              COVID-19: Understanding the Granulocyte Response and Exploring Their Therapeutic Interventions.
              </a>
            </td>
          <td>
            Zahra Farjami, Mina Moradi, Neshat Ebrahimi, Mohammad Mehdi Akbarin
          </td>
          <td>2025-10-31</td>
          <td>Viral immunology</td>
          <td>0</td>
          <td>11</td>
        </tr>

        <tr id="Washington University polyomavirus (WUPyV), a member of the polyomavirus family capable of infecting the human respiratory tract, exhibits high prevalence in human populations. However, confirmation of its pathogenicity and aetiology has been hindered by challenging culture conditions. To investigate the infective endocytosis of WUPyV, a novel infection model was developed using human airway organoids (HAOs); viral replication dynamics, cell tropism, endocytosis mechanisms, and morphogenesis in human airway epithelium (HAE) were characterized. The results indicated that WUPyV replicates efficiently and infects multiple cell types within the respiratory epithelium. After JC polyomavirus, WUPyV is the second human polyomavirus known to enter cells via clathrin‐mediated endocytosis, independent of caveolar/lipid raft‐mediated endocytosis or macropinocytosis. Consistent with other polyomaviruses, WUPyV is transported to the nucleus for replication and assembly through a lipid‐dependent pathway requiring tyrosine kinase activity and endosome/lysosome acidification. Assembled viral particles were observed in nuclear pores; they were ultimately released extracellularly through vesicles and schistocytes. High‐titre WUPyV infection caused extensive structural damage to the HAE and its cilia. Our findings provide important insights into the endocytosis, morphogenesis, and ultrastructural damage induced by WUPyV, supporting the notion that WUPyV is an underestimated human pathogen.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/316300572a77909debb29a4ff0aa7420f2993535" target='_blank'>
              Cytopathic Effect and Morphogenesis of WUPyV in Human Airway Epithelial Cells
              </a>
            </td>
          <td>
            Yiman Huang, Chao Wang, Aijun Chen, Saizhen Zeng, Xiaocao Meng, Shiyuan Fan, Jingdong Song, Lishu Zheng
          </td>
          <td>2025-11-01</td>
          <td>Journal of Medical Virology</td>
          <td>0</td>
          <td>8</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/49246f12cda5db6de29940b1471d472c0dead5bd" target='_blank'>
              MUC5AC gene expression in COVID-19 nasal discharge with rhinorrhea symptoms.
              </a>
            </td>
          <td>
            D. Irfandy, A. Afriwardi, E. P. Andani, J. B. Bestari
          </td>
          <td>2025-11-01</td>
          <td>The Medical journal of Malaysia</td>
          <td>0</td>
          <td>0</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/3d9fdff2c96c23d992f68887e5d8b5023f241d69" target='_blank'>
              Mycophenolate mofetil reduces the branching of microglial processes
              </a>
            </td>
          <td>
            Rin-ichiro Teruya, Kentaro Ueda, Takumi Taketomi, Takushi Yamamoto, Naoki Yamashita, Hana Konno, Fuminori Tsuruta
          </td>
          <td>2025-11-13</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>17</td>
        </tr>

        <tr id="


 Neuroinflammation is typically attributed to the sustained activation of resident immune cells in the brain, such as microglia. However, in acute inflammation, cells are activated rapidly and reconstruct the blood-brain barrier (BBB) in order to prevent further damage. Given that acute inflammation causes significant damage to the brain in a short period of time, the impact on the immune system may persist for an extended duration. In this study, we observed a significant infiltration of monocytes and macrophages into the brain following the induction of acute inflammation by LPS. This infiltration was accompanied by a reduction in IL-10 and an increase in IL-1β levels one day after injection, which then returned to baseline within a week. The number of microglia decreased transiently; however the cytokine expression pattern was comparable to that of macrophages. Notably, despite restoring motor and memory functions in mice, the microglial phenotype remained unresponsive even after one month. Also, those microglia exhibited numerous similarities with the chronic Alzheimer’s model at the gene level. Furthermore, acute inflammation induced by LCMV also results in temporal BBB impairment and persistent microglial phenotype alteration. In conclusion, our findings verified that acute inflammation affects the immune microenvironments of the brain in a long-lasting way, suggesting that severe inflammation may increase the risk of developing neurodegenerative disease in the future.



 Neuroimmunology (NEUR)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/fbbbe2df01483e14f37d0ce2b02a958d1cfe3f64" target='_blank'>
              The impact of acute inflammation on the brain immune environment 2896
              </a>
            </td>
          <td>
            Sehoon Moon, Cheol Gyun Kim, Min-Kyoo Shin, Hyungseok Seo
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>1</td>
        </tr>

        <tr id="The immunopathogenesis of KFDV is not well understood. The study's primary objective was to investigate the magnitude and dynamics of cytokine and cellular immune responses during the acute and convalescent phases of KFDV infection in humans. Additionally, the study aimed to identify potential biomarkers that could indicate severe KFD and help predict disease prognosis. In this study, KFDV‐positive patients were prospectively enrolled, and peripheral blood samples were collected and analyzed for cellular and cytokine levels, along with the clinical and virological characteristics. Our findings revealed distinctive cytokine profiles differentiating severe from mild KFD during the acute phase of illness. Serum levels of IFN‐γ, IP‐10, MCP‐1, HGF, and IL‐2R were markedly elevated in severe KFD. Also, the frequency of activated B cells (CD20lowCD71high) and expression of exhaustion markers (PD‐1, CTLA‐4) on CD8+ T cells was significantly increased in severe cases. The study also describes the persistence of elevated cytokines during the convalescent phase, indicating that prolonged inflammation may be due to dysregulated immune response characterized by sustained T cell activation, cytotoxic activity (Granzyme B, Perforin), and elevated exhaustion markers (PD‐1, CTLA‐4), particularly in patients with severe KFD. This novel work has important implications for KFDV vaccine research and may aid clinical decision‐making in treating severe KFDV infections in humans.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/d4e3ac58f066ecd1e55540367ff4cfb8eedc9b2c" target='_blank'>
              Temporal Dynamics of the Immune Response in Severe Cases of Human Kyasanur Forest Disease Virus (KFDV) Infection
              </a>
            </td>
          <td>
            Naren Babu N, Nitin Gupta, A. Pattanaik, C. Mukhopadhyay, Santhosha Devadiga
          </td>
          <td>2025-11-01</td>
          <td>Journal of Medical Virology</td>
          <td>0</td>
          <td>9</td>
        </tr>

        <tr id="


 Neutrophils heavily infiltrate the brain following acute and chronic brain insults. Neutrophils infiltrating brain tumors display a prolonged lifespan compared to blood neutrophils. We investigated presence and potential function of neutrophils in the brain following infection with Theiler’s Murine Encephalomyelitis (TMEV) and kainic acid-induced seizures. Both total myeloid cells and neutrophils started infiltrating the brain as early as day 1, peaked at day 3, and remained elevated at least 7 days post-infection. Further characterization of the neutrophils revealed upregulation of MHC-II, indicating a potential role in antigen presentation. We detected similar accumulation of total myeloid cells and neutrophils in the brain of mice following seizures. MHC-II expression was upregulated on infiltrating neutrophils. Given the sustained and unusual accumulation of neutrophils in the brain past innate time points, we evaluated the bone marrow niche for evidence of myelopoiesis. Frequencies of Lin-Sca-1+c-Kit + (LSK) were significantly higher in all bone marrow compartments in mice infected intracranially with TMEV. This increase in LSK cells concurred with an increase in frequencies of total myeloid cells. These changes were not observed when mice were infected with TMEV systemically. Our data highlights dysregulation of bone marrow hematopoiesis and a potential novel role of neutrophils in response to neuroinflammation following intracranial pathologies.



 Neuroimmunology (NEUR)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/07628d2a8c082d3276b9f4ff08b030b0c457e760" target='_blank'>
              Brain injuries lead to sustained neutrophil generation in the bone marrow and infiltration into the brain 3257
              </a>
            </td>
          <td>
            Eliese M. Moelker, Alexandra M. Hoyt-Miggelbrink, R. Reesman, Delaney M. Anani-Wolf, Anthony D. Umpierre, Pamela K. Norberg, Aaron J. Johnson, K. Ayasoufi
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>20</td>
        </tr>

        <tr id="


 PLCG2, a critical immune regulator, has emerged as a key factor in Alzheimer’s disease, with genetic variants conferring both risk and protection. In the brain, PLCG2 is mainly expressed in microglia, influencing cellular functions including calcium signaling. We investigated PLCG2’s role in neuroinflammation using constitutive and inducible knockout mouse models with LPS-induced acute inflammation. In the constitutive KO, LPS treatment induced >200 differentially expressed genes in the brain, altering pathways related to innate and adaptive immune responses, inflammatory signaling, and microglial function. KO mice exhibited a distinct gene signature in response to LPS, with upregulated genes associated with interleukin signaling, prostaglandin response, and interferon pathways. Interferon-responsive genes were upregulated in homozygote KO mice post-LPS treatment, a phenotype that has been linked to white matter pathology. Consistently, principal component analysis of myelin-enriched genes revealed LPS-treated homozygote KO samples clustering separately from other genotypes. Behaviorally, LPS-treated KO mice displayed reduced locomotion in open field tests, correlating with expression of sickness behavior-related genes. These findings suggest PLCG2 deficiency enhances interferon responses, potentially driving behavioral changes and myelin pathology phenotypes. Inducible KO mice showed distinct behavior, with ongoing efforts focused on assessing their brain transcriptomes.



 This research was supported by the Alzheimer’s Association (AARG-21-846012, SH and JPP) the William and Ella Owens Medical Research Foundation (JPP), and intramural funding (SH and JPP).



 Neuroimmunology (NEUR)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/5a467f58282d37f7f95ab646aaa61616cbf597fc" target='_blank'>
              PLCG2 deficiency alters the neuroinflammatory transcriptome and sickness behavior response to LPS 9336
              </a>
            </td>
          <td>
            Eduardo Gutierrez Kuri, Juliet Garcia Rogers, Sabrina Smith, Kevin F. Bieniek, Ann Griffith, J. Palavicini, Sarah C. Hopp
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>18</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c18b6c3d94e0b245a2073ceeb35d02bd592fc6fc" target='_blank'>
              The compounding roles of gut-immune-brain axis and COVID19 in manifestation of idiopathic Parkinson’s disease
              </a>
            </td>
          <td>
            Ankita Das, Vani Vivek, P. Aich
          </td>
          <td>2025-11-08</td>
          <td>Discover Immunity</td>
          <td>0</td>
          <td>21</td>
        </tr>

        <tr id="With the global rise in population aging, establishing effective strategies for the prevention and treatment of age-related neurodegenerative diseases, as well as their prodromal stage of cognitive frailty, has become an urgent challenge. Recent studies have revealed that the neural basis of both frailty and age-related disorders is closely associated with chronic neuroinflammation and impaired clearance of cellular debris, processes that are primarily regulated by microglia, the resident immune cells of the brain. As aging progresses, microglia exhibit reduced surveillance and motility, diminished phagocytic efficiency, and transition into a proinflammatory, hyperresponsive state. Such maladaptive microglia contribute to synaptic loss, white matter deterioration, and the spread of neurodegenerative pathology. Conversely, single-cell transcriptomic studies have identified distinct microglial subsets, including CD11c+ microglia, which show upregulation of lysosomal and lipid metabolism pathways, enhanced debris clearance, and elevated neurotrophic factor expression. These features suggest that certain microglial populations adopt protective or adaptive phenotypes that preserve neural integrity. However, under chronic inflammation or pathological conditions, even protective microglia may become inflammation-promoting. This review summarizes current evidence on microglial changes in aging, frailty, and neurodegeneration, emphasizing their dual roles and discussing strategies that modulate microglial function to maintain brain health and prevent or treat frailty and age-related diseases.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/951a2bde7a1ce8313cd885132ad9f0b3d11cffc8" target='_blank'>
              Microglia in Brain Aging and Age-Related Diseases: Friends or Foes?
              </a>
            </td>
          <td>
            Kentaro Ishikawa, Risako Fujikawa, Kayoko Okita, Fumika Kimura, Takuya Watanabe, S. Katsurabayashi, Katsunori Iwasaki
          </td>
          <td>2025-11-27</td>
          <td>International Journal of Molecular Sciences</td>
          <td>0</td>
          <td>27</td>
        </tr>

        <tr id="Many studies have shown an association between herpes simplex virus type 1 (HSV-1) infection and the development of neurodegeneration processes later in life, such as Alzheimer’s disease. The Fas/FasL death pathway plays an important role in the complex regulation of the local inflammatory response and mounting of the specific antiviral response in HSV-1 infection. Here, we applied a mouse model of latent HSV-1 neuroinfection to Fas- and FasL-deficient mice (lpr and gld) to explore whether the lack of functional Fas/FasL pathway protects from inflammation-related neurodegeneration. The latently infected Fas- and FasL-deficient mice (lpr and gld) were not protected from virus replication despite the accumulation of virus-specific cytotoxic T cells. However, the lack of Fas/FasL pathway decreased neuroinflammation- and neurodegeneration-related markers, including cognitive impairment, amyloid-β protein, and tau hyperphosphorylation. The use of a glucocorticoid, dexamethasone, to decrease neuroinflammation in wild-type mice did not protect from cognitive impairment, despite the improved antiviral response. Our data indicate that excessive neuroinflammation via the Fas/FasL pathway during HSV-1 infection is associated with neurodegeneration. Furthermore, the administration of immunomodulatory agents to ameliorate the outcome of HSV-1 latent infection should be restricted to the peak of neuroinflammation.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/4ae344fac498d71f5308786f29214c408bb4c753" target='_blank'>
              Lack of Fas/FasL Does Not Protect from Latent Herpes Simplex 1 Infection but Decreases Virus-Induced Neurodegeneration
              </a>
            </td>
          <td>
            Magdalena Patrycy, Agnieszka Kauc, Martyna Janicka, Aleksandra Osińska, Andrzej Kowalczyk, Katarzyna Skulska, Małgorzata Antos-Bielska, Marcin Chodkowski, Kristina Eriksson, Małgorzata Krzyżowska
          </td>
          <td>2025-12-01</td>
          <td>Cells</td>
          <td>0</td>
          <td>7</td>
        </tr>

        <tr id="


 The effect of COV-19 infection or post-acute sequelae of SARS-CoV-2 (PASC) increases risk of thrombotic events. The mechanism underlying cardiovascular complications post-COV-19 infections remains incompletely understood. During severe COV-19 infection, viral antigens trigger , initiating and amplifying the immune response. This cytokine storm serves to eliminate the virus but inflicts significant collateral damage on the surrounding cellular environment, especially the vascular endothelium. In this study, we hypothesized that the antibody-mediated response to COV-19 infection activates the vascular endothelium and alters endothelial barrier integrity. We also investigated the mechanism driving endothelial activation and dysfunction which fosters a procoagulant state during COV-19 infection and PASC.
 To assess endothelial dysfunction and creation of a procoagulant state post-severe COV-19 infection, primary human umbilical vein endothelial cells (HUVEC) were isolated and incubated with 100 µg/mL IgG for 12 h. We compared the effects of IgG from 56 COV-19 patients with IgG from 12 healthy donors (HD IgG), as controls. Relative to HD-IgG, COV-19 IgG increased surface expression of vascular cell adhesion molecule-1, VCAM-1 (A450nm = 0.491±0.09 in case of COV-19 IgG compared to A450nm= 0.15±0.02 in HD IgG; P<0.05) used as a marker of endothelial cell activation. Using an assay of plasma clot formation in which HUVEC treated with HD or COV-19 IgG was exposed to normal human plasma and clot formation measured by turbidity (A405nm), we observed that 11 COV-19 IgG that induced increased VCAM-1 expression caused enhanced clot formation on HUVEC with maximal Vmax of 55±18 and decreased lag time of 18±5 min compared to HD-IgG (Vmax=35±5; lag time= 43±7 min). Increased clot formation was associated with increased expression of tissue factor mRNA (fold change increase = 4), plasminogen activator inhibitor type 1, PAI-1 (fold change increase =30), and TMEM-16F mRNA (fold change increase=2.5), though the relative contribution of each of these mediators to the prothrombotic phenotype is under investigation. We also observed delayed clot lysis after initial clot formation on HUVEC, possibly reflecting the effects of PAI-1, which was the highest upregulated HUVEC gene after exposure to COV-19 IgG.
 COV-19 infection is also associated with increased vascular permeability that contributed substantially to the clinical manifestations of the disease. To investigate the potential effects of COV-19 on endothelial cell barrier function we stained COV-19 treated HUVEC for VE-cadherin, an important adhesion molecule in endothelial cells. We observed that COV-19 IgG induced internalization and nuclear localization of VE-cadherin, in association with the formation of extensive contractile stress fibers leading to destabilization of cell-cell contacts.
 In preliminary analyses we observed that the correlation (r2) between levels of CL IgG and LBPA IgG in CoV -19 IgG fraction was 0.6545, whereas that between the EC activation markers, VCAM-1 or PAI-1 and CL IgG was 0.5479 and 0.6066 respectively. The correlation between VCAM-1 or PAI-1 and LBPA IgG were 0.2256 and 0.3791 respectively.
 The nature of the endothelial cell reactive antibodies contained in COV-19 IgG is uncertain at this point, but the effects observed occurred in the absence of added β2GPI. Analysis of proteins immunoprecipitated by COV-19 IgG is currently being undertaken.
 Previous studies have shown that IgG fractions from COV-19 patients are prothrombotic, but the mechanisms of these antibodies and the cellular antigens they recognize are uncertain. Our studies begin to address these concerns on a molecular mechanistic level and may lead to better understanding of the endotheliopathy that may underlie several viral syndromes.
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f6ebbe57cc1bb77e223e5d583feca3d2b468e47a" target='_blank'>
              COVID-19 IgG antibodies drive endothelial cell activation and dysfunction
              </a>
            </td>
          <td>
            Bhagwati Joshi, Charles Sukin, Wolfram Ruf, Keith R McCrae
          </td>
          <td>2025-11-03</td>
          <td>Blood</td>
          <td>0</td>
          <td>7</td>
        </tr>

        <tr id="Children with central nervous system malaria (CNS-M) have gene expression profiles and plasma biomarkers of malaria pathogenesis that differ from children with uncomplicated malaria (UM, malaria infection with fever and no systemic organ dysfunction) or acute febrile non-malaria illness (AFN). However, there is scant knowledge of the temporal dynamics of gene expression and plasma biomarkers during recovery from CNS-M. We compared serial changes of peripheral blood mononuclear cell transcriptomes at 6 weeks after recovery and plasma biomarkers of malaria pathogenesis at 6 weeks and 6 months after recovery in cohorts of Kenyan children who presented with CNS-M (n = 37), UM (n = 20) and AFN (n = 12). Upregulated genes and Reactome pathways of interleukin/cytokine signaling, neutrophil degranulation and innate immunity and downregulated pathways of protein biosynthesis of children presenting with CNS-M were partially reversed at hospital discharge 2–6 days later and 6 weeks. CNS-M and UM transcriptomes before treatment versus 6 weeks after recovery shared several pathways, but megakaryocyte/platelet production, IL-4/IL-13/IL-10 signaling and overexpression of LAG3, CCR5, PDGFRB and ICMT were specific to CNS-M. The Hemostasis Reactome pathway was uniquely downregulated in CNS-M at 6 weeks. Biomarkers of coagulation, fibrinolysis, neutrophil activation, endothelium integrity and cytokine signaling correlated with high plasma cell-free DNA in acute CNS-M and persisted for 6 weeks, whereas these values normalized at 6 weeks in UM and AFN. Recovery from pediatric CNS-M is associated with prolonged dysregulation of gene expression and biomarkers associated with coagulation, fibrinolysis and platelet activation. Future studies are needed to evaluate whether this dysregulation is associated with neurocognitive sequelae following recovery. Not applicable.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/4942b63b4c5464413c8a8dbe8d60c3b063a47b28" target='_blank'>
              Prolonged dysregulation of gene expression and biomarkers of coagulation, fibrinolysis, and endothelium in pediatric central nervous system malaria
              </a>
            </td>
          <td>
            Arlene E. Dent, B. Rosa, K. Dobbs, Sidney Ogolla, D. Midem, P. Embury, Yelenna Skomorovska-Prokvolit, Emily R. Hannon, Emmily Koech, A. H. Schmaier, Walter Otieno, M. Mitreva, J. Kazura
          </td>
          <td>2025-11-05</td>
          <td>BMC Infectious Diseases</td>
          <td>0</td>
          <td>58</td>
        </tr>

        <tr id="


 As the number of COVID-19 survivors continues to rise, the rates of post-acute sequalae of COVID19 (PASC) have also increased, emerging as a major public health concern. However, the role of monocytes on PASC development has not been fully explored. In this study, we aimed to determine whether monocyte dysregulation persists and contribute to driving inflammation and fibrosis after COVID-19 infection. RNA was isolated from purified monocytes from study participants who had pulmonary PASC (PPASC), had COVID-19 infection but no residual symptoms (Recovered), and had no COVID-19 infection (Healthy). We performed bulk RNA sequencing to profile monocytes to identify dysregulated genes and pathways associated with inflammation and fibrosis. In comparison to Recovered and Healthy, PPASC had an enrichment of immune activation signatures, such as neutrophil degranulation, IL8/IL-6 signaling, and macrophage response genes, while IL-10 pathway was down-regulated. Furthermore, disease prediction analysis showed that enriched genes in PPASC were linked to lung diseases such as pneumonia and lower respiratory tract disorder compared to those in Recovered. Transcriptomic analysis revealed that monocytes from PPASC individuals were continuously dysregulated with up regulation of pathways associated with immune activation, inflammation, and fibrosis. Our data demonstrate that monocyte dysregulation persists after viral resolution, impacting the pulmonary sequelae in PASC individuals.



 NIH/NIMHD (U54MD007601)



 Viral Immunology (VIR)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/cc86198c15fa6664f1c94ceb5073217cc1f39b91" target='_blank'>
              Long-term consequence of SARS-CoV-2 on monocyte phenotype in COVID-19 survivors 3120
              </a>
            </td>
          <td>
            T. Awamura, Stefanos Giannakopoulos, N. Subia, V. Khadka, Domic Chow, Cecilia M. Shikuma, G. Devendra, Juwon Park
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>19</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/aef3340a61cdce0385f6dd2d911f9a1b6fe80ce1" target='_blank'>
              Early-Life Commensal Lung Bacteria Shape Immune Responses and RSV Susceptibility in Neonatal Mice
              </a>
            </td>
          <td>
            Q. Marquant, C. Chottin, C. Ferret, Eloi Poucet, Vinciane Saint-Criq, Daphné Laubreton, Carole Drajac, Edwige Bouguyon, A. Rémot, Samuel Constant, Song Huang, Edouard Sage, Isabelle Schwartz-Cornil, Muriel Thomas, S. Riffault, D. Descamps
          </td>
          <td>2025-12-09</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>26</td>
        </tr>

        <tr id="


 SARS-CoV-2-induced excessive inflammation and cytokine storm cause acute lung injury and fatal pneumonia. We previously showed that an increased myeloid cell activity during coronavirus infections is highly inflammatory and causes severe lung pathology. However, the key myeloid cell factors that promote lethal inflammation are not well understood. Upon viral infection, myeloid cells elicit inflammatory response through TLR/TRAF6/NF-kB or MAPK pathway. Since TRAF6 is a common adapter molecule upstream of both MAPK and NF-kB, we examined the role of TRAF6 in SARS-CoV-2-induced lethal inflammation. Our preliminary work had showed that myeloid cell TRAF6 activity promotes robust SARS-CoV-2 structural protein induced inflammatory response. Therefore, we hypothesized that myeloid cell TLR-TRAF6 signaling is highly inflammatory and blocking TRAF6 suppresses inflammation while enhancing antiviral IFN response. We show that TRAF6 plays a critical role in viral RNA and protein induced dysregulated immunity and blocking TRAF6 activity specifically suppressed MAPK-ERK1/2 activity. Interestingly, decreased ERK1/2 activity upon blocking TRAF6 signaling correlated with significantly lower inflammatory cytokine and an improved antiviral IFN-I response in macrophages. In summary, our results show novel and contrasting role of TRAF6 activity in SARS-CoV-2-induced antiviral and inflammatory response and highlight therapeutic potential of blocking TRAF6 in host protection.



 NIH R21AI186028-01; NIH R01HL165423-01A1; NIH P30GM149368-02



 Innate Immune Responses and Host Defense: Cellular Mechanisms (INC)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a341e176bf297aee2aaec2915b5aa63c1ae31051" target='_blank'>
              Critical role of myeloid cell TRAF6 signaling in coronavirus-induced antiviral and inflammatory responses 3866
              </a>
            </td>
          <td>
            Roshan Ghimire, Cody Whitley, P. Johnson, Rudra Channappanavar
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>4</td>
        </tr>

        <tr id="Multiple sclerosis (MS) is a chronic, inflammatory condition characterized by neurodegeneration and lost myelin, or demyelination. This lost myelin may be regenerated in people with MS through a process called remyelination, that is prone to failure and is impaired with age. Remyelination is facilitated by microglia but our understanding of the microglial response during remyelination is incomplete. Here, we profile the microglial response during remyelination in the lysolecithin mouse model using single-cell RNA sequencing and find several distinct microglial states during the early stages of remyelination that coalesce into a resolved state defined by the presence of myelin transcripts, a state also present in MS brains. We also observe a delay in the appearance of several microglial states with age, in concordance with delayed remyelination. This multi-faceted microglial response during efficient remyelination provides the basis of multi-faceted microglia-specific targets for future MS therapies. Microglial states throughout remyelination are incompletely understood. Here, the authors show that microglia form several states during the early stages of remyelination that coalesce into a partially resolved state that is dysregulated with age.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/89f58ee42dc387c6b9d9bec82580a8d43e52f669" target='_blank'>
              Age-impaired remyelination is associated with dysregulated microglial transitions
              </a>
            </td>
          <td>
            Sameera Zia, Marianela E. Traetta, Charbel S. Baaklini, Brady P Hammond, Rebecca K. John, Katherine M. Souter, Niels Meijns, Larry K. A. Afun, Sharmistha P Panda, F. González Ibáñez, Mena K. Burr, Eva Dhupia, Abhisha M Rathod, Andre O. Faria, Dhruvish Zaveri, Sowmya Challa, Eugene Hahn, S. B. Manesh, Kelly V. Lee, Madelene F. S. Ho, Timothy N. Friedman, Aislinn D. Maguire, Arina Pang, Olivia Farkas, Bożena Szulc, Luiz Tenorio, Diya Vyas, Olivia R. La Caprara, W. Tetzlaff, Sarthak Sinha, G. Duncan, Anastassia Voronova, Bradley J Kerr, Marie-Ève Tremblay, Jeff Biernaskie, G. Schenk, J. Plemel
          </td>
          <td>2025-11-12</td>
          <td>Nature Communications</td>
          <td>0</td>
          <td>21</td>
        </tr>

        <tr id="


 Many viral infections have been linked to the development of debilitating neurological disorders. However, the mechanism governing virus-induced neuropathology remains poorly understood, particularly when the virus is not directly neuropathic. Using a mouse model of Zika virus (ZIKV) infection, we find that brain ZIKV titers do not correlate with the severity of neurological disease. Instead, ZIKV-infected brains exhibit microglial activation and infiltration of ‘bystander activated’ CD8+ T cells expressing the NK cell receptor, NKG2D. To assess the role of these T cells in virus-induced neuropathology, we treated ZIKV-infected mice with antibodies to deplete CD8+ T cells or block NKG2D signaling. Both treatments completely prevented against the development of paralysis without altering the viral load in the serum or brain, suggesting that bystander activated T cells mediate virus-induced neurological disease. Interestingly, depletion of brain-resident microglia using the drug PLX3397 also prevented development of neurological disease. However, microglia depletion did not reduce bystander activated T cell numbers in the brain, suggesting that microglia influence bystander T cell function rather than recruitment. Overall, we have identified a novel mechanism where microglia promote bystander activation and function of CD8+ T cells neurological disease. Our findings reveal several strategies for further investigation of treatments for virus-induced neurological diseases.



 Canadian Institutes for Health Research



 Viral Immunology (VIR)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/fab2ac785254407a4aa683cd871f705bd8afc9fa" target='_blank'>
              Microglia promote bystander activated T cell-mediated neurological disease during viral infection 3059
              </a>
            </td>
          <td>
            Elizabeth Balint, Emily Feng, Amelia Montemarano, Jonathan K Monteiro, Elizabeth C Giles, Tyrah M. Ritchie, Alexander S Qian, Fatemeh Vahedi, Ana L. Portillo, Veronique Miron, Bernardo L. Trigatti, A. Ashkar
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>56</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f8602892f5a451d75b2917aa6aa3b1a249d99d98" target='_blank'>
              COVID-19-associated Autoimmune and Inflammatory Diseases: Molecular Mechanisms and the Role of IVIG Therapy
              </a>
            </td>
          <td>
            Sukanya Bordoloi, S. Singh, Jagadeesh Bayry
          </td>
          <td>2025-11-13</td>
          <td>Clinical Reviews in Allergy & Immunology</td>
          <td>0</td>
          <td>1</td>
        </tr>

        <tr id="Severe influenza is frequently associated with bacterial or viral co-infections. Although immune-mediated mechanisms have been extensively investigated, the cell-intrinsic responses of respiratory epithelial cells prior to immune engagement remain poorly characterized. To model co-infection in vitro, we pre-activated B16 melanoma cells using the TLR9 agonist CpG ODN, followed by infection with influenza A virus (IAV) strain FM1. Key molecular events, including STING expression and activation, were assessed by Western blotting and RT-qPCR. The in vivo relevance was assessed in a mouse model of intranasal CpG ODN pre-treatment and IAV challenge. RNA-seq was performed as a supplementary approach to explore possible cell death pathways. Pre-activation significantly enhanced IAV-induced cell death within a restricted vulnerability window (≤ 24 h), independent of viral replication or TLR9 signaling. This was associated with inflammatory priming and initial STING activation. However, IAV infection subsequently suppressed STING phosphorylation and elevated inflammatory cell death. Mice pre-treated with CpG ODN exhibited increased mortality and aggravated lung injury following IAV challenge. RNA-seq analysis suggested the potential involvement of pyroptosis. These findings demonstrate that cellular pre-stimulation exacerbates influenza severity by promoting inflammatory cell death, a process mechanistically linked to the subsequent suppression of STING activation. This study reveals a novel pathogenic cell-intrinsic mechanism in co-infection pathogenesis. Supplementary Information The online version contains supplementary material available at 10.1038/s41598-025-28063-w.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/3439ff28ee00f2494a3463487f23bdd0ebdcd631" target='_blank'>
              Pre-activation timing determines influenza severity and viral pathogenicity via STING Inhibition
              </a>
            </td>
          <td>
            Tong Zhu, Mengru Zhu, Feiyu Lu, Kuo Qu, Hong Wang, Shengnan Wang, Zhengyi Sun, Yongli Yu, Liying Wang, Chaoying Yan
          </td>
          <td>2025-12-24</td>
          <td>Scientific Reports</td>
          <td>0</td>
          <td>5</td>
        </tr>

        <tr id="Sepsis remains a leading cause of critical illness worldwide. Despite advances in supportive care, durable benefit from immune-directed therapies is limited, reflecting heterogeneity with immune low-response states (‘immunoparalysis’) across innate and adaptive compartments. In this review we summarize advances from single-cell RNA and ATAC profiling, immune-repertoire assays and 3D spatial transcriptomics that resolve monocyte, dendritic-cell (cDC1, cDC2 and pDC), lymphocyte and NK-cell programs, and appraise translational opportunities spanning endotype-guided risk stratification, pharmacodynamic monitoring and spatial biomarkers. We also discuss enduring challenges—including assay standardization, harmonized thresholds for monocyte HLA-DR and whole-blood stimulation, and limited availability of clinically compatible spatial platforms—that temper implementation. By integrating bedside function (HLA-DR trajectories, LPS-induced cytokine capacity) with single-cell endotypes (MS1/HLA-DR^low S100A^high monocytes, dendritic-cell attrition, checkpoint-biased T cells) and host–pathogen topology from FFPE-ready spatial assays, emerging strategies aim to restore antigen presentation, reconstitute priming, disrupt inhibitory myeloid–lymphoid circuits and prevent secondary infection. Our synthesis provides an appraisal of the evolving landscape of immunoparalysis-informed precision medicine in sepsis and outlines pragmatic standards for composite biomarkers, patient selection and on-therapy decision rules. We hope these insights will assist investigators and clinicians as they endeavor to convert descriptive immune low-response states into tractable, reversible clinical entities.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/8bbe4c9833c37301d015a1fe8298eb3d5c890be7" target='_blank'>
              Decoding immune low-response states in sepsis: single-cell and 3D spatial transcriptomic insights into immunoparalysis
              </a>
            </td>
          <td>
            Yulian Yang, Yi Zhang, Jingjing Wu, Yi Liu, Xianying Lei
          </td>
          <td>2025-11-05</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="Neurotropic viruses infect the central nervous system (CNS) and can cause severe neurological disorders. Theiler’s murine encephalomyelitis virus (TMEV) infection in C57BL/6 mice serves as a model for virus-induced encephalitis and hippocampal damage. C-type lectin domain family 12 member A (CLEC12A) is an inhibitory receptor, which modulates immune responses during inflammatory processes. However, the role of CLEC12A during neurotropic virus infections remains unclear. In this study, CLEC12A-deficient (CLEC12A−/−) and wild type C57BL/6 mice were infected with TMEV. Neuroinflammatory responses, viral load, and immune cell infiltration were analyzed using immunohistochemistry, RT-qPCR, and flow cytometry. CLEC12A−/− mice exhibited increased T cell sequestration in the brain, along with a higher expression of pro-inflammatory cytokine (TNF-α, IL-1β) and antigen presentation genes (CD11c, CD80, MHC-I) during acute infection. This led to an improved viral clearance in the hippocampus. CLEC12A deficiency also activates splenic CD4+ T cells and CD8+ cytotoxic T cells upon infection. Despite increased peripheral T cell activation and neuroinflammation, CLEC12A−/− mice displayed less hippocampal damage with improved neuronal and axonal integrity. In conclusion, CLEC12A signaling in C57BL/6 mice contributes to suppressive immune modulation, delaying viral elimination and exacerbating brain damage during acute neurotropic virus infection.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/0c06a34914feb56293f8f56d9bcc2e6259a3943c" target='_blank'>
              CLEC12A signaling represses protective immune responses and contributes to hippocampal pathology in neurotropic picornavirus infection
              </a>
            </td>
          <td>
            M. K. Ameen, M. Stoff, S. Pavasutthipaisit, T. Ebbecke, M. Ciurkiewicz, T. Störk, J. Ruland, B. Lepenies, A. Beineke
          </td>
          <td>2025-11-10</td>
          <td>Scientific Reports</td>
          <td>0</td>
          <td>8</td>
        </tr>

        <tr id="Abstract Background Recently approved Alzheimer's disease (AD) therapies leverage immunization strategies targeting amyloid‐β (Aβ). While most studies focus on microglial responses to these treatments, evidence suggests that sustained immune activity and Aβ clearance drive broader cellular changes. Astrocytes, which accumulate at microglia‐targeted Aβ plaques, may play a complementary role in clearance. This study examines how astrocyte phenotypes are altered by Aβ immunization and their contribution to Aβ clearance. Methods We performed single‐cell RNA sequencing and spatial transcriptomics on post‐mortem brain tissue from 16 AD patients—10 immunized (9 with AN1792 from the first active Aβ immunotherapy trial, 1 with lecanemab) and 6 non‐immunized controls. We identified astrocyte states enriched in immunized brains and analyzed their transcriptomic profiles. Additionally, we mapped astrocyte states localized at microglia‐targeted Aβ plaques. Results A distinct astrocyte population emerged following immunization with both AN1792 and lecanemab, characterized by upregulated CHI3L1 and other reactive astrocyte markers. Spatial analysis revealed these astrocytes preferentially localize at microglia‐targeted Aβ plaques post‐lecanemab treatment. Ongoing analyses aim to further define astrocyte phenotypes in terms of morphology, protein expression, Aβ uptake, and spatial relationships with Aβ pathology and microglia. Conclusion We identify a unique astrocyte phenotype induced by Aβ immunization in AD, marked by high CHI3L1 expression. This astrocyte state may be driven by microglia at Aβ plaques and contribute to plaque clearance. Our findings highlight distinct astrocyte responses to Aβ immunization, shedding light on their role in therapeutic outcomes.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/cc7159ce560d018f315b60c3e4c1c97a198abbee" target='_blank'>
              Distinct astrocyte phenotypes aid microglia‐mediated Aβ clearance in immunized Alzheimer's disease patients
              </a>
            </td>
          <td>
            Alex J. Edwards, Lily Camp, Anne V. Forsyth, Joshua Kuruvilla, Brooke Simonton, Pouya Jamshidi, Rudolph J. Castellani, James Ar Nicoll, Delphine Boche, Lynn van Olst, David Gate
          </td>
          <td>2025-12-01</td>
          <td>Alzheimer's & Dementia</td>
          <td>0</td>
          <td>11</td>
        </tr>

        <tr id="Neurocognitive impairment is a prevalent co-morbidity in virologically suppressed people living with HIV (PLWH), yet the underlying mechanisms remain elusive and treatments lacking. We explored use of participant-derived directly induced neurons (iNs) to model neuronal biology and injury in PLWH. iNs retain age- and disease-related donor features, providing unique opportunities to reveal important aspects of neurological disorders. We obtained primary dermal fibroblasts from six virologically suppressed PLWH (range: 27-64 years, median: 53; 83% Male) and seven matched people without HIV (PWOH) (range: 27-66, median: 55; 71% Male). iNs were generated using transcription factors NGN2 and ASCL1, and validated by immunocytochemistry, single-cell-RNAseq, and electrophysiological recordings. Transcriptomic aging analyses confirmed retention of donor age-related signatures. Bulk-RNAseq identified 29 significantly differentially expressed genes between PLWH and PWOH iNs. Of these, 16 were downregulated and 13 upregulated in PLWH iNs. Protein-protein interaction network mapping indicates iNs from PLWH exhibit differences in extracellular matrix organization and synaptic transmission. IFI27 was upregulated in PLWH iNs, complementing independent post-mortem studies demonstrating elevated IFI27 expression in PLWH-derived brain tissue. FOXL2NB-FOXL2-LINC01391 expression was reduced in PLWH iNs and negatively correlated with neurocognitive impairment. Thus, we identified an iN gene signature of HIV revealing mechanisms of neurocognitive impairment in PLWH.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/5ed7c586e77d0113c401ac4f4b8dda15f9a05841" target='_blank'>
              Transcriptional signature of induced neurons differentiates virologically suppressed people with HIV from people without HIV.
              </a>
            </td>
          <td>
            P. N. Ostermann, Youjun Wu, S. Bowler, Samuel Martínez-Meza, M. A. Siddiqui, David H Meyer, Alberto Herrera, Brandon A Sealy, Mega Sidharta, K. Ramnarine, Leslie St. Bernard, Desiree Byrd, R. Jones, Masahiro Yamashita, Douglas F. Nixon, L. Ndhlovu, Ting Zhou, Teresa H. Evering
          </td>
          <td>2025-11-25</td>
          <td>JCI insight</td>
          <td>0</td>
          <td>43</td>
        </tr>

        <tr id="Abstract Background We have recently established that microglia in the aged and AD human brain exist in discrete, transcriptionally defined states that have complex associations with clinicopathological features of AD (PMID: 33257666). This multifaceted relationship made it clear that we should develop approaches that allow for fine‐tuning of microglia population structure in order to achieve therapeutic benefit in AD. However, how Ad genes affect the cell intrinsic regulatory networks that shape human microglia phenotypes is yet unknown. To fill in this gap we investigated how AD genes affect the transcriptional regulatory networks that underlie microglia phenotypic specification. Method To achieve this goal, we utilized CROP‐seq, that enables pooled CRISPR screens with single‐cell transcriptome resolution. To assemble the guide RNA (gRNA) library for this study, we focused on nascent AD drug targets that were nominated by the National Institute on Aging's AMP‐AD consortium and TREAT‐AD centers and were expressed in microglia. gRNA library transduction was performed according to our recently published protocol (PMID: 38600587), and the cells were then submitted to a modified single cell RNA‐sequencing pipeline on the 10x Genomics Chromium platform. Result Generally, we found that genetic perturbation of AD genes in microglia resulted in changes in transcriptional regulatory networks associated with inflammation and lipid metabolism. More specifically, interestingly, the microglia subsets that were most affected by perturbations in AD genes were the previously described cluster 8 and cluster 9 microglia (PMID: 33257666). Previously we found cluster 8 microglia subset to be enriched in genes associated with metabolic changes while cluster 9 was characterized by genes involved cell proliferation. Both of these subsets had a negative association tau pathology in a large ROS/MAP transcriptomic dataset, suggesting that these microglia phenotypes might be protective in AD and that perturbations in AD genes might dysregulate the transcriptional regulatory networks involved in phenotypic specification of these subsets. Conclusion Our findings prioritize two human microglia subsets as being primarily affected by perturbations in AD genes, and identify transcriptional regulatory networks that could be targeted to modulate microglia population structure in a way that will potentially support the maintenance and/or restoration of tissue homeostasis in AD.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/eb1b2f817c2be7ae5aa9510c914b951f560502f1" target='_blank'>
              Identification of regulatory networks involved in microglia subset specification
              </a>
            </td>
          <td>
            Jason C. Ngo, Emily Lee, Nivedita Nimmagadda, Vilas Menon, Falak Sher, Marta Olah
          </td>
          <td>2025-12-01</td>
          <td>Alzheimer's & Dementia</td>
          <td>0</td>
          <td>9</td>
        </tr>

        <tr id="


 Emerging evidence has suggested that primary infection and/or insult can “train” or “prime” long-term alterations in the transcriptional and epigenetic profiles of innate immune cells, particularly macrophages. Currently, it is unknown whether those “infection-experienced” macrophages can facilitate adaptive immune memory responses after infection resolution. Here, we show that influenza virus infection induces lasting transcriptional and epigenetic changes in lung alveolar macrophages (AMs) compartment following the resolution of primary infection. Further analysis showed that the IL-1b was persistently upregulated in the “infection-experienced” AMs at the memory phase compared to those of AMs from the naïve mice, and the “primed” AMs represent the major source of IL-1b in the infection-experienced lungs. Strikingly, blocking IL-1β or ablating it in myeloid cells during the memory phase led to decreased number of antigen-specific CD8 resident memory T cells (Trm) specifically in the airway but not the lung parenchyma. Consistently, IL-1b blockade caused diminished Trm-mediated protective immunity during heterologous influenza virus re-challenge. Our data suggest that infection-primed innate immune compartment facilitates protective local adaptive immune memory in the respiratory mucosa after the resolution of primary infection. Our findings may inform future vaccine design aiming to induce strong mucosal CD8 T cell immunity against respiratory viral infections.



 Immune Response Regulation: Cellular Mechanisms (IRC)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c545200b85997582aa0e6b4cd460d5da7beff03a" target='_blank'>
              Infection-experienced alveolar macrophages sustain airway T cell memory 3555
              </a>
            </td>
          <td>
            I. Cheon, Y. Son, J. Im, Jie Sun
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>21</td>
        </tr>

        <tr id="

 SARS-CoV-2, the pathogen of COVID-19, disrupts the alveolar epithelial barrier and triggers exacerbation of airway inflammation. The envelope (E) protein plays a key role in promoting epithelial damage and sustaining inflammation. We previously identified a SARS-CoV-2 variant (F8) containing a 12-bp deletion in the E gene. Compared to the 8X strain, which possesses the wild-type E gene, F8 could induce a higher expression of inflammatory factors in Calu-3 cells.



 This study analyzed the miRNA expression profiles in Calu-3 cells infected with either the F8 variant or the 8X strain. Quantitative Reverse Transcription Polymerase Chain Reaction (RT-qPCR) was employed to validate the differential expression of candidate miRNAs. Subsequent functional verification assays like ELISA were performed to elucidate the regulatory roles of these miRNAs in host signaling pathways, such as inflammatory responses.



 We discovered that F8 infection significantly upregulated miR-361-3p and downregulated let-7b-5p. Furthermore, miR-361-3p regulated the PI3K-Akt pathway by directly targeting and inhibiting TSPAN1, ultimately promoting PTEN expression. The downregulation of let-7b-5p might release the suppression on inflammatory cytokines (IL-6, IL-8, PTX3), and partially disorder ZO-1 expression in maintaining the barrier function.



 This study is the first to demonstrate that the SARS-CoV-2 E protein mutant F8 remodeled the host miRNAs network to coordinate the immune responses and barrier function. All findings provided valuable insights into the pathogenesis of SARS-CoV-2 variants.
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/8e3e728bf0af1f00a31c1d2eadcc47ca6aa1e2d4" target='_blank'>
              MicroRNA-mediated regulation of the immune response in Calu-3 cells infected with a SARS-CoV-2 E gene variant
              </a>
            </td>
          <td>
            Chenfan Sun, Fang Xu, Zhongji Pu, Hanping Zhu, Yu-dong Li, Hangjing Lu, Bei-Bei Wu, Yi-Sheng Sun, Ping-Ping Yao, Jian-Ming Jiang
          </td>
          <td>2025-12-15</td>
          <td>Frontiers in Microbiology</td>
          <td>0</td>
          <td>13</td>
        </tr>

        <tr id="Brucellosis is a severe zoonotic disease caused by Brucella infection, which remains prevalent in several regions worldwide and poses a significant public health challenge. The host deploys complex immune mechanisms to combat the pathogen, including the recognition of pathogenic signals, secretion of inflammatory factors, and activation of innate and adaptive immune responses. Brucella, as a facultative intracellular pathogen, replicates within host cells and establishes chronic infections through diverse immune evasion strategies. These include subversion of Toll-like receptor (TLR) signaling, disruption of antigen presentation, and interference with T cell responses. This review focuses on Brucella species with significant human infectivity, such as B. melitensis and B. abortus, summarizing their interactions with the host immune system. Recent studies have highlighted TLR pathway inhibition, antigen presentation impairment, and T cell dysregulation as key mechanisms of immune evasion. Understanding these processes is crucial for elucidating Brucella pathogenesis and developing novel therapeutic and vaccine strategies against brucellosis.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/09f26f3db52f5a11fc17e40e1ba459f8ee3fd969" target='_blank'>
              Brucella Immune Escape: TLR Subversion, Antigen Presentation Destruction and T Cell Disorder
              </a>
            </td>
          <td>
            Hanwei Jiao, Gengxu Zhou, Shengping Wu, Chi Meng, Lingjie Wang, Cailiang Fan, Jixiang Li, Yuefeng Chu
          </td>
          <td>2025-11-01</td>
          <td>Cells</td>
          <td>0</td>
          <td>7</td>
        </tr>

        <tr id="Enterovirus A71 (EV-A71) is a critical global pathogen, primarily causing Hand-Foot-and-Mouth Disease (HFMD) but frequently leading to severe neurological complications, including fatal neurogenic pulmonary edema (PE). This review elucidates the complex interplay between viral pathogenesis and the host immune response. EV-A71 utilizes receptors like SCARB2 and PSGL-1 for entry, while its proteases (2Apro, 3Cpro) efficiently evade innate immunity by cleaving key signaling adaptors (MAVS, TRIF), suppressing Type I IFN response. Critical to disease progression is the age-dependent vulnerability in infants and the subsequent shift toward immunopathology. Severe disease is driven by a systemic cytokine storm and T cell dysregulation, characterized by a loss of control from Treg cells and a profound Th17/Treg imbalance, resulting in high levels of pathogenic cytokines (e.g., IL-17A, IFN-γ). Clinical progression is predicted by specific biomarkers, including Treg depletion, monocyte exhaustion (PD-1/PD-L1), and suppressed regulatory signaling (low cAMP). These findings highlight that effective therapeutic strategies must target host-mediated damage through immunomodulation (e.g., by exploring interventions against key pathogenic axes like IL-6 and IL-1β) and call for the development of next-generation vaccines capable of eliciting balanced cellular immunity to prevent immunopathology.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/0c94423fb623958f352400377f15120efff0cd02" target='_blank'>
              The Host Immune Response to Enterovirus A71 (EV-A71): From Viral Immune Evasion to Immunopathology and Prognostic Biomarkers of Severe Disease—A Narrative Review
              </a>
            </td>
          <td>
            Anna Andronik, Dawid Lewandowski, Artur Sulik, Kacper Toczyłowski
          </td>
          <td>2025-11-25</td>
          <td>Viruses</td>
          <td>0</td>
          <td>12</td>
        </tr>

        <tr id="


 La Crosse Encephalitis virus (LACV) is the leading cause of pediatric mosquito-borne encephalitis in North America. Infection is established in the layer of skin-associated muscle following a mosquito blood meal, but the virus ultimately reaches the brain and causes neuronal cell death. In the current study, we analyzed the innate immune response in the two primary cell types infected by LACV, muscle cells in the skin and neurons in the brain. We utilized human cell lines of muscle (M007) and neuronal (SH-SY5Y) origin to assess the antiviral responses to virus infection with type I interferon (IFN) treatment. LACV replicates inefficiently in the M007 cells, which are resistant to LACV-mediated death. In contrast, the SH-SY5Y cells succumb to infection after two days with high virus titers. We found differences between the cell types in the ability of the type I IFNs to protect against virus infection and in interferon stimulated gene (ISG) expression. We also saw differences between the type I IFN subtypes in their ability to protect both M007 and SH-SY5Y cells against LACV infection. These experiments identify cell-type specific responses to LACV infection which help to define mechanisms of LACV pathogenesis.



 National Institute of Allergy and Infectious Diseases, National Institutes of Health



 Innate Immune Responses and Host Defense: Cellular Mechanisms (INC)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/0a87256ea8987cb294461ff37d12e1452f6be720" target='_blank'>
              Type I interferon alpha subtype inhibition of la crosse virus infection in muscles cells and neurons 4575
              </a>
            </td>
          <td>
            Annabel Coyle, Christine Schneider-Lewis, Emily Kirby, Hollis Baker, Paul F. Policastro, Tyson A. Woods, Clayton Winkler, K. Sutter, Ulf Dittmer, Karin Peterson
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>22</td>
        </tr>

        <tr id="


 Acute fulminant myocarditis (AFM) represents a severe inflammatory cardiac condition with limited therapeutic options. We evaluated JAK/STAT pathway inhibition as a novel therapeutic strategy in AFM through detailed immunological profiling. In a patient with biopsy-confirmed AFM presenting with cardiogenic shock, administration of ruxolitinib (10mg BID) led to rapid clinical improvement. Comprehensive single-cell analyses, including RNA-seq, CITE-seq, and TCR/BCR-seq, revealed pre-treatment hyperactivation of JAK/STAT signaling in specific immune populations. Post-treatment analyses demonstrated significant suppression of interferon-stimulated genes in myeloid cells, reduction in cytotoxic lymphocyte populations, and restoration of physiologic immune TCR/BCR homeostasis, correlating with clinical recovery. These findings establish JAK inhibition as a promising therapeutic approach in AFM and provide mechanistic insights into immune modulation in cardiac inflammation.



 UCSF Catalyst Award 7032062 AHA’s Second Century Early Faculty Independence Award 24SCEFIA1246915



 Immune Mechanisms of Human Disease (HUM)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/217c5964efbce02426769221d97235b889569d8e" target='_blank'>
              JAK Inhibition Reprograms Immune Response in Fulminant Myocarditis 2562
              </a>
            </td>
          <td>
            Juan Qin
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>4</td>
        </tr>

        <tr id="The Coronavirus Disease 2019 (COVID‐19) pandemic, caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS‐CoV‐2), has revealed the virus's ability to induce multi‐organ damage, including significant liver injury. The molecular mechanisms of liver dysfunction in COVID‐19 patients are explored, focusing on direct viral infection, immune‐mediated damage, and the gut–liver axis. SARS‐CoV‐2 enters liver cells through the Angiotensin‐Converting Enzyme 2 (ACE2) and Transmembrane Serine Protease 2 (TMPRSS2) receptors, but alternative pathways, such as CD209/Dendritic Cell‐Specific Intercellular adhesion molecule‐3‐Grabbing Non‐integrin (DC‐SIGN) and AXL receptors, can also contribute to viral entry. Additionally, immune responses, particularly the cytokine storm, exacerbate liver inflammation, leading to hepatocyte damage. Pre‐existing liver conditions, such as metabolic‐associated fatty liver disease (MAFLD), alcohol‐related liver disease (ALD), and liver fibrosis, heighten the risk of severe outcomes in COVID‐19 patients. Post‐COVID‐19 liver complications, including fibrosis progression and persistent liver damage, have been reported, with emerging evidence suggesting chronic inflammation, viral persistence, and autoimmune reactions as potential contributors. Furthermore, Drug‐Induced Liver Injury (DILI) from COVID‐19 treatments remains a concern, highlighting the need for careful management. Consequently, understanding the interplay between SARS‐CoV‐2 and the liver is critical for improving patient outcomes and developing targeted therapies to mitigate liver‐related complications in both acute and Long COVID‐19 phases.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/d8e7ab48363fa154c104250ae482911ee316a6df" target='_blank'>
              SARS‐CoV‐2: A Liver Brief
              </a>
            </td>
          <td>
            Youness Limami, Hicham Wahnou, Martin Ndayambaje, Soufyane Hba, Oumaima Chgari, Mounia Ammara, Riad El Kebbaj, Abdallah Naya, M. Oudghiri, Raphael Georges Duval
          </td>
          <td>2025-11-01</td>
          <td>WIREs Mechanisms of Disease</td>
          <td>0</td>
          <td>20</td>
        </tr>

        <tr id="Respiratory syncytial virus (RSV) is the most common cause of acute bronchiolitis and pneumonia in children under 5 years of age. RSV infection is characterized by lung inflammation, viral expansion, and airway barrier destruction. The crosstalk between neurons and immune and non-immune cells develops from early life onwards. The lungs and airways are densely innervated by sympathetic neurons where they secrete the neurotransmitter noradrenaline (NA) at homeostasis and following injury in adult mice. NA, once secreted into the lungs, can act on immune and non-immune cells through β-adrenergic receptors (β-ARs). However, it is unknown whether NA-β-AR signaling axis regulates antiviral immunity during early-life infections. In a mouse model of neonatal RSV infection, we find that stimulation of adrenergic signaling via β2-AR agonist increases viral clearance, anti-inflammatory responses, and disease recovery. By contrast, loss of sympathetic neurons and β2-AR increases the RSV viral load and immunopathology in neonates. Stimulating β2-AR signaling has several downstream effects, including reduced airway mucus secretion and protection from endothelial barrier disruption, which together prevent airway blockade, respiratory failure, and facilitate control of RSV infection. Collectively, our studies demonstrate that sympathetic neurons and β2-AR signaling protect neonates from viral expansion and lung barrier breakdown, promoting antiviral defense.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a1080e6779c79237f286db40fc699be83e24e36f" target='_blank'>
              β2-adrenergic signaling controls neonatal respiratory syncytial virus infection by promoting viral clearance and airway protection
              </a>
            </td>
          <td>
            Sandeep Adhikari, Camille Carrier, P. Joshi, Pankaj Baral
          </td>
          <td>2025-12-18</td>
          <td>Nature Communications</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1c8423d9fefb3d644864a26f8dbc02503abeb9ee" target='_blank'>
              Blood pro-thrombotic analytes and platelet activation are associated with post-acute sequelae of COVID-19.
              </a>
            </td>
          <td>
            Luke A Whitcomb, K. Berry, S. LaVergne, Nicole Natter, Bridget Baxter, Sangeeta Rao, M. Tipton, Marina A. Gritsenko, Karl K. Weitz, Vince Gerbasi, L. Bramer, P. Piehowski, Tracy L. Webb, Marcela Henao-Tamayo, Adam J. Chicco, J. Dunn, Taru S. Dutt, Elizabeth P. Ryan
          </td>
          <td>2025-12-10</td>
          <td>BMC infectious diseases</td>
          <td>0</td>
          <td>11</td>
        </tr>

        <tr id="Background Rhinovirus (RV) is the most common trigger of viral-induced pediatric asthma exacerbations. The impact of IL-13-driven inflammation, common in pediatric asthma, on airway epithelial antiviral and inflammatory responses to RV remain unclear. Objective Determine how IL-13-driven T2 inflammation modulates pediatric bronchial epithelial cell responses to RV infection. Methods Bronchial epithelial cells (BECs) were collected from children with (n=50) and without (n=11) asthma. They were differentiated at an air-liquid interface for 21 days, pretreated with IL13 (10ng/mL) for 7 days to model T2 inflammation, then infected with RV-A16 (MOI 0.5). RNA sequencing of BECs was performed prior to and on days 2, 4, 7, and 10 post infection. Linear and generalized additive models partnered with pathway analysis identified differentially expressed gene clusters. Results RV infection, IL-13 stimulation, and their interaction each induced differentially expressed genes (7,808; 10,251; and 7,095 genes, respectively; FDR<0.05). IL-13 pretreatment did not alter RV load or a cluster enriched for interferon response and regulation genes, including IFNB1, IFNL1-3, STAT1/2, and CXCL10/11. In contrast, IL-13 reduced expression of distinct antiviral effectors (e.g. MX1/2, RSAD2, IFITM1-3; FDR=1.85×10⁻⁴) and increased a secondary proinflammatory response cluster enriched for IL-15, TNF, ER stress, and cell-death pathways (FDR=3.63×10⁻⁶). These clusters correlated with viral load in RV-infected cells, but IL13 pretreatment eliminated those associations. Conclusions IL-13 does not modify viral load or interferon induction but selectively suppresses epithelial antiviral effector programs and enhances secondary inflammatory pathways during RV infection. These findings provide mechanistic insight into how T2 inflammation contributes to viral-triggered asthma morbidity. Key Messages – IL-13 did not alter rhinovirus viral load or epithelial interferon induction but selectively suppressed antiviral effector programs. This indicates that T2 inflammation reshapes antiviral defenses downstream of interferon signaling rather than impairing interferon production itself. – IL-13 enhances a distinct secondary proinflammatory cluster enriched for IL-15, TNF signaling, ER stress, and cell-death pathways. These late-phase responses may contribute to the heightened airway inflammation and injury observed during viraltriggered exacerbations in T2-high pediatric asthma. – IL-13-driven changes decouple epithelial immune responses from viral load, revealing mechanisms that may persist even with anti-IL-4Rα/IL-13 therapy. These findings identify epithelial antiviral effector pathways and IL-15/TNF-associated inflammatory programs as potential therapeutic targets for patients who experience breakthrough viral exacerbations despite IL-13 blockade. Capsule Summary IL-13 did not alter rhinovirus load or epithelial interferon but selectively suppressed antiviral effectors and amplified secondary inflammatory pathways, revealing how T2-inflammation may worsen viral-triggered asthma exacerbations and contribute to breakthrough exacerbations despite IL-4Rα/IL-13-targeted therapy.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/8534d6df54bf150ef5da348dfd8ea2420fc6c8b1" target='_blank'>
              IL-13 Modulates Antiviral Effector and Proinflammatory Pathways in Rhinovirus-Infected Pediatric Bronchial Epithelium
              </a>
            </td>
          <td>
            P.C. Dela Cruz, Basilin Benson, N. Jayavelu, Weston T. Powell, Lucille M. Rich, Elizabeth R. Vanderwall, C. Gates, M. White, Nyssa B. Samanas, Kourtnie Whitfield, T. Hallstrand, Steven F. Ziegler, Gail H. Deutsch, Matthew C. Altman, Jason S. Debley
          </td>
          <td>2025-12-08</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>45</td>
        </tr>

        <tr id="Background: COVID-19 has taken millions of lives and continues to affect people worldwide. Post-Acute Sequelae of SARS-CoV-2 Infection (also known as Post-Acute Sequelae of COVID-19 (PASC) or more commonly, Long COVID) occurs in the aftermath of COVID-19 and is poorly understood despite its widespread effects. Methods: We created a machine-learning model that distinguishes PASC from PASC-similar diseases. The model was trained to recognize PASC-dysregulated metabolites (p ≤ 0.05) using molecular descriptors. Results: Our multi-layer perceptron model accurately recognizes PASC-dysregulated metabolites in the independent testing set, with an AUC-ROC of 0.8991, and differentiates PASC from myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), Lyme disease, postural orthostatic tachycardia syndrome (POTS), and irritable bowel syndrome (IBS). However, it was unable to differentiate fibromyalgia (FM) from PASC. Conclusions: By creating and testing models pairwise on each of these diseases, we elucidated the unique strength of the similarity between FM and PASC relative to other PASC-similar diseases. Our approach is unique to PASC diagnosis, and our use of molecular descriptors enables our model to work with any metabolite where molecular descriptors can be identified, as these descriptors can be generated and compared for any metabolite. Our study presents a novel approach to PASC diagnosis that partially circumvents the lengthy process of exclusion, potentially facilitating faster interventions and improved patient outcomes.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/3e99799d2fa814d4b81df362f165d526e759988b" target='_blank'>
              Metabolomics-Based Machine Learning Diagnostics of Post-Acute Sequelae of SARS-CoV-2 Infection
              </a>
            </td>
          <td>
            Ethan Cai, V. Kouznetsova, Igor F. Tsigelny
          </td>
          <td>2025-12-01</td>
          <td>Metabolites</td>
          <td>0</td>
          <td>25</td>
        </tr>

        <tr id="


 Severe COVID-19 is associated with excessive lung inflammation and impaired antiviral response. SARS-CoV-2 structural spike (S), nucleocapsid (N), and envelope (E) proteins are key mediators of excessive inflammation. The immune sensors and signaling pathways for S-, N-, and E-proteins are well described. However, the role of M-protein in SARS-CoV-2-induced immunity, and the immune sensor and downstream pathways promoting M protein-induced immunity are not well defined. Here, we stimulated murine bone marrow derived macrophages (BMDMs) with M-protein and examined host response, identified immune sensor, and defined key adapter molecules that facilitated excessive inflammation and impaired antiviral response. We show that M-protein elicits robust inflammation and suppresses antiviral immunity. Using wild-type and knock-out BMDMs, we identified TLR4 as primary immune sensor, while Myd88 and TRIF facilitated M-protein-induced inflammation via both NFkB and MAPK activation. Interestingly, M-protein suppressed antiviral interferon (IFN) response via ERK1/2 activation, while blocking M-protein-induced ERK1/2 activity reduced inflammation while improving IFN-I response. Collectively, we defined the role of M-protein in SARS-CoV-2-induced inflammation and identified TLR4 and Myd88/TRIF as key molecules orchestrating dysregulated immunity largely via the ERK1/2 pathway; specifically targeting these pathways may mitigate SARS-CoV-2-mediated dysregulated immunity and severe disease.



 Supported by NIH R21AI186028; NIH P20GM103648; P30GM149368; SRTP OSU-CVM; FFAR Veterinary Student Research Fellowship.



 Viral Immunology (VIR)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/6dad1a93bbd5352c9219bcf5ca58ca76a8cc63e4" target='_blank'>
              TLR4 and Myd88/TRIF signaling serve as novel immune sensor and adapters of SARS-CoV-2-membrane (M) protein induced immune response 2730
              </a>
            </td>
          <td>
            P. Johnson, Rakshya Shrestha, Cody Whitley, Rudra Channappanavar
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="Abstract Background Chronic inflammatory microglia is a key pathological hallmark of Alzheimer's Disease (AD) requiring high metabolic demand. Glucose is a key metabolite vital for microglia responses, and sustained hyperglycaemia is a significant risk for AD development. Understanding how microglia fuel their inflammatory responses is key to understanding how to modulate their behaviour in neurodegenerative diseases. Method Microglia were isolated from APP‐NL‐G‐F mice at different key time points in disease progression (1, 3 and 6 months, n = 4‐6 per time point) and interrogated using mass spectrometry and proteomic analysis. Result Proteomic analysis revealed by microglia massively upregulate their glycolysis machinery at 6 months coinciding with significant increases in inflammatory and disease associated protein expression. Interestingly, expression of glucose receptors were significantly decreased, yet increases in proteins involved in glycogen breakdown were increased. Acute (24hr) depletion of glucose in vitro also had no effect on microglia inflammatory responses to lipopolysaccharide (LPS) and glycolysis was maintained, yet longer (48hr) depletion significantly altered the microglia response. This suggests that microglia rely on glycogen reserves for metabolic flexibility and to fuel their inflammatory responses. Conclusion Microglia utilise their internal stores of glycogen to fuel their inflammatory responses to amyloid (in vivo) and to LPS (in vitro). Glycogen regulated microglia responses may represent a novel therapeutic strategy for targeting microglia inflammation in neurodegenerative diseases.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/84417cd7c664f84a6a592673ab7bf61afa8669b4" target='_blank'>
              Investigating how Microglia Fuel their Immune Responses in Alzheimer's Disease
              </a>
            </td>
          <td>
            Amy F. Lloyd
          </td>
          <td>2025-12-01</td>
          <td>Alzheimer's & Dementia</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="


 Chronic inflammatory stress is a key characteristic of bone marrow failure syndromes (BMFS) and myelodysplastic syndromes (MDS), but we do not fully understand how hematopoietic stem cells (HSCs) respond to and are affected by this ongoing stress. HSCs can show immunological memory after short-term exposure to inflammation. This leads to lasting changes in their transcription, metabolism, and function. However, the molecular basis of this memory and its role in MDS pathogenesis remain poorly defined. Here, we identify mitochondrial antiviral signaling protein (MAVS) as a critical mediator of dsRNA-induced HSC immune memory and inflammation-driven hematopoietic dysfunction.
 Using repeated polyinosinic-polycytidylic acid (polyIC) exposure as a dsRNA mimetic, we show that HSCs undergo persistent transcriptional and epigenetic remodeling marked by increased expression and accessibility of immune and mitochondrial genes. ATAC-seq of polyIC-treated LSK cells revealed long-lasting chromatin changes with open region for CTCF, IRF1, and PU.1 binding motifs, closed regions for RUNX1, ERG, ETS binding motifs. RNA-seq identified sustained upregulation of innate immune effectors (CD74, S100a8/9) and mitochondrial regulators. We performed single-cell RNA-seq analysis of the LSK-SLAM pool. We identified 6 clusters, comprised of 3 clusters expressing HSC markers, one expressing multipotent progenitor markers, and 2 expressing cell cycle genes with megakaryocyte priming, consistent with LSK-SLAM heterogeneity. Interestingly, polyIC challenges expanded one HSC cluster marked by expression of immune genes (CD81, CD24a, Nr4a1, Cebpb), AP1 complex genes (Fos, Jun, Junb), as well as metabolic genes (OXPHOS, TCA, mTOR), at the expanse of other HSC-enriched clusters. This inflammatory signature is similar to what is found following LPS or mycobacterial challenges and consistent with immune memory. Immune memory involves metabolic reprograming. Mitochondria serve as platform of innate immune signaling, activating the inflammasome and the dsRNA sensing adaptor mitochondrial antiviral signaling protein (MAVS) to trigger immune responses. Confocal microscopy demonstrated persistent MAVS aggregation on mitochondria and elevated mitochondrial content in polyIC-challenged murine HSCs, months after transient polyIC challenge. Remarkably, MAVS-deficiency prevented expansion of HSC clones with immune memory in response to polyIC challenges. MAVS–/– mice resisted polyIC-induced HSC functional decline, and retained superior HSC engraftment capacity in serial competitive repopulation assay. Finally, MAVS-deficiency prevented the sustained activation of caspase-1 in HSCs that persisted in WT HSC months after polyIC challenge, linking MAVS to the inflammasome in polyIC-induced HSC dysfunction. Hence, HSC immune memory is mediated by MAVS.
 To probe MAVS's pathogenic potential, we utilized an inducible model of active TGF-β1 overexpression (TgCre+) that phenocopies key features of high-risk MDS upon inflammatory stimulation. PolyIC-treated TgCre+;MAVS+/+ mice developed cytopenias, myeloid dysplasia, increased HSC frequencies, elevated mitochondrial membrane potential, and persistent MAVS aggregation with increased caspase-1 activity. MAVS deletion (TgCre+;MAVS–/–) reversed cytopenias, normalized stem/progenitor ratios, and prevented dysplastic features, establishing MAVS as a central node connecting inflammation, mitochondrial stress, and ineffective hematopoiesis. These observations were extended to human MDS. CD34+CD38- cells from high-risk MDS patients showed elevated phospho-SMAD2, mitochondrial aggregation, sustained MAVS clustering, and caspase-1 activation, similar to murine data.
 Together, these findings indicate that repeated exposure to dsRNA elicits MAVS-dependent immune memory in HSCs, and causes HSC functional decline with expansion of a subset of inflammatory HSCs. MAVS-deficiency not only preserves HSC integrity following inflammatory stress but also reverses MDS-like features in vivo. Our findings establish MAVS as a critical molecular link between inflammation and hematopoietic failure and suggest mitochondrial associated immune signaling may be a promising therapeutic target in inflammation-driven MDS and related disorders.
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/3c6b5f7f34187a78587b80d05002010f5646c168" target='_blank'>
              Mavs mediates inflammatory memory in hematopoietic stem cells and promotes ineffective hematopoiesis
              </a>
            </td>
          <td>
            Waseem Nasr, V. Pham, Juying Xu, Micheal Jordan, Amit K. Verma, Gang Huang, M. Filippi
          </td>
          <td>2025-11-03</td>
          <td>Blood</td>
          <td>0</td>
          <td>32</td>
        </tr>

        <tr id="


 The vulnerability of older adults to severe viral infections and cancers highlights the importance of understanding immunosenescence, a process of age-related immune dysfunction. Older individuals have lower percentages of type I interferon (IFN-I) producing plasmacytoid dendritic cells (pDC) compared to younger individuals (p = 0.008). These cells are critical for antiviral immunity and are the most potent producers of IFN-I in response to viral stimulation. To investigate this decline, we examined how mitochondrial health, particularly mitochondrial reactive oxygen species (mtROS) and mitochondrial membrane potential (MMP), differ in pDC between younger (20s) and older (60+) individuals. Our results show pDC from older individuals exhibit lower mtROS expression and MMP levels than younger donors, both at baseline and following influenza A (IAV) stimulation. While stimulation increased mtROS in younger donors, no increase occurred in older donors. MMP differences between age groups were also seen in mock and stimulated conditions, with MMP trending downward after stimulation. To examine the role of mtROS in IFN-I production, we used Antimycin A, a mitochondrial complex III inhibitor. Early mtROS induction inhibited IFN-I production, while later mtROS induction enhanced it. These findings suggest that age-related mitochondrial changes, marked by altered mtROS and MMP, impair pDC IFN-I responses and highlight the importance of mitochondrial dynamics in pDC senescence.



 Viral Immunology (VIR)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/0d5623a5627077205216fc59779c9b4b0d5597fc" target='_blank'>
              Mitochondrial function in aging plasmacytoid dendritic cells and its role in type I interferon responses 3813
              </a>
            </td>
          <td>
            Nica Mariz Aquino
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>0</td>
        </tr>

        <tr id="


 Respiratory syncytial virus (RSV) is a major cause of severe respiratory illness. While most symptoms of RSV infection are linked to airway inflammation, emerging clinical data reveals that RSV can infiltrate the central nervous system (CNS), and lead to neurological manifestations such as seizures and central apnea, and in rare cases, encephalopathy, that can have long-term neurodevelopmental consequences. Despite detection of viral infection in the CNS, the pathophysiological mechanisms of RSV-mediated CNS disease are not well defined. Here, we have modeled RSV-infection of the CNS using human primary neuronal cultures and human brain organoid models of infection. Using confocal microscopy, biochemical and single-cell genomics approaches, we have identified that RSV could productively infect neurons, caused cell death and inflammatory responses, and altered the overall transcriptome of neurons and non-neuronal CNS cell populations after infection. Moreover, we have identified key cell-surface adhesion molecules that are critical for RSV infection in the CNS, and optimized soluble forms of these cell-surface glycoproteins to block viral infection. Our findings advance our understanding of RSV dissemination into the CNS and highlight a potential soluble receptor-based therapy to mitigate against lung and CNS inflammation. This work paves the way for new therapeutic strategies against RSV, and establishes an approach for characterizing viral infection in the human CNS.



 Supported by Children’s Mercy Research Partners, Children’s Mercy Research Institute and Paul Henson Endowment Clinical Scholar Award.



 Viral Immunology (VIR)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a31e2366a9a7df016f4bc922e0f7dae7542f7a45" target='_blank'>
              Identification of the cellular mechanisms of neurological inflammation after RSV infection using a human brain organoid model 3139
              </a>
            </td>
          <td>
            Eric S. Geanes, Rebecca McLennan, J. Gage Greening, Santosh Khanal, Daniel A. Louiselle, Elin Grundberg, Marc Herman, Todd Bradley
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>7</td>
        </tr>

        <tr id="Background: Long COVID—defined as the persistence of symptoms or the development of new symptoms beyond four weeks after acute SARS-CoV-2 infection—affects an estimated 10–30% of individuals recovering from COVID-19, posing a significant public health burden. Emerging evidence suggests that type I interferons (IFNs) (a critical group of cytokines in the antiviral defense) and hematologic alterations, such as lymphopenia and elevated inflammatory markers, are linked to both the severity of acute COVID-19 and the likelihood of developing long-term symptoms. The aim of this study is to explore the association between type I IFN signatures and long COVID. A second aim is to examine the relationship between laboratory findings during acute infection and long COVID. Methods: The study included 61 patients investigated for the presence of long COVID symptoms 16.5 ±1.5 months after acute infection. Patients were divided into two groups of higher symptom burden of long COVID and those with milder symptoms based on demographic, laboratory, and clinical data as well as type I IFN-inducible gene expression (MX-1, IFIT-1, and IFI-44) measured in peripheral blood by real-time PCR. Data collected during acute infection were recorded. Peripheral blood samples were collected during the acute phase of infection, within the first 48 h of hospital admission. IFN-inducible gene expression was measured prospectively at that time, and RNA was extracted immediately for subsequent analysis. Results: History of intubation emerged as a significant associated factor of severe long COVID, with 75% of intubated patients reporting >8 persistent symptoms approximately 16 months post-infection. Higher white blood cell (WBC) and neutrophil counts but lower eosinophil and monocyte counts in acute infection were found to be associated with a high burden of long COVID symptoms. Interestingly, absolute monocyte count was found to independently correlate with higher long COVID symptom burden. Lactate dehydrogenase (LDH) and serum glutamic-oxaloacetic transaminase (SGOT) also differed significantly between groups, with higher levels correlating with a high burden of long COVID symptoms. Notably, MX-1 transcript levels in peripheral blood at the time of acute infection were reduced in patients with a high burden of long COVID symptoms, suggesting that dysregulated immune responses during the acute phase may contribute to persistent symptoms. Conclusions: These findings suggest the potential association of hematological and immune markers with long COVID severity, as well as the importance of monitoring these parameters to identify at-risk patients for early interventions.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/55948e1961f89d1c723409be2502799de1b2eb5e" target='_blank'>
              Type I Interferon-Related Gene Expression and Laboratory Abnormalities in Acute Infection Are Associated with Long COVID Symptom Burden
              </a>
            </td>
          <td>
            M. Emmanouil, V. Georgakopoulou, Konstantinos Drougkas, Panagiotis Lembessis, Charalampos Skarlis, A. Gkoufa, N. Sipsas, C. Mavragani
          </td>
          <td>2025-11-01</td>
          <td>Journal of Clinical Medicine</td>
          <td>0</td>
          <td>44</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/8b1f851971ca708410ff0c33c84532d4113e8c34" target='_blank'>
              The antiviral Interferon pathway drives astrocyte aging and motor decline
              </a>
            </td>
          <td>
            Lara Labarta-Bajo, Ayesha R. Thanawalla, Irene L Gutierrez, Su May Lei Soe, Brent Y. Chick, Ioanna Andritsogianni, Setareh Metanat, Diana C. Hargreaves, S. Kaech, Eiman Azim, Nicola J. Allen
          </td>
          <td>2025-11-13</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>9</td>
        </tr>

        <tr id="Early-life infections can produce durable changes in immune function and behavior. We propose a mechanistic hypothesis positioning the mechanistic target of rapamycin (mTOR) as the link between peripheral inflammation and central nervous system dysfunction in pediatric post-infectious syndromes. Based on clinical, translational, and experimental literature, we outline a stepwise pathway. First, sustained mTOR activation skews T-cell and macrophage differentiation toward pro-inflammatory and autoimmune states. Second, endothelial mTOR signaling weakens tight junctions and increases vesicular transport, compromising blood–brain barrier integrity. Third, cytokines and sometimes autoreactive cells enter the brain and engage mTOR in microglia and neurons, driving neuroinflammation, impaired synaptic maintenance and plasticity, and neurotransmitter disruption. This framework accounts for features observed in Long COVID, myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), and pediatric acute neuropsychiatry syndrome (PANS/PANDAS) and yields testable predictions on pathway activity and barrier permeability. It also motivates targeted interventions that modulate mTOR-related processes in immune and endothelial compartments and within neural circuits in children. So, this article aims to outline a mechanistic framework linking infection-driven mTOR activation to post-infectious neuropsychiatric syndromes.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/2b2799fce36a305b1d54001a243bb97442880817" target='_blank'>
              Proposed Mechanistic Axis of Infections and mTOR Hyperactivation: A Multidisciplinary Review of Immune, Rheumatologic, and Psychiatric Links
              </a>
            </td>
          <td>
            Giovanni Fronticelli Baldelli, Danilo Buonsenso
          </td>
          <td>2025-11-25</td>
          <td>Children</td>
          <td>0</td>
          <td>1</td>
        </tr>

        <tr id="Survivors of COVID-19 can experience long-term lung complications (pulmonary sequelae), but the underlying mechanisms remain unclear. While most patients with COVID-19 lung injury eventually recover essentially completely, some experience significant residual damage. To investigate the underlying differences, we analyzed, using bronchoalveolar lavage fluid (BALF), the alveolar immune cell compartments of a group of patients with post-COVID-19 interstitial lung disease (ILD) six months after acute COVID-19. Patients were categorized into two groups, based on High-Resolution Computed Tomography (HRCT) evaluation a year later: those with persistent HRCT abnormalities compatible with fibrosis (persistent post-COVID-19 ILD, n=6) and those with resolved lung lesions (resolved post-COVID-19 ILD, n=13). Additionally, 6 patients with pre-existing ILD were included in the study, after recovery from COVID-19. Bulk RNA transcriptomics analyses of BALF cells revealed innate immunity and inflammation pathways of neutrophil and monocyte chemotaxis to be enriched in patients with persistent HRCT abnormalities post-COVID-19, consistent with an increase in monocyte-like cell recruitment in the lungs. Pro-fibrotic SPP1 gene expression was significantly upregulated similarly to other fibrotic lung diseases. Conversely, patients with resolved post-COVID-19 ILD showed enhanced BALF cell gene expression signatures indicative of adaptive immune response activation. BALF gene expression patterns of low T-cell activation, high pro-fibrotic macrophage activation and neutrophil chemotaxis were similarly observed in patients with pre-existing fibrotic ILD following COVID-19. These findings suggest that immune response imbalance leading to prolonged activation of innate immunity and subdued adaptive immune responses may be associated with persistent post-COVID-19 ILD and the development of pulmonary fibrosis.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/3f0faca69cfb328bb72907f38427c47bebf12818" target='_blank'>
              BALF gene expression profiling reveals a fibrosis associated innate immune activation bias in persistent post-COVID-19 ILD.
              </a>
            </td>
          <td>
            Katerina M Katerina Antoniou, E. Vasarmidi, A. Galaras, M. Lourou, Ioanna Argyriou, D. Zevla, N. Bizymi, C. Skiadas, I. Lambiri, P. Hatzis, V. Aidinis, Nikolaos Tzanakis, A. Wells, E. Tsitoura
          </td>
          <td>2025-11-14</td>
          <td>American journal of physiology. Lung cellular and molecular physiology</td>
          <td>0</td>
          <td>43</td>
        </tr>

        <tr id="Despite substantial progress in medical care, acute myocarditis remains a life-threatening disorder with a sudden onset, often unexpectedly complicating a simple and common upper respiratory tract infection. In most cases, myocarditis is triggered by viral infections (over 80%), with an estimated incidence of 10–106 per 100,000 annually. The clinical course may worsen in cases of mixed etiology, where a primary viral infection is complicated by secondary bacterial pathogens, leading to prolonged inflammation and an increased risk of progression to chronic active myocarditis or dilated cardiomyopathy. We present a case report illustrating the clinical problem of acute myocarditis progression into a chronic active form. A central element of host defense is the inflammasome—an intracellular complex that activates pyroptosis and cytokine release (IL-1β, IL-18). While these processes help combat pathogens, their persistent activation may sustain inflammation and trigger heart failure and cardiac fibrosis, eventually leading to dilated cardiomyopathy. In this review, we summarize the current understanding of inflammasome pathways and their dual clinical role in myocarditis: they are essential for controlling acute infection but may become harmful when overactivated, contributing to chronic myocardial injury. Additionally, we discuss both novel and established therapeutic strategies targeting inflammatory and anti-fibrotic mechanisms, including IL-1 receptor blockers (anakinra, canakinumab), NOD-like receptor protein 3 (NLRP3) inhibitors (colchicine, MCC950, dapansutrile, INF200), NF-κB inhibitors, and angiotensin receptor-neprilysin inhibitors (ARNI), as well as microRNAs. Our aim is to emphasize the clinical importance of early identification of patients at risk of transitioning from acute to chronic inflammation, elucidate the role of inflammasomes, and present emerging therapies that may improve outcomes by balancing effective pathogen clearance with limitation of chronic cardiac damage.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/406aee2694b0d02672b6d60a430b3502be128f69" target='_blank'>
              Inflammasomes as Potential Therapeutic Targets to Prevent Chronic Active Viral Myocarditis—Translating Basic Science into Clinical Practice
              </a>
            </td>
          <td>
            N. Przytuła, Jakub Podolec, T. Przewłocki, Piotr Podolec, A. Kabłak-Ziembicka
          </td>
          <td>2025-11-01</td>
          <td>International Journal of Molecular Sciences</td>
          <td>0</td>
          <td>30</td>
        </tr>

        <tr id="Respiratory syncytial virus (RSV) is a major cause of severe respiratory tract infections in infants, older adults, and immunocompromised individuals. Despite decades of research, effective therapies are limited, largely due to an incomplete understanding of how infected cells and immune responses interact to shape disease outcomes. Recent evidence indicates that RSV activates multiple regulated cell death (RCD) programs-including apoptosis, necroptosis, pyroptosis, ferroptosis, and autophagy-associated cell death which interact through shared molecular mediators to form a multimodal cell death (MMCD) network. This integrated system regulates the balance between viral clearance and immunopathological injury. Central mediators such as caspase-8, RIPK3, and NLRP3 act as molecular hubs coordinating these death programs and amplifying inflammatory responses. Understanding how MMCD shapes RSV immunopathogenesis provides a unified framework linking cell death to immune dysfunction. This review summarizes recent progress in elucidating the MMCD network, highlights its role in death-inflammation feedback loops, and discusses potential strategies for therapeutic modulation. Conceptualizing RSV disease through the lens of MMCD may guide the development of precision interventions that restore immune homeostasis while preserving antiviral defense.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e48caf42a43b176c4dbbd30d2ec467dfbc9dd6c6" target='_blank'>
              Multimodal cell death drives the immunopathogenesis of RSV infection
              </a>
            </td>
          <td>
            Tianxiang Yang, Zhizhong Mi, Zhaolong Li
          </td>
          <td>2025-12-12</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>1</td>
        </tr>

        <tr id="


 There is growing interest in how immune cells in the meninges, membranes surrounding the brain and spinal cord, contribute to CNS homeostasis and disease. The dura mater, the outermost layer, houses innate and adaptive immune cells and serves as a site for B cell development. Recently, we identified lymphoid architecture surrounding a fenestrated venous plexus at the rostral-rhinal confluence of sinuses, termed the rostral-rhinal venolymphatic hub (hub). It exhibits intricate immune organization, including lymphatic vessels, and scRNA sequencing revealed that a diverse innate and adaptive immune cells inhabits this structure during homeostasis. Here, we show in response to an intranasal virus infection that the hub supports local germinal center (GC) reactions consisting of T follicular helper (Tfh) cells and GC B cells that undergo proliferation, class switch, and somatic hypermutation. In addition, we demonstrate that the hub can support autoimmune reactions against CNS antigens, such as myelin debris, that preferentially accumulates in this location. During development of autoimmunity, myelin oligodendrocyte glycoprotein (MOG)-reactive CD4+ T cells localize preferentially to the hub, interact with B cells, proliferate, and convert into Tfh cells. These data highlight how dural lymphoid architecture surrounding a vascular plexus sample both foreign- and self-antigens, leading to immunity that either protects (antiviral) or harms (autoimmune) the underlying CNS parenchyma.



 Supported by NINDS/NIH



 Neuroimmunology (NEUR)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/22837c7baca10b52decdac6e5c861f7b577cab06" target='_blank'>
              Meningeal lymphoid hubs support antiviral and autoreactive immune responses 3987
              </a>
            </td>
          <td>
            N. Zanluqui, Camille A Spinner, Kory R. Johnson, Vanja Lazarevic, Dorian B. McGavern
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>10</td>
        </tr>

        <tr id="Sepsis remains a Major global health burden, accounting for an estimated 11 million deaths annually, and is characterized by a profoundly dysregulated host immune response to infection. Despite its significant morbidity and mortality, the immunopathogenesis of sepsis—particularly within underrepresented populations—remains inadequately understood. Here we report distinct immunological signatures associated with clinical outcomes among Vietnamese septic patients. To our knowledge, this represents the first comprehensive investigation of both cellular and cytokine immune parameters in the sepsis population. Our findings demonstrate that survivors of sepsis exhibited a higher proportion of circulating B cells, whereas non-survivors showed increased activation of T and natural killer (NK) cells, marked by elevated expression of activation molecules such as CD69 and GITR. There was a notable reduction in B cell numbers, and further phenotypic analysis revealed signs of B cell exhaustion, indicated by increased CD21low expression, as well as depletion of both memory and naïve B cell subsets. Collectively, these results establish compromised humoral immunity in septic patients. T cells in septic patients displayed a skewing toward effector memory phenotypes, and NK cells demonstrated impaired cytotoxic potential, as evidenced by decreased expression of key the key activating receptors including NKG2D and DNAM-1. Concurrent cytokine profiling revealed significantly elevated concentrations of both pro- and anti-inflammatory mediators in septic patients. A significantly diminished percentage of CD8+CD45RA+CD197⁻ T cells, alongside markedly elevated interleukin-6 (IL-6) levels, was observed in non-survivors, strongly supporting their role as key prognostic biomarkers for predicting sepsis-related mortality. Interestingly, tumor necrosis factor-alpha (TNF-α) levels did not significantly differ between those who survived and those who did not, a result that diverges from some prior reports and highlights the possibility of population-specific immunological nuances.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/3d9ba93ec66c35e90540391732ef84f8ac8a5d76" target='_blank'>
              Molecular analysis of immune cell subsets and cytokine profiles in septic Vietnamese patients
              </a>
            </td>
          <td>
            Chien Dinh Huynh, Phuong Minh Nguyen, Trung Dinh Ngo, Hung Xuan Nguyen, Tu Dac Nguyen, Hien Thi Mai, Huyen Thi Le, Duy Hoang, Linh Khac Le, Quan Khoi Nguyen, Hoang Viet Nguyen, Keith W. Kelley
          </td>
          <td>2025-12-05</td>
          <td>Clinical and Experimental Medicine</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/8484ee2588089976dc012a7dda6f35ef3e0a9fe0" target='_blank'>
              Sepsis-associated immunosuppression: mechanistic Insights, Biomarkers, and therapeutic perspectives
              </a>
            </td>
          <td>
            M. Ovalı, Şevval Perçin
          </td>
          <td>2025-12-01</td>
          <td>Molecular Biology Reports</td>
          <td>0</td>
          <td>10</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/5c49227a1088f0421b59ade743eedbb48b10e147" target='_blank'>
              Exposure to immune stimuli reprograms alveolar macrophages to acquire neutrophil-derived antimicrobial molecules to prevent staphylococcal pneumonia
              </a>
            </td>
          <td>
            Amit Sharma, Linda M. Heffernan, Venkatesh Mayandi, Seetharama D. Jois, William N. Beavers, Basel H. Abuaita
          </td>
          <td>2025-12-05</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>13</td>
        </tr>

        <tr id="


 High T-cell effector-to-target ratio and increased cytolytic function are characteristics of rapid containment in asymptomatic HSV-2 infection. However, our understanding of the spatial relationship and functional influence of innate immune cells on T lymphocytes is yet to be defined. Here, we applied highly multiplexed immunophenotyping and single-cell spatial transcriptomics technologies to systematically investigate the composition, distribution, function, and interaction of various innate populations and T lymphocytes in the context of ulcer-forming or asymptomatic HSV infections. We found complex yet distinct anatomic patterns among innate and adaptive immune cells. Neutrophils, monocytes, and macrophages actively penetrated the HSV-infected epidermis, whereas T cells were rarely present in areas of active viral infection and located almost exclusively in the surrounding dermis, in contrast to the contiguous area of intact epithelial adjacent to the ulceration. Among the massive infiltration of T cells, only a fraction displayed cytolytic effector function by IFN-γ and granzyme B expression. Importantly, these T cells were located at the boundary and in close contact with subsets of innate cells, suggesting local tissue influence on antiviral immunity at the site of infection. Elucidating the mechanisms that regulate T-cell effector function and distribution could help therapeutic vaccine development to control HSV-2 infection in humans.



 NIH/NIAID AI143773, AI184778



 Viral Immunology (VIR)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c98fe61b9021dcdc6be208946cb62c665035f0fc" target='_blank'>
              Spatial Landscape of innate and adaptive immune response in Human Herpes Simplex Virus 2 Infection 4413
              </a>
            </td>
          <td>
            Jia Zhu
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>20</td>
        </tr>

        <tr id="ABSTRACT Bovine viral diarrhea virus (BVDV) is a major animal pathogen with a broad host range, causing gastrointestinal, respiratory, and reproductive diseases in cattle worldwide. BVDV exists as two biotypes: cytopathic (cp) and non-cytopathic (ncp). Although both cpBVDV and ncpBVDV have developed sophisticated strategies to evade or subvert host antiviral innate immune response, the underlying mechanisms remain incompletely understood. Autophagy, a process essential for maintaining cellular homeostasis, plays an important role in regulating viral replication and antiviral immunity. In this study, we demonstrated that the induction of autophagy with rapamycin enhanced the production of infectious progeny for both cpBVDV and ncpBVDV, whereas pharmacological inhibition of autophagy with 3-MA reduced viral yields. We further showed that modulating autophagy significantly influenced the early stages of the viral life cycle and the production of type I IFN (IFN-I). Notably, overexpression of BECN1 suppressed the synthesis of IFN-α and IFN-β, thereby promoting the replication of both cpBVDV and ncpBVDV. Conversely, RNA interference-mediated knockdown of BECN1 potentiated the antiviral innate immune response and restricted viral replication. Mechanistically, BECN1 was found to inhibit RIG-I–MAVS pathway activation by promoting ubiquitination and subsequent degradation of mitochondrial antiviral signaling (MAVS) protein, leading to suppression of IFN-I production. Additionally, both cpBVDV and ncpBVDV were shown to induce autophagy via the ROS-endoplasmic reticulum stress axis. These findings deepen our understanding of how BVDV evades host immunity and may inform the development of preventive strategies against BVDV infection. IMPORTANCE Bovine viral diarrhea virus (BVDV), the causative agent of bovine viral diarrhea-mucosal disease, is a major global threat to cattle health. BVDV employs sophisticated strategies to evade host defense and facilitate its replication. Understanding these mechanisms is crucial for developing effective vaccines and antiviral agents. Our study elucidates how cytopathic BVDV and non-cytopathic BVDV subvert the host’s antiviral innate immune response by exploiting autophagy to inhibit the RIG-I–MAVS pathway. A key finding is that BECN1-mediated autophagy directly targets MAVS protein for degradation via a specific BECN1 and MAVS interaction. Furthermore, we demonstrate that BVDV activates autophagy through ROS-ER stress axis to promote its replication. These insights reveal a novel immune evasion mechanism of BVDV and highlight the therapeutic potential of autophagy inhibition in treating BVDV-related diseases. Bovine viral diarrhea virus (BVDV), the causative agent of bovine viral diarrhea-mucosal disease, is a major global threat to cattle health. BVDV employs sophisticated strategies to evade host defense and facilitate its replication. Understanding these mechanisms is crucial for developing effective vaccines and antiviral agents. Our study elucidates how cytopathic BVDV and non-cytopathic BVDV subvert the host’s antiviral innate immune response by exploiting autophagy to inhibit the RIG-I–MAVS pathway. A key finding is that BECN1-mediated autophagy directly targets MAVS protein for degradation via a specific BECN1 and MAVS interaction. Furthermore, we demonstrate that BVDV activates autophagy through ROS-ER stress axis to promote its replication. These insights reveal a novel immune evasion mechanism of BVDV and highlight the therapeutic potential of autophagy inhibition in treating BVDV-related diseases.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/6afa84209e372cb39b24c0954255185befed5aef" target='_blank'>
              Bovine viral diarrhea virus suppresses type I IFN production by inducing MAVS degradation via autophagy mediated by the ROS-endoplasmic reticulum stress axis
              </a>
            </td>
          <td>
            Jing Wang, Jiangfei Zhou, Yixin Wang, Wenlu Fan, Xinyue Xia, Jiarui Chen, Haiyue Zhu, Qianyao Wang, Xiao Li, Yimei Liu, Jiayi Xiang, Han Yu, Moxuan Mao, Renjie Xu, Jiacun Liu, Shuo Jia, Yuan Li, Yigang Xu
          </td>
          <td>2025-12-09</td>
          <td>Journal of Virology</td>
          <td>0</td>
          <td>12</td>
        </tr>

        <tr id="


 Zika virus (ZIKV) is a neurotropic pathogen linked to neuropathogenesis in adults, causing conditions such as Guillain-Barré syndrome (GBS) and fatal encephalitis. While studies using intracranial injection or infection in immunocompromised mice have shown neuroinflammation and subsequent brain damage, the mechanisms underlying ZIKV-induced neuroinflammation in immunocompetent mice via peripheral infection remain unclear. To investigate this, we utilized a murine model of ZIKV infection through foot-pad injection. Our findings reveal that acute ZIKV infection induces significant neuronal apoptosis and chronic neuroinflammation in the adult brain, persisting up to 28 days post-infection. Notably, ZIKV infection triggers apoptosis in the hippocampus and cortex—key regions involved in memory—and induces early immune cell infiltration. Additionally, microglial activation occurs following infection, with viral proteins detected in the brain. This activation is likely driven by infiltrating monocytes, as inhibiting monocyte recruitment reduced the expression of microglial activation genes. Bulk RNA sequencing of the hippocampus at 28 days post-infection further reveals the activation of inflammatory pathways, underscoring the prolonged neuroinflammatory response in the infected brain. As such, targeting monocyte-induced inflammatory mediators may provide therapeutic intervention.



 NIH Grant DK122737 to YH



 Neuroimmunology (NEUR)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/829993c08f76b76e78e4257695e69be9de947daa" target='_blank'>
              Infiltrated monocytes following ZIKV infection drive microglia activation and chronic CNS damage in immunocompetent adult mice 9066
              </a>
            </td>
          <td>
            Josefina Garcia Diaz, Sujung Park, Lou Legouez, Tina Comlekoglu, Chia-Yi Kuan, Young S. Hahn
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>1</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/3699e431a06cd7ad4755bd9013aec2000fc9db4b" target='_blank'>
              SARS-CoV-2 mRNA vaccines: unresolved mechanisms of myocardial damage.
              </a>
            </td>
          <td>
            Hartmut H Glossmann
          </td>
          <td>2025-12-08</td>
          <td>Archives of toxicology</td>
          <td>0</td>
          <td>0</td>
        </tr>

        <tr id="Type I and III interferons (IFNs) are among the first lines of defense against viral infection, yet they are generally only produced by a tiny fraction of infected cells. Here, we show that cellular heterogeneity in IFN induction potential upon treatment with immunostimulatory RNA is not due to variability in sensing of stimuli but instead is shaped by heterogeneity in tonic cell signaling state. Using complementary single-cell approaches, we found that baseline variation in the c-Jun N-terminal kinase (JNK) and activator protein (AP)-1 transcription factor families correlated with IFNL1 expression predisposition. We further show that drug-based inhibition of JNK signaling virtually eliminates the innate antiviral response to immunostimulatory RNA. Finally, we show that single cell heterogeneity in IFN induction potential is heritable and stably maintained over numerous generations. Together, our study emphasizes the influence of intrinsic variability in cell state on innate immune regulation and IFN induction heterogeneity.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/71e7c3adef73e98b884e9b3e9c6a173252c38e29" target='_blank'>
              Single-cell heterogeneity in interferon induction potential is heritable and governed by variation in cell state
              </a>
            </td>
          <td>
            Elizabeth A. Thayer, Gabriela Shipman, Joel Rivera-Cardona, Tarun Mahajan, Q. Teo, J. S. Paez, Joseph Lederer, Jie Chen, Nicholas C. Wu, Sergei Maslov, C. Brooke
          </td>
          <td>2025-12-12</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>9</td>
        </tr>

        <tr id="


 The generation and maintenance of effective immunity is a dynamic and continuous process impacted by age. As people age, their immune systems become more susceptible to infections and respond less effectively to vaccines, yet the precise biological shifts driving these changes are not fully understood. To address this, we used multi-omic profiling (scRNA-seq, proteomics, flow cytometry) on over 300 adults, including 96 people tracked for two years with annual flu vaccination, generating >16 million PBMC profiles across 71 immune cell subsets in our Human Immune Health Atlas. This effort identified unique immune cell compositions and transcriptional states in homeostasis, after vaccination, and with aging. We find that T cells earlier in differentiation accumulate distinct age-related transcriptional changes more than other immune cells, independent from systemic inflammation and chronic perturbation. Moreover, impaired memory B cell responses to vaccination, including antibody isotype and neutralization function, are linked to gradual GATA3/Th2 polarization in multiple T cell subsets in older adults, revealing new features of immune dysregulation with healthy aging. Our study uncovers key age-driven shifts in immune cell states, identifying potential drivers of immune dysregulation as targets to augment functional immunity across age.



 Research was supported by the Allen Institute, Benaroya Research Institute and by National Institute on Aging award K01AG068373 (C.E.G.)



 Lymphocyte Differentiation and Peripheral Maintenance (LYM)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/44e611893641580ad1bfb65deb13b510b35bf536" target='_blank'>
              Longitudinal multi-omic immune profiling reveals age-related immune cell dynamics in healthy adults 4083
              </a>
            </td>
          <td>
            Qiuyu Gong, Mehul Sharma, Emma L. Kuan, Marla C. Glass, Aishwarya Chander, Mansi Singh, Lucas T. Graybuck, Zach Thomson, Christian M. LaFrance, Samir Rachid Zaim, Tao Peng, L. Okada, Palak C. Genge, Kathy Henderson, Elisabeth M. Dornisch, Erik Layton, Peter J. Wittig, A. Heubeck, Nelson M. Mukuka, Julian Reading, Charles R. Roll, Veronica Hernandez, Vaishnavi Parthasarathy, Tyanna J. Stuckey, B. Musgrove, Elliott Swanson, Cara Lord, M. Weiss, C. Phalen, Regina R Mettey, Kevin J. Lee, John B. Johanneson, Erin K. Kawelo, Jessica Garber, Upaasana Krishnan, Megan Smithmeyer, E. Wherry, L. Vella, S. E. Henrickson, Mackenzie S. Kopp, Adam K. Savage, Lynne A. Becker, Paul Meijer, Ernie Coffey, Jörg J. Goronzy, C. Speake, Thomas F. Bumol, Ananda W. Goldrath, Troy R. Torgerson, Xiao-jun Li, Peter J. Skene, Jane H. Buckner, Claire E. Gustafson
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>65</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c3de68178f204f50d4f5e9e5e298b21f11011eca" target='_blank'>
              Multidimensional single-cell analysis reveals immune dysfunction and inflammatory response in Lymphatic malformations.
              </a>
            </td>
          <td>
            Chunxiao Chen, Wenhao Ju, Xueying Li, Kexin Yao, Jun Cao, Songqi Duan, Xueqi Lv, Tianli Zhang, Sanlin Li, Jiawen Li, Feng He, Baofa Sun, Gang Shen
          </td>
          <td>2025-11-22</td>
          <td>Protein & cell</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="Innate immunity provides the critical first line of defense against infection and sterile triggers. Inflammatory cell death is a key component of the innate immune response to clear pathogens, but excessive or aberrant cell death can induce inflammation, cytokine storm, and pathology, making it a central molecular mechanism in inflammatory diseases. Alcohol-associated liver disease (ALD) is one such inflammatory disease, and the specific innate immune mechanisms driving pathology in this context remain unclear. Here, by leveraging RNA-seq and protein expression analyses in tissues from clinical samples, we identified increased expression of the innate immune sensor ZBP1 in patients with ALD. ZBP1 expression correlated with ALD progression in patients and that ethanol induced ZBP1-dependent lytic cell death, PANoptosis, in immune (macrophages, monocytes, and Kupffer cells) and nonimmune cells (hepatocytes). Mechanistically, the interferon regulatory factors (IRFs) IRF9 and IRF1 upregulated basal ZBP1 expression. Activation of ZBP1 led to PANoptosis via caspase-8 and cell membrane rupture through NINJ1, independent of gasdermin D, gasdermin E, and MLKL. In mouse models of ALD, ZBP1-deficient mice were significantly protected from disease pathology and liver damage. Furthermore, the expressions of ZBP1 and NINJ1 were upregulated in both liver and serum samples from patients with ALD, implicating these molecules as potential biomarkers. Overall, our findings establish the critical role of the IRF-ZBP1-caspase-8-NINJ1 axis in driving inflammatory cell death, PANoptosis, suggesting that targeting these molecules will have therapeutic potential in ALD and other inflammatory conditions.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e551315b2660a15121e726e3430a082b5c47db38" target='_blank'>
              Identification of an IRF-ZBP1-caspase-8-NINJ1 axis in driving PANoptosis and pathology during alcohol-associated liver disease.
              </a>
            </td>
          <td>
            Qiang Qin, Wen Chen, Clay D King, Sivakumar Prasanth Kumar, C. E. El Farran, Peter Vogel, Rebecca E. Tweedell, T. Kanneganti
          </td>
          <td>2025-12-08</td>
          <td>Proceedings of the National Academy of Sciences of the United States of America</td>
          <td>0</td>
          <td>132</td>
        </tr>

        <tr id="
 Introduction:
 While heart failure (HF) is a leading cause of death and indication for transplant in single ventricle congenital heart disease (SV) patients, the molecular mechanisms underlying HF progression are poorly understood. Chronic inflammation is known to initiate and accelerate pathological outcomes in nearly all forms of cardiovascular disease, yet the impacts of immunologic alterations in SV patients are inadequately explored.


 Hypothesis:
 This study tests the hypothesis that SV patients display significant immunologic alterations that contribute to progressive cardiac dysfunction.


 Methods:
 Pediatric SV patients were categorized based on ventricular function and compared to healthy controls. Immune cells, sera, and plasma were isolated from whole blood using density gradient centrifugation. Bulk and single cell RNA sequencing were performed to identify dysregulated pathways and immune cell subtypes. Metabolic function was evaluated using the Seahorse Bioanalyzer (Agilent) and circulating inflammatory mediators were assessed via cytokine array, global proteomic and global lipidomic analysis.


 Results:
 RNA-seq analysis of circulating immune cells identified alterations in several key immune cell subtypes, including altered T helper cells across all SV groups, and significantly increased expression of markers for B cells, monocytes, macrophages, and proinflammatory macrophages in SV-HF. Additionally, pathways associated with immune cell activation, exhaustion, and senescence were increased across all SV groups (Figure 1A). Peripheral immune cells from both stable and SV-HF patients also exhibited dysregulated mitochondrial metabolic function, including significantly decreased basal respiration, maximal respiration, and ATP production with increased levels of extracellular acidification (Figure 1B). Moreover, several differentially expressed circulating pro-inflammatory mediators were significantly increased, such as IL-1β, CCL2, BAFF, p-selectin, CCL14, S100A8, RAGE, ICAM1, VCAM1, Cystatin C, and lactosylceramide. RNA-seq analysis of SV tissue identified immunologic alterations as a hallmark of the SV myocardium (Figure 1C).


 Conclusions:
 This study provides novel insights into the immunologic drivers of SV pathophysiology, highlighting critical pathways that could serve as targets for future therapeutic strategies to mitigate disease progression and multi-organ dysfunction in this vulnerable population.
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/75fe1317af7853ada35526eea0216f139997bdda" target='_blank'>
              Abstract 4370063: Immune and Inflammatory Dysregulation Across the Single Ventricle Spectrum: A New Frontier for Therapeutic Innovation&Intervention
              </a>
            </td>
          <td>
            Anastacia Garcia, Mary E Turner, A. Pietra, Praveen Ramaswamy, Cristina Velasquez, Anis Karimpour-Fard
          </td>
          <td>2025-11-04</td>
          <td>Circulation</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="While the public health burden of SARS-CoV-2 infection has lessened due to natural and vaccine-acquired immunity, emergence of less virulent variants, and antiviral medications, COVID-19 continues to take a significant toll. There are thousands of new hospitalizations and hundreds of deaths per week in the United States, many of whom develop long COVID. Early identification of individuals at high risk of severe COVID-19 is key for monitoring and supporting respiratory status and improving outcomes. Therefore, precision tools for early detection of patients at high risk of severe disease can reduce morbidity and mortality. Here, we report an untargeted, longitudinal plasma metabolomics study of COVID-19 patients. One-carbon metabolism, a pathway previously shown as critical for viral propagation and disease progression, and a potential target for COVID-19 treatment, scored strongly as differentially abundant in patients with severe COVID-19. Targeted metabolite profiling revealed that one arm of the one-carbon metabolism pathway, the methionine cycle, is a major driver of the metabolic profile associated with disease severity. Further, genomic data from the profiled patients revealed a genetic contributor to methionine metabolism and identified the C677T allele of the MTHFR gene as a preexisting contributor to disease trajectory-patients that show aberrant one-carbon metabolite levels and that are homozygous for the MTHFR C677T, have higher incidence of severe COVID. Our results raise the possibility that MTHFR variant status may inform precision COVID-19 treatment strategies.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/418b303866505804929458193b7ddba0fd6bf39e" target='_blank'>
              MTHFR allele and one-carbon metabolic profile predict severity of COVID-19.
              </a>
            </td>
          <td>
            Boryana Petrova, Caitlin Syphurs, Andrew J. Culhane, Jing Chen, Ernie Chen, Chris Cotsapas, Denise Esserman, R. Montgomery, Steven H. Kleinstein, K. Smolen, Kevin Mendez, Jessica Lasky-Su, Hanno Steen, Ofer Levy, J. Diray-Arce, Naama Kanarek
          </td>
          <td>2025-12-18</td>
          <td>Proceedings of the National Academy of Sciences of the United States of America</td>
          <td>0</td>
          <td>19</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/29f76a55277cfc7ac327aabf44366ec7aa5e2076" target='_blank'>
              Single-cell transcriptomic profiling reveals aberrant CD4⁺ naive T cell differentiation driving immune activation in Behçet's uveitis.
              </a>
            </td>
          <td>
            Lu Zhang, Yimeng Sun, Xinyu Yao, Chun Yan, Yunfei Liu, D. Qiao, Ziyu Du, Cong Hu, Fuying Guo, Ziwei Meng, Wei Chi
          </td>
          <td>2025-12-02</td>
          <td>Journal of translational medicine</td>
          <td>0</td>
          <td>5</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/ef22925dbf8420c830bbb314903df88e10e8411a" target='_blank'>
              Hspa8 modulation of immune responses mitigates ischemic brain injury.
              </a>
            </td>
          <td>
            Xiaokun Wu, Zong-Shan Wu, Han Yan, Zhe Zu, Hebo Wang
          </td>
          <td>2025-11-01</td>
          <td>Genes and immunity</td>
          <td>0</td>
          <td>5</td>
        </tr>

        <tr id="This study evaluated hepatic pathological and phenotypic alterations, along with the inflammatory response, following sequential dengue virus (DENV) infection in Callithrix penicillata, a relevant model for human endemic scenarios. Twenty-six animals were initially infected subcutaneously with DENV-3. Thirteen were euthanized between 1 and 7 days post-infection (dpi) to assess the acute phase, and up to 60 dpi for the convalescent phase. The remaining animals received a secondary DENV-2 infection two months later. Liver samples underwent histopathological and immunohistochemical analysis. Viral antigens were identified in hepatocytes, Kupffer cells, and Councilman bodies. Observed liver changes included apoptosis, lytic necrosis, midzonal inflammation, Kupffer cell hyperplasia and hypertrophy, sinusoidal dilation, and hemosiderin deposition. Both primary and secondary infections increased activated macrophages, NK cells, S-100 protein, and B lymphocytes. Primary infection was associated with elevated CD4+ T cells, IFN-γ, TGF-β, IL-10, and Fas expression, whereas secondary infection induced higher IFN-γ, TNF-α, IL-8, Fas, and VCAM levels. These findings mirror hepatic alterations in severe human dengue cases and underscore the role of direct viral effects and immune dysregulation in liver injury. The results support C. penicillata as a suitable non-human primate model for studying DENV pathogenesis.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/78aa87bb7bfd1a6ad8ddde63bb659a9c40432e18" target='_blank'>
              Sequential Dengue Virus Infection in Marmosets: Histopathological and Immune Responses in the Liver
              </a>
            </td>
          <td>
            D. F. Henriques, L. Casseb, Milene S. Ferreira, Larissa S. Freitas, H. T. Fuzii, C. Pagliari, Luciane Kanashiro, Paulo Henrique Gomes Castro, Gilmara A. Siva, Orlando Pereira Amador Neto, V. M. Campos, Beatriz C. Belvis, F. D. dos Santos, Lilian R. M. de Sá, Pedro F C Vasconcelos
          </td>
          <td>2025-12-01</td>
          <td>Viruses</td>
          <td>0</td>
          <td>25</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/34c1eda3dd77e97db86183ac40ee4518ef4e94d0" target='_blank'>
              Old dogs-new tricks: multifaceted functions of MAVS beyond antivirus activity in human health and diseases.
              </a>
            </td>
          <td>
            Yating Lu, Yaxuan Qi, Qingqing Yinliang, Rui Zhu, Alexey Sarapultsev, Shanshan Luo, Jing Cui, Desheng Hu
          </td>
          <td>2025-12-04</td>
          <td>Cell & bioscience</td>
          <td>0</td>
          <td>4</td>
        </tr>

        <tr id="Background Severe burn injuries can cause long-term cognitive impairments, potentially driven by lipid-mediated neuroinflammation in the central nervous system (CNS). The disruption of lipid homeostasis may contribute to neuroinflammatory responses, exacerbating neuronal damage. This study investigates whether acipimox, an anti-lipolytic agent, modulates lipid accumulation and neuroinflammation in the prefrontal cortex following severe burns. Methods Sprague Dawley rats were randomized into four groups: sham vehicle, sham acipimox, burn vehicle, and burn acipimox. A scald injury covering 40–60% of total body surface area was induced, and rats were treated with acipimox (50 mg/kg/day, intraperitoneally) or vehicle for seven days. Lipidomic analysis assessed alterations in lipid profiles, while machine learning (XGBoost) identified key lipid drivers of burn-induced neuroinflammation. Additionally, mRNA expression of inflammatory markers, including interleukin-1β (IL-1β), nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB), and toll-like receptor 4 (TLR4), was quantified to evaluate neuroinflammatory responses. Cytokine–lipid correlations were also examined using Spearman analysis. Results Lipidomic analysis identified significant alterations in a subset of the 21 lipid classes analyzed, particularly long-chain and very-long-chain fatty acids, including lysophosphatidylethanolamines, lysophosphatidylcholines, phosphatidylglycerols, phosphatidylethanolamines, and triacylglycerols (p < 0.05). Machine learning (XGBoost) identified these lipids as significantly modulated with burn injury (AUC > 0.80). Acipimox treatment reduced lipid accumulation, restoring levels to sham values. Furthermore, mRNA analysis showed group differences in IL-1β (overall ANOVA p = 0.030), with significant pairwise difference observed for burn-vehicle vs sham-acipimox. Acipimox also modulated NF-κB and TLR4 expression, indicating attenuation of inflammatory signaling. IL-1β and LPL positively correlated with lipid classes elevated by burn and reversed by acipimox, while IL-6, TNF-α, NF-κB, and TLR4 showed predominantly negative associations. Discussion These findings suggest that severe burns induce significant lipid dysregulation in the CNS, contributing to neuroinflammation and potential cognitive impairment. By targeting lipolysis, acipimox mitigates lipid accumulation, suppresses inflammatory pathways, and normalizes lipid levels, highlighting a potential therapeutic mechanism. Conclusion This study establishes a mechanistic link between elevated lipolysis and CNS inflammation following severe burns. Acipimox effectively modulates lipid profiles and reduces neuroinflammation, underscoring its potential for managing burn-induced neurological complications. Further studies are needed to validate these findings and explore clinical applications.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/3c72ef4a077990233d65996dcf91eb3c7bea3679" target='_blank'>
              Altered lipid profiles in the prefrontal cortex are associated with neuroinflammation after severe burn injury
              </a>
            </td>
          <td>
            Sean O’Leary, A. Prasai, A. Robledo, Christopher Thang, Ye Wang, R. Deshpande, William K. Russell, Andrew J. Murton, Steven E. Wolf, Amina El ayadi
          </td>
          <td>2025-12-01</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>12</td>
        </tr>

        <tr id="


 Trained immunity is a functional state of the innate immune system that is characterized by long-term epigenetic and metabolic reprogramming of cells associated with potent immune responses. It benefits to host defense but has also detrimental outcomes in immune-mediated and chronic inflammatory diseases. Pristane treated mice develop clinical and serological manifestations of lupus along with a TLR7-driven type I interferon signature. Although trained immunity is seen in many cell types, we will focus on monocytes/M?, which are central to the induction of lupus by pristane. Akt-mTOR-Hif1α-mediated reprogramming of metabolism toward aerobic glycolysis is critical to the enhanced innate immune response in trained immunity. Epigenetic reprogramming in trained immunity is associated with trimethylation of histone 3 at lysine 4 (H3K4me3) in the promoter regions of proinflammatory genes like Tnfa. We found the monocyte and macrophages from pristane treated mice showed increased glycolytic metabolism, HIF1a expression and TNFa production. In vitro, exposure of mouse J774 or RAW264.7 to pristane substantially increases R848 and LPS, but not CpG, stimulated IL-6, CCL2, and TNFα production. The augmented responsiveness to TLR7 or TLR4 ligand stimulation is not seen after MO or squalene exposure and is not due to increased intracellular (or cell surface) TLR7 expression. These findings indicate the role of trained innate immunity in the mechanism of pristane induced lupus.



 NIAMS R01-AR44731



 Innate Immune Responses and Host Defense: Cellular Mechanisms (INC)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/901c81d2ce3a6b4c825932e2df2b5155e6052f27" target='_blank'>
              Trained immunity in pristane induced lupus 2213
              </a>
            </td>
          <td>
            Shuhong Han, Haoyang Zhuang, Westley H Reeves
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>22</td>
        </tr>

        <tr id="


 The regional progression of brain atrophy in Alzheimer’s disease highly correlates with tau accumulation. There are changes in adaptive immunity in AD and the increases in activated CD8+ T cells in the brain correlate with tau pathology. Further, there is a dynamic transformation of the CD8+ T cell cellular characteristics from activated to exhausted states along with unique TCR clonal expansion. Depletion of brain-resident microglia, infiltrated T cells, as well as, inhibiting IFN-γ signaling all significantly ameliorated brain atrophy. To date, little is known about the interaction between T cells and brain resident microglia. Here we use APOE isoforms-dependent mouse models and human neuroimmune axis models to show that microglia coordinate immune modulatory response against immune challenges in AD. Adaptive immune deficiency had strongly decreased microglial reactivity and microglia-mediated synaptic engulfment in tauopathy. Adaptive Immune deficiency ameliorates Tau-linked glial lipid accumulation. Of note, using large-scale transcriptome and chromatin profiling, we show that T cell shape microglia-specific metabolic plasticity in both genetic and epigenetic resolution. Our results thus reveal a tauopathy and neurodegeneration-related immune hub involving activated microglia and T cell responses, which could potentially serve as therapeutic targets for preventing neurodegeneration in AD and primary tauopathies.



 This research was supported by Cure Alzheimer’s Foundation and Alzheimer’s Association Foundation.



 Neuroimmunology (NEUR)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1a048ed04f1c514de4cd4a4215ce730ec41db03d" target='_blank'>
              T cell drives microglia specific metabolic plasticity and neurodegeneration in Alzheimer disease 4098
              </a>
            </td>
          <td>
            Xiaoying Chen
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>0</td>
        </tr>

        <tr id="


 Neurotropic virus infections are a continuous threat to public health as severe neuroinflammation leads to acute and chronic illnesses with potential lifelong neurological sequelae or even death. Varying degrees of neuropathologies have been associated with viral infection by many arboviruses, including members of the Peribunyaviridae and Togaviridae families. The lack of approved antiviral therapeutics against these viruses has underscored the need for understanding the molecular mechanisms and cellular responses underlaying severe disease caused by infection in the brain. Microglia and astrocyte cell populations play a key role in immune and inflammatory cell responses, synaptogenesis and support of neuronal function, making these cells crucial to integrate into in vitro models to address key questions regarding complex cell defense processes against viruses. We utilized our induced pluripotent stem cell (iPSC-) derived brain-region specific human neural spheroid platform to investigate neurotropic viral infection and disease in a human-relevant tissue-based platform, allowing us to explore both cell-virus interactions and response to infection. We evaluated La Crosse virus (LACV) and Chikungunya virus (CHIKV) and describe the virus mediated disruption of the spheroid’s neural activity profiles then, using transcriptome and secreted cytokine profiling we investigated the changes induced by infection in these neural spheroids to evaluate innate immune mechanisms of defense.



 NIH Intramural Research Program, TR000437.



 Viral Immunology (VIR)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/407b11909ecc23dc485fd10b673b943b76d107cf" target='_blank'>
              Insights into innate immune and inflammatory response resulting from neurotropic virus infections in a neural spheroid organotypic model elucidated through transcriptome and cytokine profiling 2292
              </a>
            </td>
          <td>
            Angelica Medina, Jiajing Zhang, Yu-Chi Chen, Sarah C. Ogden, Samantha Cotsmire, Marc Ferrer, Emily M. Lee
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>4</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/dde7037fd6fb313c3da4817af04195fa2f070236" target='_blank'>
              Basic Science and Pathogenesis.
              </a>
            </td>
          <td>
            Falak Sher
          </td>
          <td>2025-12-01</td>
          <td>Alzheimer's & dementia : the journal of the Alzheimer's Association</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/aab56a374cbf5ee6260c69533626e491afa089f3" target='_blank'>
              Long COVID involves activation of proinflammatory and immune exhaustion pathways.
              </a>
            </td>
          <td>
            Malika Aid, Valentin Boero-Teyssier, K. McMahan, Rammy Dong, Michael Doyle, Nazim Belabbaci, E. Borducchi, A. Y. Collier, J. Mullington, D. Barouch
          </td>
          <td>2025-12-12</td>
          <td>Nature immunology</td>
          <td>0</td>
          <td>116</td>
        </tr>

        <tr id="


 Single-cell RNA sequencing analysis reveals distinct platelet subpopulations that may serve as critical biomarkers in COVID-19 and sepsis patient outcomes. Using an integrated approach combining machine learning, Universal Cell Embeddings (UCE), and single-cell transcriptomics, we identified three key platelet subpopulations: coagulation-active, hypoxic, and quiescent. The platelet-to-T-cell ratio emerged as a significant predictor of survival outcomes (AUC 0.754). Our analysis demonstrated that platelet heterogeneity and their interactions with other immune cells, particularly T-cells and endothelial cells, play crucial roles in disease progression. The study utilized data from multiple COVID-19, sepsis, and SLE patient cohorts, employing foundation models for robust cell type annotation and trajectory analysis. These findings suggest that early platelet precursor populations could serve as potential therapeutic targets, while distinct platelet signatures may help predict disease trajectories and inform treatment strategies.



 This research received no external funding.



 Computational and Systems Immunology (COMP)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/490a6b3525a74e1819dfbc05d02fd4e8bbce598f" target='_blank'>
              Single-cell analysis of platelet heterogeneity in COVID-19 and sepsis using foundation models 2811
              </a>
            </td>
          <td>
            Xinru Qiu
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>6</td>
        </tr>

        <tr id="


 Dysregulated inflammation drives neuronal damage in cryptococcal meningitis (CM). To elucidate cell subsets’ contributions, single-cell transcriptome of CNS leukocytes was analyzed over time in a highly inflammatory CM mouse model (C57BL6/52D) and partially protected CXCR3-/- CM mice, using 10X platform. Inflammatory module score increases initially in microglia (Mg) followed by macrophages (Mp), and T cells (T), marking Mg as first-responders. Over time 14 Mg clusters show sequential cluster replacements and proliferation and their increased antigen presentation capacity. Among 13 gradually expanding T clusters, some helper and cytotoxic T expansion coincides with CM pathology. The 10 distinct Mp clusters represent the resident brain Mp and both recruited classical and non-classical monocytes with rapidly evolving signatures. Early Mp show antigen processing and presentation, chemokine and TNF-signaling, while JAK/STAT, MAPK and NF-kB signaling, and metabolic regulation pathways dominate later. Enrichment in Mp pathways linked to neurodegenerative diseases reflects their long-term impact on neuronal health and CNS-tissue integrity. Reduced Mp and cytotoxicity T-linked pathways in CXCR3-/- CM mice support their joint involvement in immunopathology. Finally, the diversity and strength of cell-cell interactions peak on days 7&14, preceding the peak in overall inflammatory cell scores, marking a dropout of proper immunoregulatory crosstalk during the ongoing inflammatory damage.



 This work was supported by VA RCS IK6BX005966, VA Merit 101BX000656, VA 121BX006349 Awards to MAO, and VA CDA2 Award to KG.



 Neuroimmunology (NEUR)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f572543972b5f1017f393f88b854cf122c547f09" target='_blank'>
              Inflammatory cellular transcriptome unravels drivers of clearance and pathology processes during cryptococcal meningoencephalitis 3863
              </a>
            </td>
          <td>
            Michal A Olszewski, Fang Huang, Rylan Hissong, Hailong Li, Kristie D. Goughenour, Anutosh Ganguly, Kai Guo, Jintao Xu
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>12</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/2a16339760ff8ace2ca5d18abc0a92d2ce40cb4c" target='_blank'>
              Drug Development.
              </a>
            </td>
          <td>
            Manuela Polydoro, Ivana Geric, Jin Zheng, Tina Sommer Bisgaard, Ashley Comer, Laura Sans, Ashley Lu, Joachim Vilstrup, L. Wolfs, Arya Nair, Morten S Andersen, Ninna Frederiksen, Peter Flagstad, M. Dalby, R. BALICE-GORDON, N. Plath
          </td>
          <td>2025-12-01</td>
          <td>Alzheimer's & dementia : the journal of the Alzheimer's Association</td>
          <td>0</td>
          <td>13</td>
        </tr>

        <tr id="Hepatitis is a systemic disease marked by neuroimmune dysregulation beyond hepatic inflammation. Using a systems biology approach, we conducted transcriptomic meta‐analyses across in vitro models, liver tissues, and PBMCs from hepatitis virus‐infected patients to identify neuroimmune signatures. We found a robust neuroimmunome signature, with neuroimmune‐related genes showing consistent differential expression across datasets. Functional enrichment revealed disruptions in neurotransmission (including synaptic, glutamatergic, noradrenergic and neuregulin pathways) and immune signaling (such as cytokines, interleukin‐1 response, T cell receptor, and trans‐synaptic signaling). Linear discriminant analysis (LDA) demonstrated that neuroimmune genes can predict disease severity. Several of these genes were also altered in hepatocellular carcinoma (HCC) samples from The Cancer Genome Atlas Program (TCGA), implicating them in oncogenic transformation. Ligand‐receptor analysis revealed dysregulated neuroimmune interactions in liver tissue, notably involving DBH‐ADRA1A/B/D, ADRA2A/B/C, ADRB1/2/3, IL33‐IL1RL1, and NRG1‐ERBB4. Critically, we observed an inverse correlation between neuroimmune gene expression and inflammation markers in advanced HCC, suggesting that neuroimmune suppression may facilitate immune evasion. These findings highlight the neuroimmunome as a potential biomarker and therapeutic target in hepatitis and its complications, reinforcing the role of neuroimmune crosstalk in liver disease progression.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/b000aa7ae36186fc1909fe6b105f1cd03e012a87" target='_blank'>
              The Neuroimmunome of Hepatitis Patients Associates With Disease Severity
              </a>
            </td>
          <td>
            A. Nóbile, A. Adri, J. Usuda, F. Y. N. D. Vale, Y. L. G. Côrrea, Débora Gomes de Albuquerque Freitas, Roseane Galdioli Nava, Pedro Marçal Barcelos, L. Schimke, Taj Ali Khan, R. S. de Aguiar, N. O. Câmara, Gustavo Cabral-Miranda, Rodrigo J. S. Dalmolin, H. Nakaya, L. Onuchic, Haroldo Dutra Dias, I. Filgueiras, Otávio Cabral-Marques
          </td>
          <td>2025-12-01</td>
          <td>Journal of Medical Virology</td>
          <td>0</td>
          <td>28</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/9fd9aa966dfb77faaa502fe9f01e154291f58262" target='_blank'>
              Lingering echoes of SARS-CoV-2: mechanistic insights and management of long COVID syndrome.
              </a>
            </td>
          <td>
            Jagat Pal Yadav, Seema Yadav, N. Dubey, Indra Pal Yadav, Prateek Pathak, Amita Verma
          </td>
          <td>2025-11-30</td>
          <td>Inflammopharmacology</td>
          <td>0</td>
          <td>15</td>
        </tr>

        <tr id="Astrocytes and microglia constitute nearly half of all central nervous system cells and are indispensable for its proper function. Both exhibit striking morphological and functional heterogeneity, adopting either neuroprotective (A2, M2) or proinflammatory (A1, M1) phenotypes in response to cytokines, pathogen-associated molecular patterns (PAMPs)/damage-associated molecular patterns (DAMPs), toll-like receptor 4 (TLR4) activation, and NOD-like receptor family pyrin domain containing 3 (NLRP3) inflammasome signaling. Crucially, many of these phenotypic transitions arise during the earliest stages of neurodegeneration, when glial dysfunction precedes overt neuronal loss and may act as a primary driver of disease onset. This review critically examines glial-centered hypotheses of neurodegeneration, with emphasis on their roles in early disease phases: (i) microglial polarization from an M2 neuroprotective state to an M1 proinflammatory state; (ii) NLRP3 inflammasome assembly via P2X purinergic receptor 7 (P2X7R)-mediated K+ efflux; (iii) a self-amplifying astrocyte–microglia–neuron inflammatory feedback loop; (iv) impaired microglial phagocytosis and extracellular-vesicle–mediated propagation of β-amyloid (Aβ) and tau; (v) astrocytic scar formation driven by aquaporin-4 (AQP4), matrix metalloproteinase-9 (MMP-9), glial fibrillary acidic protein (GFAP)/vimentin, connexins, and janus kinase/signal transducer and activator of transcription 3 (JAK/STAT3) signaling; (vi) cellular reprogramming of astrocytes and NG2 glia into functional neurons; and (vii) mitochondrial dysfunction in glia, including Dynamin-related protein 1/Mitochondrial fission protein 1 (Drp1/Fis1) fission imbalance and dysregulation of the sirtuin 1/peroxisome proliferator-activated receptor gamma coactivator 1-alpha (Sirt1/PGC-1α) axis. Promising therapeutic strategies target pattern-recognition receptors (TLR4, NLRP3/caspase-1), cytokine modulators (interleukin-4 (IL-4), interleukin-10 (IL-10)), signaling cascades (JAK2–STAT, nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB), phosphoinositide 3-kinase–protein kinase B (PI3K–AKT), adenosine monophosphate-activated protein kinase (AMPK)), microglial receptors (triggering receptor expressed on myeloid cells 2 (TREM2)/spleen tyrosine kinase (SYK)/ DNAX-activating protein 10 (DAP10), siglec-3 (CD33), chemokine C-X3-C motif ligand 1/ CX3C motif chemokine receptor 1 (CX3CL1/CX3CR1), Cluster of Differentiation 200/ Cluster of Differentiation 200 receptor 1 (CD200/CD200R), P2X7R), and mitochondrial biogenesis pathways, with a focus on normalizing glial phenotypes rather than simply suppressing pathology. Interventions that restore neuroglial homeostasis at the earliest stages of disease may hold the greatest potential to delay or prevent progression. Given the complexity of glial phenotypes and molecular isoform diversity, a comprehensive, multitargeted approach is essential for mitigating Alzheimer’s disease and related neurodegenerative disorders. This review not only synthesizes pathogenesis but also highlights therapeutic opportunities, offering what we believe to be the first concise overview of the principal hypotheses implicating glial cells in neurodegeneration. Rather than focusing on isolated mechanisms, our goal is a holistic perspective—integrating diverse glial processes to enable comparison across interconnected pathological conditions.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a04dbd89de3e6284b34d7515741d711f1b224ef7" target='_blank'>
              Glial Cells in the Early Stages of Neurodegeneration: Pathogenesis and Therapeutic Targets
              </a>
            </td>
          <td>
            Eugenia Ahremenko, Alexandr Andreev, D. Apushkin, Eduard Korkotian
          </td>
          <td>2025-12-01</td>
          <td>International Journal of Molecular Sciences</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="Microglia, the innate immune cells of the brain, play a defining role in the progression of Alzheimer’s disease (AD)1. The microglial response to amyloid plaques in AD can range from neuroprotective to neurotoxic2. Here we show that the protective function of microglia is governed by the transcription factor PU.1, which becomes downregulated following microglial contact with plaques. Lowering PU.1 expression in microglia reduces the severity of amyloid disease pathology in mice and is linked to the expression of immunoregulatory lymphoid receptor proteins, particularly CD28, a surface receptor that is critical for T cell activation3,4. Microglia-specific deficiency in CD28, which is expressed by a small subset of plaque-associated PU.1low microglia, promotes a broad inflammatory microglial state that is associated with increased amyloid plaque load. Our findings indicate that PU.1low CD28-expressing microglia may operate as suppressive microglia that mitigate the progression of AD by reducing the severity of neuroinflammation. This role of CD28 and potentially other lymphoid co-stimulatory and co-inhibitory receptor proteins in governing microglial responses in AD points to possible immunotherapy approaches for treating the disease by promoting protective microglial functions. PU.1low CD28-expressing microglia may act as suppressive cells in Alzheimer’s disease, mitigating its progression by reducing neuroinflammation and amyloid plaque load, indicating potential immunotherapeutic approaches for treatment.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/d99030ecdcbce116c8eebf00a66a049c3f93b40b" target='_blank'>
              Lymphoid gene expression supports neuroprotective microglia function
              </a>
            </td>
          <td>
            Pinar Ayata, Jessica M Crowley, Matthew F Challman, Vinaya Sahasrabuddhe, Maud Gratuze, Sebastian Werneburg, Diogo Ribeiro, Emma C Hays, Violeta Durán-Laforet, Travis E. Faust, Philip Hwang, Francisco Mendes Lopes, Chrysa Nikopoulou, Sarah Buchholz, Robert E. Murphy, Taoyu Mei, A. A. Pimenova, Carmen Romero-Molina, Francesca Garretti, Tulsi Patel, Claudia De Sanctis, Angie V. Ramirez Jimenez, Megan Crow, Felix D. Weiss, J. Ulrich, Edoardo Marcora, John W Murray, Felix Meissner, A. Beyer, Dan Hasson, J. Crary, Dorothy P. Schafer, David M. Holtzman, A. Goate, Alexander Tarakhovsky, Anne Schaefer
          </td>
          <td>2025-11-05</td>
          <td>Nature</td>
          <td>2</td>
          <td>45</td>
        </tr>

        <tr id="


 Infection-associated chronic illnesses (IACI) represent a growing public health concern with limited diagnostic and therapeutic options. Our translational approach combines preclinical and clinical investigations to address this challenge. We have developed a murine model of long-term Borrelia burgdorferi infection which recapitulates key features of human IACI to identify early immune responses that predict long-term outcomes. Notably, we observe significant age and sex-dependent differences, with older females exhibiting the greatest morbidity across distinct genetic strains. We are developing predictive diagnostics to distinguish between protective and catastrophic immune responses, the latter characterized by atopic dermatitis, connective tissue breakdown, profound gynepathologies, compromised barrier integrity, and loss of tolerance to self-flora, with potential for neuroinflammation and mitochondrial dysfunction. In our clinical study, MAESTRO, we are employing a comprehensive approach to profile these catastrophic responses in individuals with IACI from Lyme or COVID by conducting neurological assessments, including eye movement tracking, cognitive function testing, and hypermobility assessments, incorporated with survey data and deep biological sample (including urine, sweat, saliva, blood, vaginal and rectal swabs) profiling for pathogen loads, dysbiosis, genomics, metabolomics and innovative immune trajectory mapping.



 R01 AI178713-01, MLSC, Emily and Malcolm Fairbairn donor advised fund



 Immune Mechanisms of Human Disease (HUM)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e2d3d10a7ffec39b2234bff3787e396a64154af5" target='_blank'>
              Unraveling the immunopathology of infection-associated chronic illnesses: sex differences and predictive diagnostics 4058
              </a>
            </td>
          <td>
            M. C. Tal
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>17</td>
        </tr>

        <tr id="


 The COVID-19 pandemic, caused by the SARS-CoV-2, has led to the emergence of multiple variants with distinct characteristics. Understanding the differential impacts of these SARS-CoV-2 variants is essential for developing effective prevention and treatment strategies. This study investigated the differing pathologies of the original Wuhan strain and the Omicron variant of SARS-CoV-2 using a K18-hACE2 transgenic mouse model. We compared mortality rates, viral loads, and histopathological changes in lung and tracheal tissues, while also focusing on alterations in the respiratory and digestive tract microbiota based on the strains. To achieve this, we analyzed microbiome samples from the lungs and intestines. Our results demonstrated significant differences in disease severity between the Wuhan and Omicron variants. Microbiome analyses revealed distinct shifts in the lung and intestinal microbiota corresponding to each variant, suggesting that microbiome dynamics may influence disease outcomes. This comparative study highlights the critical role of the microbiome in affecting disease severity and host responses to viral infections. Distinct microbial shifts associated with infections from various SARS-CoV-2 variants were identified, indicating potential microbiome-related mechanisms that could be targeted to improve disease outcomes.



 Supported by the National Research Foundation of Korea grants (NRF-2021M3A9H3015688, NRF-2021M3A9D3026428, NRF-2023R1A2C3003825, and RS-2024-00342560) and the Korea Research Institute of Chemical Technology grant (K-GRC GO! KRICT project BSF24-113).



 Viral Immunology (VIR)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a1144c3c75816ce6d1e26691b5a2d38dc7304ab7" target='_blank'>
              Pathogenesis and microbiome characterization of SARS-CoV-2 variants in K18-hACE2 transgenic mice 9174
              </a>
            </td>
          <td>
            K. Ku, Chae Won Kim, Insu Hwang, H. Jung, Kyun-Do Kim, Heung Kyu Lee
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>21</td>
        </tr>

        <tr id="


 Respiratory infections pose significant health challenges, particularly for high-risk groups. Understanding host responses to respiratory pathogens may open new avenues for therapeutic strategies. Human-relevant models are essential for studying host-targeting therapies that modulate immune responses and enable rapid, adaptable treatments. This study characterizes a human precision cut lung slice (hPCLS) model to investigate early, cell-type-specific inflammatory responses seen during pulmonary infections. hPCLSs were exposed to TNF-α, a pro-inflammatory cytokine induced during infection, and cellular and molecular changes were assessed using single-cell RNA sequencing. The data identified T cells, B cells, NK cells, macrophages, as well as epithelial, fibroblast, and endothelial populations. Notably, following a 24-hour exposure to TNF-α, minimal cell proliferation was observed across these populations. Macrophages exhibited the highest TNF-α receptor expression and upregulation of myeloid migration and chemotaxis genes. TNF-α exposure elevated chemokine expression (CXCL17, CCL2) in endothelial, macrophage, and epithelial cells. Additionally, epithelial cells upregulated apoptosis-related genes, indicating a damage response. These findings highlight the hPCLS model’s ability to capture early, cell-specific lung responses to inflammation, reinforcing its value as a preclinical tool to study host-pathogen interactions and inform future therapeutic strategies.



 This work was performed under the auspices of the U.S. Department of Energy by Lawrence Livermore National Laboratory under Contract DE-AC52-07NA27344. Funding was provided by internal Lawrence Livermore National Laboratory Directed Research and Development funds (24-ERD-025) to N.R.H. LLNL-ABS-2001042.



 Cellular Adhesion, Migration, and Inflammation (CAM)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1647ad00531bdd64a4cb51bf31d8068465dce83b" target='_blank'>
              Assessing pulmonary response to TNF-α in human precision-cut lung slices using single-cell RNA sequencing 4294
              </a>
            </td>
          <td>
            N. Leon, Long P. Nguyen, Oscar A. Davalos, D. Weilhammer, A. Sebastian, N. Hum
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>22</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f717c7343d691b2f665717d1011e75b567875353" target='_blank'>
              Integrated multiomics reveals host-virus coadaptation in persistent foot-and-mouth disease virus infection.
              </a>
            </td>
          <td>
            Shuang Wang, Zhihui Zhang, Sumin Wei, Guoliang Huang, Shuanghui Yin, Suyu Mu, Hu Dong, Shiqi Sun, Huichen Guo
          </td>
          <td>2025-11-24</td>
          <td>Cellular and molecular life sciences : CMLS</td>
          <td>0</td>
          <td>9</td>
        </tr>

    </tbody>
    <tfoot>
      <tr>
          <th>Abstract</th>
          <th>Title</th>
          <th>Authors</th>
          <th>Publication Date</th>
          <th>Journal/Conference</th>
          <th>Citation count</th>
          <th>Highest h-index</th>
      </tr>
    </tfoot>
    </table>
    </p>
  </div>

</body>

<script>

  function create_author_list(author_list) {
    let td_author_element = document.getElementById();
    for (let i = 0; i < author_list.length; i++) {
          // tdElements[i].innerHTML = greet(tdElements[i].innerHTML);
          alert (author_list[i]);
      }
  }

  var trace1 = {
    x: ['2024', '2025'],
    y: [2, 4],
    name: 'Num of citations',
    yaxis: 'y1',
    type: 'scatter'
  };

  var data = [trace1];

  var layout = {
    yaxis: {
      title: 'Num of citations',
      }
  };
  Plotly.newPlot('myDiv1', data, layout);
</script>
<script>
var dataTableOptions = {
        initComplete: function () {
        this.api()
            .columns()
            .every(function () {
                let column = this;

                // Create select element
                let select = document.createElement('select');
                select.add(new Option(''));
                column.footer().replaceChildren(select);

                // Apply listener for user change in value
                select.addEventListener('change', function () {
                    column
                        .search(select.value, {exact: true})
                        .draw();
                });

                // keep the width of the select element same as the column
                select.style.width = '100%';

                // Add list of options
                column
                    .data()
                    .unique()
                    .sort()
                    .each(function (d, j) {
                        select.add(new Option(d));
                    });
            });
    },
    scrollX: true,
    scrollCollapse: true,
    paging: true,
    fixedColumns: true,
    columnDefs: [
        {"className": "dt-center", "targets": "_all"},
        // set width for both columns 0 and 1 as 25%
        { width: '7%', targets: 0 },
        { width: '30%', targets: 1 },
        { width: '25%', targets: 2 },
        { width: '15%', targets: 4 }

      ],
    pageLength: 10,
    layout: {
        topStart: {
            buttons: ['copy', 'csv', 'excel', 'pdf', 'print']
        }
    }
  }
  new DataTable('#table1', dataTableOptions);
  new DataTable('#table2', dataTableOptions);

  var table1 = $('#table1').DataTable();
  $('#table1 tbody').on('click', 'td:first-child', function () {
    var tr = $(this).closest('tr');
    var row = table1.row( tr );

    var rowId = tr.attr('id');
    // alert(rowId);

    if (row.child.isShown()) {
      // This row is already open - close it.
      row.child.hide();
      tr.removeClass('shown');
      tr.find('td:first-child').html('<i class="material-icons">visibility_off</i>');
    } else {
      // Open row.
      // row.child('foo').show();
      tr.find('td:first-child').html('<i class="material-icons">visibility</i>');
      var content = '<div class="child-row-content"><strong>Abstract:</strong> ' + rowId + '</div>';
      row.child(content).show();
      tr.addClass('shown');
    }
  });
  var table2 = $('#table2').DataTable();
  $('#table2 tbody').on('click', 'td:first-child', function () {
    var tr = $(this).closest('tr');
    var row = table2.row( tr );

    var rowId = tr.attr('id');
    // alert(rowId);

    if (row.child.isShown()) {
      // This row is already open - close it.
      row.child.hide();
      tr.removeClass('shown');
      tr.find('td:first-child').html('<i class="material-icons">visibility_off</i>');
    } else {
      // Open row.
      // row.child('foo').show();
      var content = '<div class="child-row-content"><strong>Abstract:</strong> ' + rowId + '</div>';
      row.child(content).show();
      tr.addClass('shown');
      tr.find('td:first-child').html('<i class="material-icons">visibility</i>');
    }
  });
</script>
<style>
  .child-row-content {
    text-align: justify;
    text-justify: inter-word;
    word-wrap: break-word; /* Ensure long words are broken */
    white-space: normal; /* Ensure text wraps to the next line */
    max-width: 100%; /* Ensure content does not exceed the table width */
    padding: 10px; /* Optional: add some padding for better readability */
    /* font size */
    font-size: small;
  }
</style>
</html>







  
  




  



                
              </article>
            </div>
          
          
<script>var target=document.getElementById(location.hash.slice(1));target&&target.name&&(target.checked=target.name.startsWith("__tabbed_"))</script>
        </div>
        
          <button type="button" class="md-top md-icon" data-md-component="top" hidden>
  
  <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M13 20h-2V8l-5.5 5.5-1.42-1.42L12 4.16l7.92 7.92-1.42 1.42L13 8v12Z"/></svg>
  Back to top
</button>
        
      </main>
      
        <footer class="md-footer">
  
  <div class="md-footer-meta md-typeset">
    <div class="md-footer-meta__inner md-grid">
      <div class="md-copyright">
  
  
    Made with
    <a href="https://squidfunk.github.io/mkdocs-material/" target="_blank" rel="noopener">
      Material for MkDocs
    </a>
  
</div>
      
    </div>
  </div>
</footer>
      
    </div>
    <div class="md-dialog" data-md-component="dialog">
      <div class="md-dialog__inner md-typeset"></div>
    </div>
    
    
    <script id="__config" type="application/json">{"base": "..", "features": ["navigation.top", "navigation.tabs"], "search": "../assets/javascripts/workers/search.b8dbb3d2.min.js", "translations": {"clipboard.copied": "Copied to clipboard", "clipboard.copy": "Copy to clipboard", "search.result.more.one": "1 more on this page", "search.result.more.other": "# more on this page", "search.result.none": "No matching documents", "search.result.one": "1 matching document", "search.result.other": "# matching documents", "search.result.placeholder": "Type to start searching", "search.result.term.missing": "Missing", "select.version": "Select version"}}</script>
    
    

      <script src="../assets/javascripts/bundle.c8d2eff1.min.js"></script>
      
    
<script>
  // Execute intro.js when a button with id 'intro' is clicked
  function startIntro(){
      introJs().setOptions({
          tooltipClass: 'customTooltip'
      }).start();
  }
</script>
<script>
  

  // new DataTable('#table1', {
  //   order: [[5, 'desc']],
  //   "columnDefs": [
  //       {"className": "dt-center", "targets": "_all"},
  //       { width: '30%', targets: 0 }
  //     ],
  //   pageLength: 10,
  //   layout: {
  //       topStart: {
  //           buttons: ['copy', 'csv', 'excel', 'pdf', 'print']
  //       }
  //   }
  // });

  // new DataTable('#table2', {
  //   order: [[3, 'desc']],
  //   "columnDefs": [
  //       {"className": "dt-center", "targets": "_all"},
  //       { width: '30%', targets: 0 }
  //     ],
  //   pageLength: 10,
  //   layout: {
  //       topStart: {
  //           buttons: ['copy', 'csv', 'excel', 'pdf', 'print']
  //       }
  //   }
  // });
  new DataTable('#table3', {
    initComplete: function () {
        this.api()
            .columns()
            .every(function () {
                let column = this;
 
                // Create select element
                let select = document.createElement('select');
                select.add(new Option(''));
                column.footer().replaceChildren(select);
 
                // Apply listener for user change in value
                select.addEventListener('change', function () {
                    column
                        .search(select.value, {exact: true})
                        .draw();
                });

                // keep the width of the select element same as the column
                select.style.width = '100%';
 
                // Add list of options
                column
                    .data()
                    .unique()
                    .sort()
                    .each(function (d, j) {
                        select.add(new Option(d));
                    });
            });
    },
    // order: [[3, 'desc']],
    "columnDefs": [
        {"className": "dt-center", "targets": "_all"},
        { width: '30%', targets: 0 }
      ],
    pageLength: 10,
    layout: {
        topStart: {
            buttons: ['copy', 'csv', 'excel', 'pdf', 'print']
        }
    }
  });
  new DataTable('#table4', {
    initComplete: function () {
        this.api()
            .columns()
            .every(function () {
                let column = this;
 
                // Create select element
                let select = document.createElement('select');
                select.add(new Option(''));
                column.footer().replaceChildren(select);
 
                // Apply listener for user change in value
                select.addEventListener('change', function () {
                    column
                        .search(select.value, {exact: true})
                        .draw();
                });

                // keep the width of the select element same as the column
                select.style.width = '100%';
 
                // Add list of options
                column
                    .data()
                    .unique()
                    .sort()
                    .each(function (d, j) {
                        select.add(new Option(d));
                    });
            });
    },
    // order: [[3, 'desc']],
    "columnDefs": [
        {"className": "dt-center", "targets": "_all"},
        { width: '30%', targets: 0 }
      ],
    pageLength: 10,
    layout: {
        topStart: {
            buttons: ['copy', 'csv', 'excel', 'pdf', 'print']
        }
    }
  });
</script>


  </body>
</html>